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Abstract 
 
Arterial occlusive diseases are major causes of morbidity and mortality in 
industrialized countries and represent a huge economic burden. The extent of the 
native collateral circulation is an important determinant of blood perfusion 
restoration and therefore the severity of tissue damage and functional impairment 
that ensues following arterial occlusion. Understanding the mechanisms 
responsible for collateral artery development may provide avenues for 
therapeutic intervention. Here, we identify a critical requirement for mixed lineage 
kinase (MLK) – cJun-NH2-terminal kinase (JNK) signaling in vascular 
morphogenesis and native collateral artery development. We demonstrate that 
Mlk2-/-Mlk3-/- mice or mice with compound JNK-deficiency in the vascular 
endothelium display abnormal collateral arteries, which are unable to restore 
blood perfusion following arterial occlusion, leading to severe tissue necrosis in 
animal models of femoral and coronary artery occlusion. Employing constitutive 
and inducible conditional deletion strategies, we demonstrate that endothelial 
JNK acts during the embryonic development of collateral arteries to ensure 
proper patterning and maturation, but is dispensable for angiogenic and 
arteriogenic responses in adult mice. During developmental vascular 
morphogenesis, MLK – JNK signaling is required for suppression of excessive 
sprouting angiogenesis likely via JNK-dependent regulation of Dll4 expression 
and Notch signaling. This function of JNK may underlie its critical requirement for 
native collateral artery formation. Thus, this study introduces MLK – JNK 
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signaling as a major regulator of vascular development. 
 
In contrast, we find that JNK in hematopoietic cells, which are thought to share a 
common mesodermally-derived precursor with endothelial cells, is cell-
autonomously dispensable for normal hematopoietic development and 
hematopoietic stem cell self-renewal, illustrating the highly context dependent 
function of JNK.  
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Introduction 
 
 
 
 
 
 
 
 
                                                                                                                                                                                                                                                                         
 
2 
cJUN NH2-TERMINAL KINASES (JNK) 
JNK belongs to the group of stress and mitogen activated protein kinases 
(MAPK) that mediate pleiotropic cellular responses to diverse environmental 
stimuli.1 
MAPK Signal Transduction 
Cells respond to environmental stimuli by activating diverse signal transduction 
cascades that sense, process and relay outside information into the cell in order 
to generate appropriate biological responses. Among the many signaling 
pathways that cooperate in this process, the family of mitogen activated protein 
kinases (MAPK) encompasses groups of signal transduction pathways that are 
highly conserved and play important pleiotropic roles in many biological 
processes.1-3 These signaling pathways are regulated through three-tiered kinase 
signaling cascades whereby a MAPK is activated through phosphorylation by a 
MAPK kinase (MAPKK, MKK or MAP2K), which is, in turn, activated through 
phosphorylation by a MAPKK kinase (MAPKKK or MAP3K; Figure I.1).1 In 
mammals, three groups of MAPK have been identified and include the 
extracellular regulated kinases (ERK), the p38 kinases and the cJun NH2-
terminal kinases (JNK), also known as stress-activated protein kinases (SAPK). 
Each MAPK is activated by dual phosphorylation of a tripeptide motif (Thr-Glu-
Tyr for ERK, Thr-Gly-Tyr for p38 and Thr-Pro-Tyr for JNK).1,4 The specific 
MAP2K that phosphorylate each MAPK have been well characterized. Thus, 
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MKK1, 2 and 5 phosphorylate ERK, MKK3 and 6 phosphorylate p38 (with some 
contribution from MKK4) and MKK4 and MKK7 phosphorylate JNK.1,2 However, 
the situation is much more complex with regard to the specific MAP3K that 
participate in the activation of different MAPK pathways in specific contexts in 
vivo. Particularly for p38 and JNK, the MAP3K that have been implicated in their 
activation include over a dozen members from heterogeneous families. For 
example, the MEK kinases (MEKK 1-4), the transforming growth factor (TGF)-β-
activated kinase 1 (TAK1), the tumor progression locus-2 (TPL-2), the apoptosis 
stimulating kinases (ASK1 and 2) and the mixed-lineage kinase group (MLK1-4, 
DLK and LZK) have all been shown to activate JNK or its upstream activators 
MKK4 and/or MKK7 in overexpression or in vitro kinase assays.1,2 However, the 
relevance of these MAP3K as physiologic regulators of the JNK pathway has 
only been established for a few members.  
One example is illustrated by the MAP3K, MLK2 and MLK3, for which 
biochemical and genetic data in primary cells and mice has confirmed their 
physiologically important role for JNK activation by tumor necrosis factor (TNF) 
as well as JNK activation mediated by saturated fatty acids.5,6 In contrast, MLK3 
was found to be dispensable for JNK activation by some stress stimuli, including 
ultraviolet light (UV), Anisomycin or Ceramide and by some growth factors such 
as platelet-derived growth factor (PDGF) or epidermal growth factor (EGF).7 
These studies illustrate two important points regarding MAP3K. First, they 
demonstrate that there is functional redundancy between different MAP3K family 
                                                                                                                                                                                                                                                                         
 
4 
members. Thus, combined disruption of both Mlk2 plus Mlk3 results in greater 
defects in JNK activation by TNF than disruption of Mlk3 alone.5 Second, they 
demonstrate the existence of some degree of specificity of particular MAP3K 
members for certain stimuli. These characteristics of MAP3K may provide 
avenues for targeted modulation of the MAPK signaling pathways for therapeutic 
benefit.  
JNK structure, regulation and function 
In mammals, the JNK group of MAPK includes proteins encoded by three 
separate genes.1 Jnk1 and Jnk2 are ubiquitously expressed, whereas Jnk3 
displays a much more restricted pattern of expression confined largely to the 
brain, heart and testis.1 Alternative splicing of the messenger RNA (mRNA) 
transcripts from the three Jnk genes generates ten different Jnk isoforms (Figure 
I.2).3 One alternative splicing site involves selection of one of two alternative 
exons that encode part of the kinase domain. This splice site is restricted to Jnk1 
and Jnk2, and gives rise to JNK isoforms with different substrate binding 
specificities. The second splice site at the COOH-terminus of the protein results 
in proteins that differ by 42 or 43 amino acids.3 
 
Although functional differences between different Jnk isoforms from the same 
gene transcript have not yet been characterized, significant functional 
redundancy exists between Jnk isoforms from different gene transcripts. This is 
illustrated by the analysis of mice with genetic ablation of different Jnk genes. 
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Thus, mice with disruption of single Jnk genes are viable and appear 
morphologically normal, however combined disruption of both Jnk1 plus Jnk2 
results in embryonic lethality at midgestation due to neural tube closure defects.8 
Tissue specific roles for the ubiquitously expressed Jnk1 and Jnk2 genes have 
also been reported,9 but this may reflect the particular isoform distribution profile 
from each gene transcript rather than bona fide differences between Jnk1 and 
Jnk2 isoforms.  
 
As described above, JNK is fully activated through phosphorylation by the 
upstream MAP2 kinases MKK4 and MKK7. Both kinases can activate JNK by 
dual phosphorylation on Thr and Tyr residues, however some degree of 
specificity is conferred via activation of MKK4 or MKK7 by MAP3K in different 
contexts. For example, stimulation by various cytokines preferentially activates 
MKK7, whereas some environmental stress stimuli primarily activate MKK4.10 
 
Additional layers of regulation of the JNK signaling pathway are afforded by 
Ser/Thr phosphatases, Tyr phosphatases or dual specificity phosphatases that 
can dephosphorylate and inactivate JNK.1 Furthermore, scaffold proteins 
including JNK-interacting protein (JIP1, 2 and 3) have been identified that 
organize MAPK modules incorporating a MAP3K, a MAP2K and a MAPK, thus 
facilitating their interaction leading to modulation of MAPK activity.1   
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Upon activation, JNK phosphorylates Ser/Thr-Pro motifs on numerous proteins 
that include transcription factors and cytoplasmic proteins. JNK phosphorylates 
several members of the activator protein 1 (AP-1) transcription factor complex, 
including cJun, JunB and activating transcription factor 2 (ATF2).1 Indeed, JNK1 
was molecularly cloned as a protein kinase, activated by UV and Ha-Ras, that 
binds and phosphorylates the activation domain of cJun.11 JNK-mediated 
phosphorylation of cJun on Ser-63 and Ser-73 promotes the transcriptional 
activity of the AP-1 transcription complex resulting in gene expression changes 
that often underlie the multitude of biological processes that are regulated by 
JNK, including its role in cancer and metabolism.12,13 In addition, JNK has been 
reported to phosphorylate a number of cytoplasmic targets. These include p53, 
cMyc, and Itch, several B-cell CLL/lymphoma 2 (BCL-2)-family members, 
including the anti-apoptotic factors BCL-2, BCL-XL and myeloid cell leukemia 
(MCL-1), and the pro-apoptotic factors BCL-2-interacting mediator of cell death 
(BIM), BCL-2-modifying factor (BMF), BH3-interacting domain death agonist 
(BID) and BCL2-associated agonist of cell death (BAD), among other 
cytoplasmic proteins.1,12 Thus, through its effects on gene transcription and direct 
phosphorylation of cytoplasmic proteins, JNK affects many biological processes 
from apoptosis and cell survival to embryonic development, inflammation, 
metabolism and cancer. 
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Role of JNK in cell death and survival 
The role of JNK in cell death and survival is complex and highly context 
dependent. The time course of JNK activation appears to have a significant 
impact.14 Thus, in mouse embryonic fibroblasts (MEF), sustained JNK activation 
by TNF, particularly in the context of nuclear factor (NF)-κB inhibition can induce 
apoptosis, whereas transient JNK activation is required for cell survival.14 
Treatment of cells with TNF causes a biphasic JNK activation response. The 
early phase of JNK activation is robust and appears to signal a JunD-dependent 
survival response that also requires cooperation with the NF-κB and AKT 
pathways.14,15 This response is thought to involve AP-1-mediated enhancement 
of anti-apoptotic gene expression by NF-κB and AKT signaling.2 The late phase 
of JNK activation appears to contribute to cell death when pro-survival signaling 
by NF-κB is inhibited.16 This role of JNK may be mediated by its ability to 
promote TNF-induced production of reactive oxygen species (ROS).17,18  
 
In hepatocytes, another mechanism proposed for a JNK1-dependent TNF-
induced increase in cell death is the ability of JNK1 to phosphorylate and activate 
the E3 ubiquitin ligase Itch.19 This was shown to promote apoptosis via Itch-
mediated ubiquitination and proteasomal degradation of the NF-κB-induced anti-
apoptotic protein c-FLIP, an inhibitor of caspase-8. Because Itch phosphorylation 
is reversible, the authors proposed that sustained JNK activity was required to 
maintain pro-apoptotic signaling in this context.19 
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JNK may also promote cell death by mediating induction of the mitochondrial 
apoptotic pathway.1,12 Indeed, compound deficiency of Jnk1 plus Jnk2 or Mkk4 
plus Mkk7 in MEF causes defects in the stress-induced apoptosis response in 
these cells.10,20 This may be due to alterations in the release of mitochondrial 
pro-apoptotic factors, including cytochrome c, that have been attributed to the 
ability of JNK to phosphorylate and either inhibit or activate the function of 
various BCL-2 family members.1,12 
 
MCL-1 is one such pro-survival factor that may function by binding to and 
sequestering the pro-apoptotic factor BAK in an inactive complex.21 JNK 
phosphorylates MCL-1 priming it for phosphorylation by glycogen synthase 
kinase 3 (GSK3), an event that promotes stress-induced MCL-1 proteasomal 
degradation.22 Thus, JNK-mediated MCL-1 degradation may allow the pro-
apoptotic function of BAK to proceed unhindered. JNK may also promote the 
function of other pro-apoptotic BCL-2 family members, including BIM and BMF by 
direct phosphorylation.1,12  
 
As the above discussion illustrates, stress-induced JNK activity, in general, has 
been associated with promotion of apoptosis and cell death with the exception 
that early transient JNK activation may contribute to cell survival.14 Additional 
evidence exists implicating JNK in survival responses. This role of JNK is 
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supported by studies showing that survival signals transduced by integrin 
engagement in fibroblasts following growth factor removal are mediated by a 
Ras/Rac1/PAK1/MKK4/JNK signaling pathway.23 Furthermore, survival signals 
during in vitro or in vivo BCR-ABL transformation of B lymphoblasts may be 
mediated by JNK1-dependent Bcl2 expression as defective transformation of 
Jnk1-/- lymphoblasts was associated with reduced Bcl2 expression, and 
transgenic restoration of Bcl2 levels rescued the defective transformation of Jnk1-
/- lymphoblasts.24 Perhaps the most compelling evidence supporting a role for 
JNK in cell survival comes form the analysis of compound mutant Jnk1−/−Jnk2−/− 
embryos, which exhibit defects in apoptosis in certain regions of the hindbrain 
during embryonic development.8 Interestingly, regions of the forebrain showed 
increased apoptosis.8 Thus, JNK may mediate both pro-survival and pro-
apoptotic responses during embryonic development depending on the specific 
cell types and likely developmental timing.    
Role of JNK during embryonic development 
The essential function of JNK during embryogenesis is underscored by the early 
embryonic death of compound mutant Jnk1−/−Jnk2−/− mouse embryos.8 This is 
likely in part due to the aforementioned perturbations in apoptotic responses in 
the developing brain that contribute to defective nervous system morphogenesis 
and exencephaly.8 In addition to its role in cell death and survival, JNK has 
important functions in cell and tissue morphogenesis via its effects on the actin 
cytoskeleton, cell polarity and cell migration. Some of the functions of JNK in cell 
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and tissue morphogenesis are evolutionarily conserved. In Drosophila 
melanogaster, JNK is required for dorsal closure, a major morphogenetic process 
whereby lateral epithelia from the two sides of the embryo come together to seal 
a dorsal hole.25 This process depends on actin cytoskeleton rearrangements that 
drive epithelial sheet movements and has many parallels with the neural tube 
closure process in vertebrates.25 In the absence of JNK, dorsal closure does not 
proceed normally resulting in a dorsal open phenotype. Two transcriptional 
targets of JNK, the TGF-β-related factor and BMP4 ortholog, Decapentaplegic 
(Dpp), and the dual specificity phosphatase, Puckered (Puc), whose expression 
is absent in JNK mutants, are required for proper dorsal closure 
morphogenesis.25 JNK also regulates convergent extension movements during 
gastrulation both in Drosophila and Xenopus.26 The process of convergence 
extension involves a series of highly coordinated movements that contribute to 
the formation of the body axis.26 JNK regulates this process through its 
involvement in the non-canonical Wnt/planar cell polarity (PCP) pathway.26,27  
 
Furthermore, in mice, in addition to its role in neural tube closure, JNK is also 
important for a number of other morphogenetic processes. The presence of one 
allele of Jnk2 in Jnk1-/-Jnk2+/- mice overcomes the embryonic death of Jnk1-/-
Jnk2-/- mice and allows the study of additional processes during mouse 
embryonic development.28,29 Jnk1-/-Jnk2+/- mice display defects in epithelial 
development in the skin, intestines and lung as well as optic fissure and eyelid 
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closure defects.28,29 Perturbations in epidermal growth factor (EGF) expression 
and EGF receptor function may underlie the eyelid closure defects in Jnk1-/-
Jnk2+/- mice,28 while the optic fissure closure defects were attributed to a JNK-
dependent decrease in bone morphogenetic protein 4 (BMP4, an ortholog of 
Drosophila Dpp) expression in the retina.29 Thus, JNK intersects with a number 
of signaling pathways to regulate developmental processes important for 
morphogenesis and maturation of various tissues and organs.  
 
 
THE VASCULAR SYSTEM 
 
Evolutionary History of the Blood Circulatory System 
The rise of multicellular organisms required a system that would overcome the 
time-distance constraints of diffusion and allow efficient gas exchange, 
distribution of necessary factors and removal of metabolic waste products from 
all cells of the organism. In all, but the most primitive metazoans, these vital 
tasks are facilitated by the circulatory system, an interconnected network of 
chambers and channels that permeates virtually all tissues bringing necessary 
factors within a few microns from all cells in organisms as small as mites and as 
large as whales.30 
Circulatory systems can be classified as open, found in arthropods (e.g. insects 
and crustaceans) and non-cephalopod mollusks (e.g. snails, slugs and clams) or 
closed, present in all other metazoans.30 Open circulatory systems consist of a 
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contractile heart and major vessels that open into the body cavity (or hemocoel), 
which is lined by the basal surface of tissue cells. Blood (called hemolymph) 
empties from the major supply vessels and heart into the hemocoel, where it 
bathes all organs. In this case, there is no physical separation and thus no 
distinction between hemolymph and interstitial/extracellular fluid. By contrast, in 
closed circulatory systems, blood remains inside channels and chambers and is 
physically separated from the interstitial fluid and tissue cells. Exchange of 
gases, nutrients and other factors between blood, the interstitium and tissue cells 
in this case occurs in capillary plexi, specialized, thin walled regions of the 
circulatory system network that facilitate diffusion.30 
The closed circulatory system of invertebrates consists of channels that are lined 
by the extracellular matrix of basement membranes of tissue epithelia. 
Vertebrates, on the other hand, have blood vessels that are lined by 
endothelium, a specialized monolayer of mesodermally derived cells with apico-
basal polarity. Intercellular junctions define the boundary between the apical side 
facing the lumen of vessels from the basolateral side which rests on a basement 
membrane surrounding all vessels.  
Development of the Circulatory System 
The cardiovascular system is essential for the development and survival of the 
organism and is the first system that forms during organogenesis.31 In 
vertebrates, vascular development starts with the emergence of angioblasts from 
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the primitive streak, which in mice occurs around embryonic day (E) 
7.5.  Angioblasts are fetal liver kinase 1 [FLK-1, also known as kinase insert 
domain receptor (KDR) or vascular endothelial growth factor receptor (VEGFR)-
2, the major receptor for VEGF-A] positive, Brachyury positive mesodermal 
precursors that migrate to the extra embryonic yolk sac, where they coalesce to 
form a network that includes clusters known as blood islands.31-33 The inner cells 
within blood islands will give rise to primitive hematopoietic precursors that 
initiate erythropoiesis. The outer cells of blood islands are endothelial cells that 
form the extra embryonic vasculature. Concurrently, in the embryo proper, 
angioblasts aggregate to form primitive vascular cords and plexi, a process 
known as vasculogenesis. These primitive vascular structures will subsequently 
lumenize and form the dorsal aorta and cardinal vein, which join the primitive 
heart tube creating the basis for the future circulatory system.31-33 
 
Following formation of primary plexi via vasculogenesis in the yolk sac and 
embryo, the vasculature continues to expand via sprouting of new vessels from 
these preexisting plexi, a process known as angiogenesis. Thus, while initial 
vessels form via direct differentiation of precursors into endothelial cells, most of 
the embryonic vasculature expands via sprouting, migration, and proliferation of 
existing endothelial cells.34  
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The retinal vasculature as a model for studying sprouting angiogenesis 
Many of the detailed aspects of the angiogenic sprouting process have been 
studied during the postnatal development of the retinal vasculature in mice.35 
This system offers unique advantages for exploring the intricate cellular and often 
molecular mechanisms of vascular development as it allows detailed analysis of 
sprouting angiogenesis in a relatively easily accessible tissue that is avascular at 
birth. Vascularization of the retina in mice occurs in the first few weeks of 
postnatal life. Extension of the retinal vascular plexus proceeds initially (P0 to 
~P9) on the inner surface of the retina in a highly stereotypic fashion from the 
center of the retina towards the periphery in two dimensions (Figure I.3) This 
enables high-resolution analysis of many cellular and molecular aspects of 
sprouting angiogenesis, including tip/stalk cell specification, extension of filopodia 
and formation of endothelial cell-to-cell junctions as well as vascular progression, 
branching morphogenesis, and maturation processes such as vascular pruning 
and mural cell recruitment.36 
 
Sprouting angiogenesis – an interplay of tips and stalks 
Angiogenesis starts when endothelial cells within the wall of existing vessels 
receive the appropriate signals from the extracellular environment, acquire high 
migratory ability and emerge (or sprout) away from the main body of a vessel 
while maintaining contact with other endothelial cells lining the vessel. Sprouting 
endothelial cells are called tip cells. They are highly motile cells with low 
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proliferative capacity that elaborate numerous filopodia and guide the extension 
of the newly forming vascular plexus. Endothelial cells trailing tip cells are 
referred to as stalk cells. They have fewer filopodia and low migratory, but high 
proliferative capacity and form the stalk (or body) of the growing nascent 
vessel.37-39      
At the growing edge of the vascular plexus, filopodia and other protrusions of tip 
cells in close proximity often encounter each other and appear to fuse together, 
forming a bridge-like structure that may represent the beginning of the formation 
of a new tubule that will subsequently incorporate endothelial cell bodies, 
lumenize and become a new addition to the developing plexus. The emergence 
of new endothelial cell sprouts from the body of the nascent tubule will result in a 
new round of sprouting, fusion, bridge formation and tubulogenesis, ensuring 
further extension of the developing plexus. Thus, the formation of an initial 
immature vascular network involves multiple rounds of sprouting and 
tubulogenesis. VEGF signaling is at the core of this angiogenic sprouting 
processes.37-39     
 
VEGF – VEGFR signaling 
VEGF-VEGFR signaling is critical for many aspects of the angiogenic sprouting 
process. In mammals, three VEGFRs (VEGFR1 [also known as fms-related 
tyrosine kinase 1 (FLT1), VEGFR2 and VEGFR3 [also known as FLT4]) and five 
VEGFR ligands, VEGF-A, B, C, D and placenta growth factor (PLGF) have been 
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identified.40 Further complexity in this signaling system is added by the existence 
of multiple splice variants of the different receptors and ligands. These ligands 
and receptors, and the ligand-receptor complexes that they form have been 
demonstrated to display both common and unique signaling properties that affect 
a multitude of processes during vascular development.40 This is accomplished 
via the interaction of activated VEGFRs with numerous components of a variety 
of other signaling pathways, leading to the modulation of their signaling output, 
and thus, the regulation of various processes, including endothelial cell 
proliferation, survival and migration as well as regulation of cell-to-(cell or 
extracellular matrix) adhesion and vascular permeability. VEGFRs belong to the 
superfamily of receptor tyrosine kinases. Upon binding VEGF ligands, VEGFRs 
undergo homo or heterodimerization and autophosphorylation at various tyrosine 
(Y) residues that facilitate interaction with a variety of proteins resulting in 
activation of signaling pathways including PI3K / AKT and PI3K / Rac1, and Ras / 
MEK / ERK, among others.40 In contrast to VEGFR2, which has high kinase 
activity, VEGFR1 displays strong binding to VEGF ligands, but has low kinase 
activity and is thought to antagonize the function of VEGFR2 by competing for 
VEGF ligands. Soluble forms of VEGFR1 have also been identified and act as a 
sink for VEGF, contributing to the regulation of VEGF bioavailability.40 The most 
studied and best understood of the VEGF–VEGFR signaling interactions is that 
between VEGF-A and VEGFR2.  
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VEGF – VEGFR signaling drives sprouting angiogenesis 
In the retina, VEGF-A is produced in part by an astrocytic network in the initially 
avascular retina and forms a chemoatractive gradient that guides the extension 
of the developing vascular plexus, while ensuring endothelial cell survival, 
proliferation and migration.37-39 Specifically, VEGF-A signaling via VEGR2 guides 
the migration of endothelial tip cells into a new sprout and stimulates extension of 
filopodia from these cells without stimulating proliferation.41 VEGF-A – VEGFR2 
signaling in stalk cells, however, stimulates their proliferation. This response is 
dependent on the concentration of VEGF-A. Thus, VEGF-A – VEGFR2 signaling 
mediates different cellular responses in distinct endothelial cell populations within 
the developing vascular plexus.41 How does the same VEGF signaling pathway 
specify distinct cell fates and responses in endothelial cells that are in physical 
contact and interacting with each other? These distinct responses in neighboring 
endothelial cells are largely defined by VEGF-mediated regulation of Notch 
signaling. 
 
Notch signaling  
(Refer to Figure I.4) 
In mammals, four receptors (Notch1-4) that interact with five canonical Notch 
ligands, namely Delta-like1 (Dll1), Delta-like3 (Dll3), Delta-like4 (Dll4), Jagged1 
(Jag1) and Jagged2 (Jag2) collectively referred to as DSL (after the invertebrate 
Delta and Serrate/Lag2 proteins) have been identified.37-39 Notch receptors and 
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their DSL ligands are transmembrane proteins that contain extracellular domains 
with numerous epidermal growth factor (EGF) repeats.37-39 Therefore, canonical 
Notch signaling requires direct physical contact between the cell expressing the 
ligand and that expressing the receptor.   
 
Notch receptors are synthesized as single polypeptide precursors, which 
following fucosylation by the enzyme Protein O-fucosyl transferase (POFUT1), 
undergo cleavage by the protease Furin in the trans-Golgi network generating 
the non-covalently linked Notch extracellular and intracellular domains (NECD 
and NICD, respectively). Upon ligand binding, Notch receptors undergo two 
additional proteolytic cleavage events. First, the NECD is cleaved at the juxta-
membrane region by a member of the a disintegrin and metalloprotease (ADAM) 
family and trans-endocytosed coupled to the ligand. Second, due to NECD 
cleavage and/or protein conformational changes imparted by NECD endocytosis 
into the ligand-presenting cell, the remaining Notch subunit becomes susceptible 
and is cleaved by γ-secretase within the transmembrane region, thus, releasing 
the NICD from the membrane. NICD translocates into the nucleus where it 
interacts with the transcription factor RBP-J (also known as CSL, named after 
mammalian CBF1, Drosophila Su(H), and Caenorhabditis elegans LAG1), 
displaces corepressors and forms a transcription complex that includes the 
coactivator Mastermind-like (Maml) and histone acetyltransferases (e.g. P300) 
driving transcription of Notch target genes such as the basic helix-loop-helix 
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(bHLH) proteins Hairy/Enhancer of Split (Hes) and Hes-related proteins (Hey).37-
39  
 
In addition to POFUT1-mediated fucosylation and sequential cleavage events, 
this pathway is regulated by a number of other receptor and ligand modifications. 
Thus, Notch receptors can be further glycosylated on several EGF repeats by 
Fringe glycosyltransferases (3 in mammals, Lunatic Fringe [LFNG], Manic Fringe 
[MFNG] and Radical Fringe [RFNG]), a modification that potentiates pathway 
activation by Delta-like ligands. Furthermore, the NICD can be ubiquitinated by 
the HECT domain E3 ligases Suppressor of deltex [Su(dx)] and Neural precursor 
cell expressed, developmentally down-regulated 4 (NEDD4) leading to Notch 
degradation and inhibition of signaling. In contrast, ubiquitination by the ring 
finger E3 ligase Deltex can antagonize Su(dx) and lead to either enhanced or 
decreased Notch signaling depending on the organism and cell type.37-39 
 
Largely via unknown mechanisms, ubiquitination of DSL ligands by the E3 
ligases Neuralized (Neurl) and Mind bomb (Mib) is important for ligand activation, 
and interaction with the ubiquitin-binding protein Epsin is required for full Notch 
pathway activity.37-39 
 
Collectively, these multiple and diverse layers of regulation ensure tight control of 
Notch signaling output as both decreased and enhanced pathway activity can 
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have dramatic consequences on cell fate specification, tissue morphogenesis 
and organismal survival.   
     
VEGF and Dll4 – Notch signaling interactions specify tip/stalk cell selection and 
vascular morphogeneis 
In the vascular endothelium, Notch signaling is crucial for tip/stalk cell 
specification, vascular morphogenesis and arterial identity. Endothelial cells 
express Notch receptors 1, 2 and 4, and the ligands Dll1, Dll4 and Jag1.37-39 
During sprouting angiogenesis, hypoxia and VEGF signaling upregulate Dll4 
expression in tip cells leading to increased Notch signaling in adjacent cells.37-39 
Enhanced Notch signaling in endothelial cells results in downregulation of 
VEGFR242,43 and VEGFR344 (and reportedly upregulation of VEGFR1),43 and 
thus, reduced VEGF responsiveness and suppression of sprouting activity, 
including decreased migration capacity and reduced numbers of filopodia; 
effectively defining them as stalk cells. In addition to VEGF signaling, Dll4 
expression is also positively controlled by Notch signaling.37,45 This suggests that 
the identity of endothelial cells as tips and stalks is not static, but highly dynamic. 
Indeed, it is thought that endothelial cells constantly compete for the tip cell 
position through the interaction of VEGF and Notch signaling.45 A balance 
between formation of new tip cells that guide the extension of the vascular plexus 
and stalk cells that proliferate and enable the growth of the tubular network must 
be established in order to maintain normal vascular patterning.  
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Perturbations in Notch signaling in endothelial cells result in dramatically altered 
vascular morphogenesis. Specifically, loss of Dll4,46 Notch1,46 LFNG,47 RBP-
J48,49 or chemical inhibition of γ-secretase with N-[N-(3,5–Difluorophenacetyl- L-
alanyl)]-S-phenylglycine t-butyl ester (DAPT)46 leads to reduced Notch signaling 
in endothelial cells and results in excessive sprouting angiogenesis, increased  
branching and density, and abnormal vascular patterning. In contrast, transgenic 
NICD overexpression50 or loss of Jag147 (which has weak signaling capacity, 
competes with Dll4 for Notch receptors and has pro-angiogenic functions)47 
results in decreased sprouting, branching and vascular density.   
Sprouting angiogenic processes driven by VEGF and Notch signaling initially 
result in formation of immature vascular networks lined only by endothelium. 
These pathways and their interaction with many others, including the ephrin-Eph 
receptor pathway, the transforming growth factor (TGF)-β pathway, the Wnt – β-
catenin pathway, the Slit – roundabout (Robo) pathway and the angiopoietin 
(Ang) – TIE pathway also play important roles in the continued patterning, 
remodeling and maturation of the vasculature.51-56 These processes include 
stabilization of intercellular junctions, branching, tubulogenesis, pruning of 
excess vessels and recruitment of supporting mural cells including pericytes and 
smooth muscle cells resulting in the formation of mature hierarchical networks; 
and upon further specialization, the formation of distinct arteries, veins and 
capillaries that have unique structural and functional characteristics.51-56 
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General Characteristics of the Circulatory System 
Vessels are tubular structures with walls composed of layers (or tunics). The 
luminal side of all vessels is lined by a monolayer of endothelial cells that is 
supported on the basal side by the basement membrane, an extracellular matrix 
layer consisting mostly of collagen and laminin. Capillary walls are lined only by 
endothelium, the basement membrane and interspersed pericytes that are 
located on the abluminal side. Arteries and veins have a more complex structure 
encompassing three distinct tunics. The endothelial/basement membrane layer 
constitutes the tunica intima. Encircling the tunica intima are several concentric 
layers of smooth muscle cells and elastic fibers that make up the tunica media. 
The media varies in thickness between arteries and veins as well as the size of 
the vessel. Arteries have thicker tunica medias with more smooth muscle and 
elastic fibers compared to veins. A third layer, the tunica externa, surrounds the 
media and is composed of fibroblasts interspersed within a matrix of connective 
tissue. 
 
By definition, arteries are vessels that take blood away from the heart and 
distribute it to peripheral tissues; in contrast, veins bring blood back to the heart. 
Thus, the arterial system is a high-pressure system as it is immediately 
downstream of the pumping action of the heart, and hence has evolved structural 
characteristics that allow it to not only withstand high pressures, but also regulate 
arterial pressure by altering lumen diameter via selective contraction and dilation 
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of the vascular wall. As large arteries travel towards peripheral tissues, they 
branch extensively into smaller caliber arteries and arterioles, progressively 
losing smooth muscle cell coverage. Small arterioles continue into capillary beds, 
where exchange of gas, nutrients, numerous other factors and metabolic waste 
products between blood and the extracellular fluid occurs. Capillaries merge to 
form postcapillary venules, which join larger venules that start to reacquire 
smooth muscle cell coverage. Venules join larger veins that eventually return 
blood to the heart, completing the systemic circulatory loop.  
 
In addition to the typical arrangement (artery>arteriole>capillary>venule>vein) 
described above, many, if not all tissues and organs, including skeletal muscle, 
heart, brain, skin and intestine display an alternative arrangement of arteries and 
arterioles consisting of direct artery-to-artery or arteriole-to-arteriole 
interconnection without an intervening capillary bed. These vessels are called 
collaterals.57,58 
 
Importance of the Collateral Circulation 
Collateral arteries interconnect adjacent arterial trees (Figure I.5). Normally, there 
is little blood flowing through collateral arteries due to the lack of a pressure 
gradient between the two ends of the vessel and their relatively narrow lumen.58 
The function of collateral vessels under normal physiological conditions remains 
unclear, however, their vital importance during vasoocclusive disease, including 
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myocardial infarction, stroke and peripheral artery disease has been 
demonstrated in numerous human studies and experimental animal models.59-63 
During certain pathological states, atherosclerotic and/or thromboembolic events 
can result in partial or complete occlusion of one or more arteries. The ensuing 
ischemia and hypoxia in tissues supplied by the occluded artery can have major 
detrimental consequences on the health and function of the affected tissue or 
organ. If blood flow, and therefore nutrients and oxygen are not restored within a 
short period of time, irreversible necrotic damage will ensue. In these 
circumstances, the native (pre-existing) collateral circulation can provide an 
alternative route for blood flow restoration to the affected region from an adjacent 
artery (Figure I.5), thus reestablishing tissue homeostasis and limiting ischemic 
damage.58  
 
Native Collateral Artery Development 
Few studies, almost exclusively from the Faber group, have traced the formation 
of native collateral arteries during ontogeny. These studies have focused on the 
development of leptomeningeal (or pial) collaterals that interconnect the medial, 
anterior and posterior cerebral artery trees in the brain and have provided 
evidence that these collaterals form during embryonic development starting 
~E13.5 as sprout-like extensions of endothelial cells from arterioles of existing 
cerebral artery trees.61 These nascent vessels appear to course above the pial 
capillary plexus and fuse with an arteriole from an adjacent arterial tree.61 By 
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E15.5 a portion of these collaterals have acquired expression of the arterial 
marker EphrinB2.64 Pial collateral density peaks ~E18.5 and is followed by 
extensive remodeling, maturation and pruning that continues postnatally, 
achieving adult form and density by P21.64 The process of collateral artery 
formation during embryonic development has been termed collaterogenesis.57,65     
 
There is extensive variability in the extent (i.e., number and size) of the native 
collateral circulation both in humans66-73 and between different mouse strains74-76, 
which correlates negatively with the magnitude of tissue damage following 
arterial occlusion. For example, the C57BL/6 is a strain that displays large 
collaterals and high collateral artery density; in contrast the BALB/c strain has 
fewer, smaller collaterals.74-76 In models of arterial occlusion, including femoral 
artery (FA)74,75 and medial cerebral artery (MCA)76 ligation, C57BL/6 mice show 
lower reductions in blood flow, faster and higher blood flow restoration and 
therefore milder ischemic sequelae compared to the BALB/c strain. Both genetic 
and environmental factors are thought to contribute to the variability in the extent 
of the collateral circulation, and some of the specific genetic determinants that 
influence native collateral artery development are beginning to be uncovered.  
 
Early clues regarding one of these genetic factors came from differential gene 
expression analysis between the C57BL/6 and BALB/c strains of mice.64,74 The 
higher number and size of pial collaterals in C57BL/6 mice correlated with higher 
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expression of VEGF-A in the collateral zone of this strain compared to that of the 
low collateral BALB/c strain.64,74 Subsequent studies utilizing VEGFlo/+, VEGFhi/+, 
VEGFR1+/- and VEGFR2+/- mice provided further evidence of the intimate 
involvement of the VEGF signaling pathway in native collateral artery 
development.61,77   
 
Several other studies have identified additional proteins that affect formation of 
the native collateral circulation including, endothelial nitric oxide synthase 
(eNOS),62 prolyl hydroxylase domain-containing protein 2 (PHD2),78 chloride 
intracellular channel 4 (CLIC4),65 platelet-endothelial cell adhesion molecule 1 
(PECAM1),79 gap junction protein connexin37 (Cx37),80,81 and the Notch ligand 
Dll4.82 Furthermore, genetic linkage analysis of F2 progeny from C57BL/6 x 
BALB/c crosses has identified quantitative trait loci (QTL) for collateral density 
and diameter.83-85 One QTL on chromosome 7 in mice appears to account for the 
majority of the collateral differences between these two strains.83,85 This QTL, 
originally named Candq1, has recently been refined from 27 to 0.737 Mb with full 
retention of the effect and is now designated as determinant of collateral extent 1 
(Dce1).85 Introgression of Dce1 into BALB/c restores collateral extent and 
rescues blood perfusion in models of FA and MCA occlusion in this low collateral 
strain to levels approaching those present in C57BL/6 mice.85 Interestingly, Dce1 
introgression into BALB/c restores pial collateral extent more efficiently (85% of 
C57BL/6) than muscle collaterals (55% of C57BL/6)85 suggesting that collateral 
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formation in different tissues is regulated by both common and distinct 
mechanisms. Clearly, much remains to be uncovered about the factors, signaling 
pathways and mechanisms that determine native collateral artery formation.    
 
Arteriogenesis 
In contrast to the paucity of studies on the mechanisms that drive native 
collateral artery development, arteriogenesis, the process of outward remodeling 
of narrow preexisting collaterals into functional conduits upon vascular occlusion, 
is a much more scrutinized process. This is in part likely due to smaller technical 
challenges, but most importantly propelled by the realization that enhancing 
arteriogenesis may provide better therapeutic benefit in vascular occlusive 
diseases compared to enhancing angiogenesis, which has been the goal of 
numerous failed clinical trials.86  
 
Angiogenesis is driven largely by ischemia and hypoxia, leading to stabilization of 
hypoxia inducible factors that drive expression of numerous hypoxia responsive 
genes including VEGF. As described above, VEGF binding to its receptors 
VEGFR1 and 2 on endothelial cells stimulates migration and proliferation of 
these cells from existing vessels initiating the formation of new capillary 
networks.85,87 While angiogenesis may provide some improvement in blood flow 
distribution, it cannot functionally replace an occluded artery because the 
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addition of small high resistance vessels increases the overall resistance of the 
vascular bed distal to the occluded artery limiting blood flow restoration.88 Thus, 
in the setting of vascular occlusion, only muscular collateral arteries are able to 
supply sufficient blood flow to prevent severe ischemia and its consequences.89 
Unlike angiogenesis, arteriogenesis does not require ischemia or hypoxia and 
can occur spatially and temporally dissociated from them.89,90 Following vascular 
stenosis or occlusion, preexisting collateral arteries undergo extensive growth 
and remodeling that harnesses their full potential at restoring blood perfusion 
downstream of an occlusion.91 Some of the mechanisms that mediate 
arteriogenic remodeling of collateral arteries will be discussed next. 
 
Flow-mediated biomechanical forces initiate arteriogenesis  
Arteriogenesis in the setting of vascular occlusion is thought to be initiated by 
biomechanical forces91-93 and requires the coordinated interaction of several cell 
types including endothelial cells, smooth muscle cells (SMC), 
monocyte/macrophages, neurons and likely other cell types.78,94,95 Vascular 
occlusion redirects blood flow to preexisting collaterals resulting in increased fluid 
shear stress (FSS) over the endothelial surface, as well as in increased 
longitudinal, circumferential and radial wall stress due to the elevated pressure 
within the collateral network.89,91 The endothelium and SMCs can sense these 
                                                                                                                                                                                                                                                                         
 
29 
physical changes and undergo molecular and morphological alterations that 
underlie collateral artery remodeling.  
 
Substantial evidence exists implicating FSS as an important early trigger for 
arteriogenesis.91,96 Increases in FSS stimulate the activity of endothelial nitric 
oxide synthase (eNOS) resulting in enhanced generation of nitric oxide (NO) that 
mediates smooth muscle cell relaxation and vascular dilation in an attempt to 
accommodate the increase in blood flow. Vascular dilation causes increased 
circumferential wall stress that, along with NO, directly contributes to smooth 
muscle cell proliferation and hypertrophy resulting in increased thickness of the 
tunica media, which is one of the most important aspects of the arteriogenic 
remodeling process. The critical importance of NO in arterial remodeling has 
been demonstrated by several studies utilizing eNOS-deficient mice that show 
markedly reduced arteriogenesis and increased collateral artery 
rarefaction.62,94,97 Inducible nitric oxide (iNOS) synthase has also been implicated 
in the arteriogenic process,98 although its role is much less well understood.  
 
Furthermore, the endothelium responds to increased FSS by acquiring an 
activated phenotype that involves cytoskeletal changes, but perhaps most 
significantly, up-regulation of numerous chemoattractants and cell surface 
adhesion molecules.91,99 Monocyte chemoattractant protein 1 (MCP-1, encoded 
by Ccl2) is one of the most important factors that has been shown to play a major 
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role during arteriogenesis following vascular occlusion.100,101 Both activated 
endothelial cells as well as SMCs produce and secrete MCP-1 setting up a 
strong chemoattractive gradient for monocytes. These adhere to the endothelial 
surface via interaction with selectins and adhesion molecules including 
intercellular adhesion molecule (ICAM-1 and 2) as well as vascular cell adhesion 
molecule 1 (VCAM-1) on the endothelial surface. Upon migration to the 
perivascular region, recruited monocytes differentiate into macrophages that 
secrete various matrix metalloproteases, which orchestrate extracellular matrix 
degradation that facilitates the arterial remodeling process. In addition, 
monocytes/macrophages produce numerous cytokines and growth factors that 
stimulate proliferation and migration of both endothelial and smooth muscle 
cells.89,102  
 
Role of macrophages in arteriogenesis 
Numerous lines of evidence support the crucial importance of the role of 
monocyte/macrophages and their secreted factors in arteriogenesis. Both blood 
monocyte levels and their recruitment to growing collaterals have been shown to 
affect collateral artery growth.63,103 Thus, chemically modulating blood monocyte 
levels correlates with the extent of collateral growth103 and impaired monocyte 
recruitment in Ccr2-/- mice results in decreased arteriogenesis.63 In contrast, 
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MCP-1 administration to the region of growing collaterals augments monocyte 
recruitment and enhances arteriogenesis.101,104  
 
The specific macrophage differentiation state appears to be particularly important 
as wound-healing/pro-angiogenic “M2-like” macrophages characterized by their 
higher expression of M2-type genes including Tie2, Arg1, Cxcr4, Ccr2, Hgf, 
Pdgfb, Nrp1, Mmp2, Cxcl12 (also known as Sdf1) and Tgfb appear to promote 
enhanced collateral artery remodeling not only in models of arterial occlusion, but 
also developmentally.78 Thus, Phd2 haplodeficiency in myeloid cells results in an 
overabundance of M2-like macrophages in pericollateral regions that is 
associated with increased collateral artery number and size at baseline and 
enhanced collateral artery growth in models of arterial occlusion.78 This was 
attributed to increased NF-κB activity in Phd2+/- macrophages that was 
hypothesized to drive a pro-arteriogenic transcriptional program including 
upregulation of Pdgfb and Sdf1. These were in turn shown to promote SMC 
migration and growth in vitro.78 A subsequent study from the same group linked 
Phd2 downregulation in macrophages to increased expression of the 
angiopoietin (ANG) receptor TIE2.105  They reported a feed-forward loop whereby 
increased ANG1 in the setting of vascular occlusion acts via TIE2 to 
downregulate Phd2, allowing enhanced NF-κB signaling and increased Tie2 
expression in macrophages, which was shown to be required for macrophage 
skewing to the proarteriogenic phenotype. Using a Herpes Simplex virus 
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thymidine kinase-gancyclovir cell suicide system, they demonstrated that TIE2-
expressing monocyte/macrophages (TEM) were indeed required for collateral 
artery growth. These data were complemented by a translational study that 
demonstrated increased numbers of TEM in the blood of patients with critical 
limb ischemia.106 TEM abundance was reduced following revascularization or 
amputation. These studies support the possibility that TEM may be relevant to 
collateral artery remodeling in humans as well as in mice.  
 
Role of growth factors in arteriogenesis 
As mentioned above, macrophages promote arteriogenesis, in part, via 
production of various chemokines and growth factors. These factors contribute to 
collateral artery remodeling via either one or both of the following mechanisms: 
(1) providing a feed forward stimulus for recruitment, survival and activation of 
additional monocytes; (2) by directly acting on endothelial and smooth muscle 
cells altering their migratory and proliferative capacity. 
 
GM-CSF and G-CSF 
Granulocyte/monocyte colony stimulating factor (GM-CSF) and G-CSF promote 
myeloid cell recruitment, proliferation and survival. Following promising results in 
augmenting arteriogenesis and blood perfusion in animal models of vascular 
occlusion,107,108 GM-CSF and G-CSF were tested in clinical trials in patients with 
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coronary artery or peripheral artery disease, however their beneficial effects in 
humans have been modest and equivocal.59,109-111 The differences in response 
between animal models and humans may be due to intrinsic biological 
differences between humans and other animals or due to factor doses selected, 
treatment regimens, patient selection, outcome measures and sensitivity of 
techniques used to measure response. Additional, better-designed studies may 
be required to definitively determine the therapeutic potential of these factors.86   
 
Fibroblast growth factors 
Other growth factors including different members of the fibroblast growth factor 
(FGF) family as well as placental growth factor (PlGF), platelet derived growth 
factor B (PDGFB) and VEGF have been shown to participate in the growth and 
remodeling of collateral arteries in the experimental setting.112,113 
 
Initial studies suggested that macrophage secreted FGFs may augment 
arteriogenesis and improve collateral artery flow114-116 likely via their ability to 
stimulate both endothelial and SMC migration and proliferation.117 FGFs may 
also act via cooperation with other growth factor systems by upregulating 
expression or promoting the action of VEGF, PDGFB, hepatocyte growth factor 
and MCP-1.113 The story is, however, quite complex as Fgf1-/-, Fgf2-/- or double 
Fgf1 plus Fgf2 knockout mice show little phenotypic vascular defects.118-120 
Additionally, clinical trials aimed at therapeutic angiogenesis in patients with 
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ischemic disease have shown little therapeutic efficacy of any single growth 
factor delivery from this family,121 pointing to the significant redundancy in the 
FGF system and indicating the need for combinatorial strategies with factors from 
the same family or combination of growth factors from different families. Thus, 
understanding the intricate details and differences in the action of various growth 
factors may lead to better therapeutic strategies.    
 
VEGF-A 
In this respect, despite the disappointing outcome of clinical trials utilizing VEGF 
at improving therapeutic angiogenesis in ischemic diseases,122 much research 
has continued to focus on understanding the arteriogenic potential of the 
VEGF/VEGFR signaling pathway.94 Numerous experimental studies in mice 
support an important role for this pathway in arteriogenesis in the setting of 
vascular occlusion.77,94,123,124 However, given this pathway’s unquestionable 
pleiotropic functions during developmental angiogenesis, specification of arterial 
identity and arterial branching morphogenesis94,125 as well as in formation of 
native collateral arteries,61,77 it is often difficult to separate whether the results 
obtained in genetically modified mice with perturbation of this pathway are due to 
developmentally-derived differences in the formation of the vasculature or 
whether VEGF signaling indeed plays a role during remodeling of collateral 
arteries in adult animals in the setting of vascular occlusion. This distinction may 
be important for the design of therapeutic modalities as well as for the 
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interpretation of the outcome of clinical trials aimed at modulating this pathway in 
patients with vaso-occlusive disease. 
 
Studies have reported the involvement of VEGF signaling during both 
developmental and adult arteriogenesis. A recent study demonstrated the 
existence of a chemokine-coupled β2 integrin-induced Rac2-Myosin 9 (Myh9) 
interaction that leads to nuclear-to-cytosolic translocation of the RNA-binding 
protein HuR and VEGF-A mRNA stabilization.123 Thus, mice with myeloid-
specific disruption of Myh9 show reduced VEGF-A expression in macrophages 
and have blunted arteriogenic responses in adulthood following femoral artery 
occlusion, but do not display measurable defects in developmental angiogenesis, 
arteriogenesis or collateral artery formation.123 These are surprising, but 
interesting findings that may truly reflect intrinsic biological differences between 
developmental and adult vascular biology. However, as the authors point out, 
these observations could be due to the timing of deletion of Myh9. Additionally, 
these findings may reflect differences in vascular development in different tissues 
since developmental vascular processes in this study were examined in the 
retina, kidney and brain, whereas adult arteriogenesis was analyzed in hindlimb 
skeletal muscle. 
 
Other studies have analyzed the mechanisms of VEGF-VEGFR2 signaling in 
endothelial cells and its importance in arteriogenesis. A critical outcome of this 
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signaling is phosphorylation and activation of the mitogen-activated protein 
kinases ERK1 and 2, which mediate endothelial cell proliferation, migration and 
tube formation and are required for vascular development and arterial branching 
morphogenesis.94 In arterial endothelial cells, VEGF-VEGFR2 mediated ERK 
phosphorylation requires VEGFR2 endocytosis and trafficking through the 
endosomal compartment, a process that is regulated in part by the VEGF and 
semaphorin non-tyrosine kinase receptor Neuropilin 1 (Nrp1) and its interaction 
with synectin and myosin-VI.124,126,127 Thus, VEGF-A binding to VEGFR2 leads to 
receptor dimerization and autophosphorylation at Y1175, an event that is required 
for subsequent ERK phosphorylation.128 Following VEGF-A binding, dimerization 
and autophosphorylation, VEGFR2 undergoes clathrin-dependent endocytosis in 
a complex that includes Nrp1, synectin and myosin-VI.94 In this complex the 
function of Nrp1, which contains a PDZ-binding domain is to facilitate interaction 
with the PDZ domain-containing protein synectin. This, in turn, interacts with the 
actin-based molecular motor myosin-VI to promote trafficking of the VEGFR2 
receptor complex from clathrin-coated pits to early endosome antigen 1+ 
(EEA1+) endosomes.94,129 Delayed trafficking of the VEGFR2 receptor complex 
in synectin or myosin-VI knockout mice126 or in knockin mice, in which Nrp1 lacks 
the cytoplasmic PDZ-binding domain124 results in reduced ERK phosphorylation 
and decreased developmental and reportedly adult arteriogenesis; although 
formal demonstration of the effects on adult arteriogenesis would require 
disruption of these components using inducible systems in adult mice. The 
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decreased ERK phosphorylation, when VEGFR2 trafficking to EEA1+ 
endosomes is delayed, has been attributed to phosphotyrosine phosphatase 1b 
(PTP1b)-mediated dephosphorylation of VEGFR2 at Y1175,94,130 which serves as 
a binding site for PLCγ and subsequent activation of Raf1/MEK/ERK 
signaling.128,131 Indeed, ERK phosphorylation is enhanced in PTP1b-deficient 
endothelial cells, and endothelial specific conditional deletion of Ptpn1 (encoding 
PTP1b) in adult mice results in enhanced arteriogenesis and improved blood 
perfusion restoration in a model of femoral artery occlusion.130  
 
Role of JNK in the vasculature 
JNK has been implicated in angiogenic responses and other aspects of vascular 
biology. Studies have reported that treatment of human endothelial cells in 
culture with VEGF causes JNK activation that may be important for tube 
formation in vitro.132,133 Using siRNA knockdown approaches in bovine aortic 
endothelial cells, one study reported that the chemokine stromal cell-derived 
factor-1α (SDF-1α, also known as CXCL12) causes selective phosphorylation of 
JNK3, but not JNK1 or JNK2, and that JNK3 was important for cell migration and 
tube formation in vitro.134 Induction of JNK3 phosphorylation by SDF-1α was 
attributed to SDF-1α-stimulated endothelial nitric oxide synthase (eNOS) 
activation leading to nitric oxide-mediated nitrosylation and inactivation of MAPK 
phosphatase 7 (MKP7).134 
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Two in vivo studies employing whole body Jnk1-/- mice or chemical inhibition of 
JNK have reported a positive regulatory role for JNK in pathological ocular 
neovascularization in a model of retinopathy of prematurity (ROP)135 and in a 
model of laser-induced choroidal neovascularization (CNV).136 One study 
showed that hypoxia activates JNK in macrophages in vitro leading to JNK-
dependent positive regulation of VEGF expression in these cells.135 Jnk1-/- mice 
exhibited decreased VEGF expression in retinas during the development of 
retinopathy and this was proposed to contribute to decreased retinal 
neovascularization in the ROP model.135 In the second study, decreased 
apoptosis in the choroid of Jnk1-/- mice following laser-induced injury was 
reported to lead to decreased macrophage recruitment, decreased VEGF 
secretion in choroidal tissues and decreased CNV size.136 
 
Two other studies have reported results that appear contradictory to those 
above. An earlier study reported a negative regulatory role for JNK1 in 
angiogenesis.137 This study showed that treatment of human endothelial cells 
with the potent natural angiogenesis inhibitor Thromobospondin-1 (TSP-1) 
activates JNK in a CD36 (a TSP-1 receptor)-dependent manner. JNK1 was then 
shown to mediate the antiangiogenic action of TSP-1 by demonstrating that TSP-
1 inhibition of basic FGF-induced corneal neovascularization in vivo or VEGF-
induced angiogenic sprouting in a corneal assay in vitro was impaired in corneas 
from Jnk1-/- mice.137 A recent study showed that increased JNK3 expression in 
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endothelial cells expressing a mutant form of EphrinB2 (lacking tyrosine residues 
important for signaling) mediates increased endothelial cell death.138 
Consequently, this study reported that Jnk3-/- mice display reduced regression 
and thus, increased branching and density of the hyaloid vasculature (a vascular 
network in the eye that in mice is present at birth and regresses in the early 
postnatal period).138   
 
Furthermore, numerous studies have implicated JNK in the response of 
endothelial cells to flow and flow-induced shear stress.139-144 Thus, acute 
exposure of endothelial cells to disturbed flow causes JNK activation that 
promotes endothelial cell inflammatory responses, including NF-κB activation, 
that have important roles in promoting regional development of atherosclerosis in 
the arterial vasculature.139,140 In contrast, exposure of the arterial endothelium to 
sustained laminar shear stress results in gene expression changes, including 
upregulation of the transcription factor KLF2, that lead to inhibition of JNK 
signaling, decreased expression of adhesion molecules on the endothelial 
surface, and decreased endothelial inflammation leading to endothelial 
normalization and protection from atherosclerosis.139,141,144 The role of JNK in 
transducing flow-induced shear stress responses during arteriogenesis has not, 
however, been explored.  
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HEMATOPOIESIS 
Hematopoiesis is the process of blood cell production.145 During embryogenesis, 
hematopoiesis occurs spatially and temporally in intimate association with 
vascular development. Indeed, hematopoietic and endothelial cells are thought to 
arise from a common precursor.33  
 
Hematopoietic and Vascular Endothelial Cells Share Common Origins  
Although still somewhat controversial, the existence of the hemangioblast, a 
common mesodermally-derived progenitor that gives rise to both hematopoietic 
and endothelial cells has been reported by several studies.33 Hematopoietic cells 
first appear within the blood islands of the extra-embryonic yolk sac in close 
apposition to endothelial cells.31,33 This association as well as the sharing of 
various markers between hematopoietic and endothelial cells and the impairment 
of both the hematopoietic and vascular systems in mutants, such as the Flk-1-/- 
mice,146 has lead to the hypothesis of the hemangioblast. Lineage tracing studies 
have provided support for a common origin between hematopoietic and 
endothelial cells, yet, definitive direct evidence that a single cell divides 
asymmetrically to form an endothelial and a blood cell in vivo is lacking.33  
Hematopoietic stem cell emergence 
During development, blood production occurs at several different sites. These 
include the yolk sac, a region surrounding the aorta called aorta-gonad 
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mesonephros (AGM), the placenta, the fetal liver and ultimately the bone 
marrow.33  In mammals, the first wave of hematopoiesis occurs in the yolk sac, is 
termed “primitive” and generates erythroid cells that are necessary for 
oxygenation of the rapidly developing embryo.33  Cells with myeloid 
characteristics are also generated at this stage.147 However, whether 
hematopoietic stem cells (HSCs) are present in the yolk sac remains 
controversial.148 HSCs are defined functionally as cells that are capable of 
generating all blood cells and that undergo self-renewing divisions, whereby a 
single cell generates daughter cells with the same characteristics and potential 
as the original cell.33   Definitive HSCs (dHSCs) with engrafting potential are first 
detected in the AGM ~E10.5 and are thought to bud off from specialized 
endothelial cells lining the aorta termed hemogenic endothelial cells.149 The 
placenta has also been shown to contain dHSCs, although it is unclear whether 
these arise de novo or colonize the placenta via the circulation.150,151 By E11.5 
HSCs have colonized the fetal liver and subsequently, the thymus, spleen and 
ultimately the bone marrow, which is the primary site of adult hematopoiesis.33      
The hematopoietic hierarchy 
HSCs stand at the top of the hematopoietic hierarchy (Figure I.6).145 They have 
definitive replication potential and are maintained in a quiescent state with a 
small number of HSCs cycling at any one time. Theoretically, HSCs can undergo 
three types of cell divisions: (1) symmetrical, giving rise to two daughter HSCs 
with the same characteristics and potential of the original cell; (2) asymmetrical 
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division, generating a daughter HSC plus a more differentiated cell with reduced 
self-renewal potential (often termed short-term HSC [ST-HSC]); and (3) 
symmetrical division resulting in the production of two ST-HSCs.33,152 ST-HSCs 
proceed down the differentiation hierarchy to successively generate more 
differentiated progenitors that will ultimately produce mature blood cells. Thus, 
ST-HSCs give rise to multipotent progenitors (MPPs) that retain multilineage 
differentiation potential, but lack self-renewal capacity. MPPs can produce both 
common myeloid progenitors (CMPs) and common lymphoid progenitors (CLPs). 
CLPs are the source of committed precursors that will generate B and T cells, 
whereas CMPs give rise to megakaryocyte/erythrocyte progenitors (MEPs) and 
granulocyte/macrophage progenitors (GMPs). Neutrophils, eosinophils, 
basophils, mast cells, dendritic cells and monocyte/macrophages arise from 
GMP-derived precursors.33       
 
Methods of stem and progenitor cell identification and functional characterization 
Immunolabeling of surface markers coupled with multicolor flow cytometry 
approaches affords the identification and isolation of stem, progenitor and mature 
hematopoietic cell populations with high purity.153 In adult mice, all HSC activity is 
contained within the Lineage-/low, Sca1+, cKit+ (LSK) population of bone marrow 
cells.153 This population is highly heterogeneous, and more specific stem and 
progenitor cell populations can be further defined by the utilization of additional 
cell surface markers.153 Indeed current methods allow identification of bone 
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marrow cell populations in which one out of two cells is a functionally confirmed 
HSC (i.e., engrafts and gives long term multilineage reconstitution in lethally 
irradiated mice).154 This is remarkable given that HSCs comprise only < 0.01% of 
bone marrow cells.153 In vivo functional characterization of stem and progenitor 
populations involves their transplantation into irradiated mice and analysis of 
blood production in recipient mice over time.155 HSCs are the only cells capable 
of conferring long term (> 4 months) multilineage reconstitution when 
transplanted into lethally irradiated mice, yet HSCs have definitive replication 
potential. The competitive serial bone marrow transplantation assay remains the 
most rigorous test for determining HSC function and self-renewal capacity. In this 
assay, as HSCs are transferred from one recipient to the next, they are 
repeatedly forced to cycle in order to repopulate the BM niches of the new 
recipient and maintain hematopoiesis. During this process, HSCs with lower self-
renewal potential will be lost earlier than HSCs with higher self-renewal potential, 
thus maintenance of multilineage blood production in recipient mice over long 
periods in multiple recipient mice can be used to infer HSC self-renewal 
capacity.155-157 
 
Role of JNK in hematopoietic cells 
JNK has been implicated in hematopoietic cell development and function in 
various contexts. JNK is activated by exposure of cells to various cytokines as 
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well as antigen or ligand binding to immune cell receptors, including T and B cell 
receptors, and toll like receptors.158 Studies employing single Jnk1-/- or Jnk2-/- 
mice or transgenic mice expressing a dominant negative JNK1 protein have 
demonstrated that JNK is not required for lymphocyte development, but may play 
a role during negative selection of thymocytes by mediating apoptotic responses 
to T cell receptor engagement.158-160 JNK has also been reported to affect 
differentiation, activation and proliferation of mature T cells. Thus, JNK1 appears 
to be required for appropriate effector T cell differentiation.161 CD4+ precursor 
cells undergo differentiation into type 1 or type 2 T helper (TH) cells that mediate 
differential immune responses. Jnk1-/- T cells exhibit enhanced production of TH2 
cytokines, undergo hyperproliferation and differentiate preferentially into TH2 
cells.161 Additionally, Jnk2-/- mice display defects in differentiation of CD4+ 
precursor cells into TH1, but not TH2 cells. Defective TH1 differentiation in Jnk2-/- 
mice has been attributed to impaired production of interferon (IFN)-γ production 
during the early stages of differentiation and can be rescued by exogenous IFN-
γ.162 In contrast to T cells, neither JNK1 nor JNK2 has been reported to contribute 
to normal B cell function including proliferation/survival or antibody production, 
despite JNK activation in B cells by various stimuli, including B cell receptor 
ligation.158 However, a positive regulatory role for JNK1 in B lymphoblast survival 
in the context of BCR-ABL transformation has been reported.24  
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JNK is activated in macrophages by inflammatory cytokines, lipopolysaccharide 
(LPS) and other stimuli.5,163,164 An important function of JNK2, but not JNK1, in 
the uptake and degradation of modified lipoproteins and foam cell formation has 
been reported and explains the protection of Jnk2-/-ApoE-/- from 
atherosclerosis.165 Mechanistically, it was demonstrated that JNK2 in 
macrophages phosphorylates scavenger receptor A (SR-A), an event that is 
required for receptor/lipoprotein complex internalization and formation of foam 
cells,165 which are critical mediators of the atherosclerotic process.166 JNK in 
macrophages has also been reported to be important for IFN-γ or LPS-induced 
pro-inflammatory cytokine expression in vitro and high fat diet-induced pro-
inflammatory macrophage polarization and inflammation in vivo.163 
 
In addition to its role in immune cell differentiation and function, the JNK signaling 
pathway has also been implicated in normal hematopoietic cell survival. Thus, 
the MAP3K, TAK1, which can mediate JNK activation by inflammatory cytokines, 
is critical for hematopoietic cell survival.167 Tak1-/- mice die during 
embryogenesis.168,169 Inducible conditional deletion of Tak1 in adult mice using a 
Mx1-Cre system results in lethality within 10 days of polyI:C administration due to 
bone marrow and liver failure resulting from massive apoptotic death of 
hematopoietic cells and hepatocytes.167 Apoptosis was confirmed in 
hematopoietic stem/progenitor cells (LSK cells), and the cell-autonomous 
requirement of TAK1 for hematopoietic cell survival was demonstrated in 
                                                                                                                                                                                                                                                                         
 
46 
transplantation experiments.167 A recent study investigated the role of JNK in 
hematopoietic stem and progenitor cell development in whole body JNK 
knockout mice and reported that Jnk2-/- and Jnk1+/-Jnk2-/- but not Jnk1-/- mice 
exhibited increased progenitor cell apoptosis and decreased numbers of HSCs 
and progenitors in the bone marrow.170 Thus, JNK may have important functions 
in hematopoietic development.  
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RATIONALE AND OBJECTIVES 
As illustrated above, in response to diverse extracellular stimuli, JNK 
phosphorylates numerous transcription factors and cytoplasmic proteins altering 
gene expression programs and regulating a multitude of biological processes that 
affect cellular, tissue and organismal physiology. JNK is ubiquitously expressed 
and exists in multiple isoforms, which may have distinct roles or may contribute 
to functional diversity via cell or tissue specific distribution profiles. However, 
often, JNK isoforms display high functional redundancy requiring careful 
interpretation of results from studies that employ disruption of distinct JNK 
isoform subsets. Standard whole body knockout mouse models disrupting 
individual or combinations of JNK genes have provided important insight into the 
pleiotropic functions of JNK in mammalian physiology. However, these studies 
have been limited by the early embryonic death of compound Jnk1-/-Jnk2-/- mice. 
The generation of conditional JNK alleles, combined with tissue specific 
constitutive and inducible Cre technology, now, affords more intimate dissection 
of tissue specific functions of JNK in mice with compound disruption of multiple or 
all JNK isoforms.  
 
Although JNK has been implicated in vascular and, more specifically, endothelial 
cell biology, both pro and anti-angiogenic functions have been reported. These 
results may stem from differential functions of specific JNK isoforms or JNK 
isoform profiles in different tissues that may affect the same biological process 
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differently. Furthermore, these studies have been focused specifically on the role 
of JNK in pathological angiogenesis or in vitro systems, which have some 
benefits, but also significant limitations. Therefore, studies that utilize multiple 
model systems that dissect different aspects of vascular biology and employ 
genetically modified mice with compound disruption of multiple or all JNK 
isoforms in specific cell types are required to definitively characterize the function 
of JNK in vascular biology. The purpose of the study presented in Chapter II was 
to provide critical and conclusive insights into the role of JNK in endothelial cell-
mediated vascular development and function.  
 
Additionally, given the intimate relationship both developmentally and physically 
between endothelial and hematopoietic cells as well as the numerous lines of 
evidence linking JNK to the regulation of immune cell gene expression, cytokine 
production, and hematopoietic cell survival and function, we aimed to generate 
and utilize previously uncharacterized mouse models with compound 
hematopoietic cell specific disruption of JNK in order to analyze its function in 
normal hematopoietic development and HSC self-renewal. These data are 
presented in Chapter III.    
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Figure I.1 MAP kinase signal transduction.  
 
Numerous mitogen activated protein kinase kinase kinases (MAP KKK) have 
been identified. Upon activation by a multitude of stimuli, MAP KKK 
phosphorylate and activate MAP kinase kinases (MAP KK). Four MAP KK are 
shown that mediate phosphorylation and activation of the MAP kinases, p38 and 
JNK. MKK4 and MKK7 mediate activation of JNK, while MKK3 and MKK6 
activate p38. MKK4 may also activate p38. Similar signaling cascades lead to 
activation of the ERK group of MAP kinases (not depicted). Upon activation, MAP 
K phosphorylate numerous substrates.  
    
Image taken from Davis, R.J. Signal transduction by the JNK group of MAP 
kinases. Cell 103, 239-252 (2000).
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Figure I.2 JNK isoforms.  
 
The c-Jun NH2-terminal kinase (JNK) is a serine / threonine kinase containing 11 
kinase subdomains (I-XI). JNK is fully activated upon phosphorylation of two 
critical residues (threonine (T) 183 and tyrosine (Y) 185) indicated by red arrows. 
Ten total JNK isoforms are generated by alternative splicing of the three Jnk 
genes (Jnk1, Jnk2 and Jnk3). One alternative splicing site located between 
subdomains IX and X (indicated by the shaded regions) involves selection of one 
of two alternative exons that encode part of the kinase domain. This splice site is 
restricted to Jnk1 and Jnk2, and gives rise to JNK isoforms with different 
substrate binding specificities. The second splice site at the COOH-terminus of 
the protein results in proteins that differ by 42 or 43 amino acids, indicated by the 
hatched regions. The functional role of these isoforms is not known.  
 
Image taken from Manning, AM and Davis, RJ. Nat Rev Drug Discov. 
2003;2(7):554-65.
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Figure I.3 Early postnatal development of the retinal vasculature as a model 
for studying sprouting angiogenesis.  
 
At birth (postnatal day [P] 0) the retina is avascular. Formation of the superficial 
retinal vascular plexus occurs in the first few days of postnatal life from the center 
of the retina towards the periphery. This highly stereotypic process initially occurs 
in two dimensions on the inner surface of the retina, which can be flatmounted as 
shown and allows for detailed microscopic analysis of many aspects of the 
sprouting angiogenic process.  
 
Image taken from Stahl, A., Connor, K.M., Sapieha, P., Chen, J., Dennison, R.J., 
Krah, N.M., Seaward, M.R., Willett, K.L., Aderman, C.M., Guerin, K.I., Hua, J., 
Lofqvist, C., Hellstrom, A. & Smith, L.E. The mouse retina as an angiogenesis 
model. Invest Ophthalmol Vis Sci 51, 2813-2826 (2010).
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Figure I.4 Notch signaling.  
 
Refer to the Notch Signaling section of the introduction for a detailed description 
of the pathway. 
 
Image taken from Roca, C. & Adams, R.H. Regulation of vascular 
morphogenesis by Notch signaling. Genes Dev 21, 2511-2524 (2007).
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Figure I.5 Collateral arteries.  
 
Collateral arteries interconnect adjacent arterial trees. Collaterals have narrow 
lumens and experience bi-directional flow. Following arterial occlusion more 
blood flow is redirected through these alternative routes. Increased proximal and 
decreased distal pressure results in unidirectional flow through collaterals in the 
setting of arterial occlusion. Collateral arteries remodel outwardly increasing in 
diameter.
59
60 
Figure I.6 The hematopoietic hierarchy. 
 
Hematopoietic stem cells (HSC) stand at the top of the hematopoietic hierarchy 
and give rise to all blood cells. The lineage-, Sca-1+, cKit+ (LSK) population of 
bone marrow cells is enriched in long-term (LT)-HSC, short-term (ST)-HSC and 
multipotent progenitors. LT-HSCs and ST-HSCs can undergo self-renewing 
divisions or can give rise to more differentiated progenitors, which will produce 
lineage specific progenitors such as the common lymphoid progenitors (CLP) 
that will lead to the generation of precursors for B, T and natural killer (NK) cells. 
Common myeloid progenitors (CMP) give rise to granulocyte/macrophage 
progenitors (GMP) and megakaryocyte/erythrocyte progenitors. GMPs generate 
granulocytes and macrophages, while MEPs generate platelets and erythrocytes.  
 
Image taken from Blank, U., Karlsson, G. & Karlsson, S. Signaling pathways 
governing stem-cell fate. Blood 111, 492-503 (2008).
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Chapter II 
 
Endothelial MLK – JNK Signaling Regulates Vascular 
Morphogenesis and is Critically Required for Native 
Collateral Artery Development 
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Abstract 
 
Arterial occlusive diseases are major causes of morbidity and mortality. Blood 
flow to the affected tissue must be restored quickly if viability and function are to 
be preserved. Collaterals are artery-to-artery or arteriole-to-arteriole 
interconnections that can bypass an occlusion by providing an alternative route 
for blood flow to the affected tissue. The increased flow and shear stress initiate 
processes that result in the remodeling (arteriogenesis) of these vessels into 
efficient conductance arteries. Here we report that the mixed-lineage kinase 
(MLK) pathway activates cJun NH2-terminal kinase (JNK) in endothelial cells. 
Disruption of Mlk2/3 or Jnk1/2 genes caused severe blockade of blood flow and 
failure to recover in the femoral artery ligation model of hindlimb ischemia 
because of abnormal collateral arteries. We show that the MLK-JNK pathway is 
essential for patterning and maturation of collateral arteries during development, 
but this pathway is not required for angiogenesis or arteriogenesis in adults. JNK 
in endothelial cells promotes Delta-like 4-induced Notch signaling and 
suppresses excessive sprouting angiogenesis during development. This function 
of the MLK-JNK pathway contributes to normal formation of native collateral 
arteries. The MLK-JNK pathway is therefore a key regulatory mechanism for 
vascular development. These data highlight the crucial importance of the 
collateral circulation in the response to arterial occlusive diseases. 
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Introduction 
 
Arterial occlusion, the common denominator in ischemic stroke, myocardial 
infarction and peripheral artery disease, blocks blood flow and can result in 
severe tissue ischemia and necrosis. To prevent loss of tissue viability and 
function, blood flow to the affected tissue must be restored quickly. Collaterals 
are natural artery-to-artery or arteriole-to-arteriole interconnections that can 
bypass an occlusion by providing an alternative route for blood flow to the 
affected tissue, thus, restoring tissue homeostasis and limiting tissue 
damage.57,58,60,94,171,172 Indeed, clinical outcome in patients with arterial occlusion 
depends on the presence of an adequate collateral circulation68,172 and animal 
models of arterial occlusion provide strong evidence for the critical importance of 
the extent of the native (pre-existing) collateral circulation in restoring blood 
perfusion and limiting ischemic sequelae following arterial occlusion.65,75,101,104,173  
 
Important characteristics of the collateral circulation include collateral artery 
number and size,60,76,174 but also collateral artery connectivity patterns and 
functional adaptation to changes in blood flow.82 Furthermore, collateral artery 
structural adaptations are also essential for adequate blood flow restoration. 
Following arterial occlusion more blood flow is diverted to the collateral 
circulation and the increased flow and shear stress in collateral arteries initiates a 
number of processes that result in the outward remodeling (arteriogenesis) of 
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these vessels into efficient conductance arteries that allow increased blood flow. 
Collateral artery remodeling includes endothelial cell activation and proliferation, 
monocyte/macrophage recruitment and smooth muscle cell proliferation, all of 
which contribute to increased collateral artery diameter, including increased 
thickness of the tunica media. These structural and functional adaptations are, 
however, likely to depend heavily on the presence of an adequate native 
collateral circulation prior to vascular occlusion.58,88,89,91,94 
 
Little is known about the cellular and morphogenetic processes, or about the 
molecular factors and mechanisms that contribute to native collateral artery 
formation. A small number of studies, largely focused on the formation of the 
leptomenengial (or pial) collateral arteries in the brain, have provided significant 
insight.61,64,77,84 In mice, pial collaterals are established during embryonic 
development with some remodeling and maturation continuing postnatally.61,64 
The process of native collateral artery formation during embryogenesis has been 
termed collaterogenesis. The molecular factors or signaling pathways that have 
been reported to contribute to native collateral artery formation include, platelet-
endothelial cell adhesion molecule 1 (PECAM1),79 gap junction protein, 
connexin37 (Cx37),80,81 prolyl hydroxylase domain-containing protein 2 (PHD2),78 
endothelial nitric oxide synthase (eNOS),62 chloride intracellular channel 4 
(CLIC4),65 Synectin95, NF-κB signaling,175 VEGF signaling,61,74 and Dll4 – Notch 
signaling.82 In addition to affecting native collateral artery formation, many of 
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these factors are known modulators of developmental angiogenesis (i.e., the 
process of new vessel formation from existing vasculature) and vascular 
morphogenesis, suggesting that the patterning of initial vascular networks may 
affect their subsequent remodeling and maturation, and formation of native 
collateral arteries.  VEGF and Dll4 – Notch signaling play critical roles in 
endothelial cell survival, proliferation and migration, and therefore, regulate 
developmental sprouting angiogenesis and vascular morphogenesis.37,54,125 They 
are also critical for formation of the native collateral circulation.82 
 
cJun-NH2 terminal kinases (JNK) are members of the stress and mitogen 
activated protein kinase (MAPK) family that are activated by diverse 
environmental stimuli, including cytokines, growth factors and flow-mediated 
shear stress.1,12,139-144 Three Jnk genes encode for transcripts that are 
alternatively spliced, generating 10 different JNK isoforms with high functional 
redundancy.1,3 JNK1 and JNK2 isoforms are ubiquitously expressed, whereas 
expression of JNK3 isoforms is restricted to brain, heart, testes1,3 and possibly 
endothelial cells.134 Signaling cascades involving one (or more) of a dozen MAPK 
kinase kinases (MAP3K) and one of two (or both) MAPK kinases (MAP2K) 
mediate JNK phosphorylation and activation. JNK phosphorylates numerous 
substrates, some of which are components of the activator protein complex 1 
(AP-1) that regulates expression of many genes. In this manner, JNK regulates 
various gene expression programs and mediates diverse cellular responses in 
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different cell types.1 
JNK has been implicated in both pro and anti-angiogenic responses in vivo.136,137 
These studies have used whole body Jnk1-/- mice in pathologic models of 
angiogenesis and thus have significant limitations. The role of other JNK 
isoforms and the specific cell types in which JNK is important for vascular biology 
as well as the role of JNK in physiologic vascular development and function 
remain outstanding questions.  
 
Here, we employ compound mutant mice with constituitive and inducible 
endothelial-specific disruption of all JNK isoforms in combination with various 
model systems to explore the role of endothelial JNK in various aspects of 
vascular biology. We find that JNK regulates Dll4 – Notch signaling in endothelial 
cells and identify a critical role for mixed lineage kinase (MLK) – JNK signaling in 
vascular morphogenesis and native collateral artery development.  
 
 
 
 
 
 
 
 
                                                                                                                                                                                                                                                                         
 
67 
Results 
 
Generation and initial characterization of mice with targeted ablation of 
all JNK isoforms in the vascular endothelium 
To examine the role of endothelial JNK in vascular development and function, we 
crossed mice with conditional alleles of Jnk to mice expressing 
a constitutively active cre recombinase (Cre) driven by the vascular endothelium 
cadherin (also known as Cdh5) promoter176 to generate mice with vascular 
endothelium specific compound deficiency of JNK1 plus JNK2 (E2KO, Cdh5Cre+ 
Jnk1LoxP/LoxP Jnk2LoxP/LoxP) or JNK1 plus JNK2 plus JNK3 (E3KO, Cdh5-Cre+ 
Jnk1LoxP/LoxP Jnk2LoxP/LoxP Jnk3-/-). Control mice included Cre+ (EWT, Cdh5-Cre+ 
Jnk1+/+ Jnk2+/+ and ECtrl, Cdh5-Cre+ Jnk1+/+ Jnk2+/+ Jnk3-/- respectively) mice as 
well as respective Cre- littermates (EfCtrl, Cdh5-Cre- Jnk1LoxP/LoxP Jnk2LoxP/LoxP and 
Cdh5-Cre- Jnk1LoxP/LoxP Jnk2LoxP/LoxP Jnk3-/-). Immunoblot analysis of lysates from 
purified (Supplementary Figure II.1D and E) lung endothelial cells from E3KO mice 
revealed a robust reduction in JNK protein levels in these cells (Figure II.1A). 
E2KO and E3KO mice used in this study developed normally and were healthy and 
fertile (see also the Methods section). We found no differences in body weight at 
birth and postnatal (P) day 6 (Supplementary Figure II.1A). Adult E2KO and E3KO 
mice were slightly smaller than control mice, but continued to gain weight 
indistinguishably from control mice (Supplementary Figure II.1B and C). 
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Endothelial (EC) and hematopoietic (HC) cells are thought to share a common 
precursor, the hemangioblast,33  and it has been reported that the Cdh5 promoter 
is active in a subset of HC.176  Indeed, polymerase chain reaction (PCR) analysis 
of bone marrow, spleen or blood from E3KO mice detected a low level of 
recombination of Jnk alleles (Supplementary Figure II.2B). However, importantly, 
immunoblot analysis showed no detectable reduction in JNK protein levels in any 
of the hematopoietic tissues from E3KO mice (Supplementary Figure II.2A). 
Furthermore, complete blood cell analysis of E3KO mice showed no major 
perturbation of any of the indices measured (Supplementary Figure II.2C). Flow 
cytometry analysis demonstrated no significant differences in the frequency of 
myeloid, B, T cells or T cell subsets in the blood of E3KO mice (Supplementary 
Figure II.2D). Finally, competitive bone marrow transplantation experiments 
indicated no significant differences in the number and function of hematopoietic 
stem/progenitor cells from E3KO mice (Supplementary Figure II.2E). These 
experiments indicate that E3KO mice have a normal hematopoietic system. 
Collectively, these data indicate that E3KO mice represent an appropriate model 
for studying the function of JNK in the vascular endothelium. 
 
JNK in the vascular endothelium is dispensable for angiogenic responses in adult 
mice 
JNK1 has recently been reported to be an important mediator of pathologic 
angiogenesis in a laser-induced model of choroidal neovascularization (CNV),136 
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however the cell type(s) in which JNK activity is responsible for this effect remain 
unknown. We examined how JNK in vascular EC affects angiogenic responses. 
JNK deficient EC formed cord like structures comparably to control EC in a tube 
formation assay in matrigel  (Supplementary Figure II.3A). Additionally, collagen 
embedded and VEGF stimulated aortic ring explants from E2KO or E3KO mice 
produced similar numbers of microvessels compared to aortic rings from control 
mice (Supplementary Figure II.3B). Consistent with these findings, we found no 
differences in the number of EC incorporating 5-ethynyl-2-deoxyuridine (Edu) or 
staining for the proliferation marker Ki-67 (Supplementary Figure II.3C and D) 
demonstrating that proliferation is not altered in JNK deficient EC. Furthermore, 
JNK deficient EC showed no defects in migration in an in vitro wound closure 
assay (Supplementary Figure II.3E).  
 
To assess the role of endothelial JNK in vivo, we examined two models of 
angiogenesis. First, we employed a laser-induced CNV mouse model in which 
laser-induced injury in the back of the eye initiates an inflammatory, pro-
angiogenic cascade that stimulates sprouting of new vessels from the choroid. 
Confocal imaging and quantification of CNV size in whole mount preparations 
revealed no significant differences between E3KO and control mice 
(Supplementary Figure II.4A and B). Second, we examined tumor angiogenesis. 
Subcutaneous injection of B16F10 melanoma cells into the flanks of E2KO or 
E3KO mice produced tumors comparable to those in control mice (Supplementary 
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Figure II.4C and D). Quantification of vascular density within tumors revealed 
only minor non-significant differences between tumors from E3KO and control mice 
(Supplementary Figure II.4E and F). In agreement with these data, JNK in 
endothelial cells was not activated by either hypoxia or VEGF (Supplementary 
Figure II.5A and B), and hypoxia responses and VEGF signaling were 
unimpaired in JNK-deficient endothelial cells (Supplementary Figure II.5C-E). 
Thus, JNK in the vascular endothelium is, dispensable for hypoxia and VEGF-
driven angiogenic responses in adult mice. 
 
Endothelial JNK deficiency results in enhanced blockade of blood perfusion and 
severe ischemic injury in models of arterial occlusion 
To examine the role of JNK in other aspects of vascular biology and function, we 
turned to a model of experimental arterial occlusion. Femoral artery ligation (FAL) 
causes hypoxia in the calf muscles stimulating angiogenesis; whereas the 
proximal adductor muscles experience little or no decrease in oxygen and 
nutrient supply due to an abundance of preexisting collateral arteries90 (Figure 
II.1B)  
 
We ligated the femoral artery (FA) between the proximal caudal femoral artery 
(PCFA) and the popliteal artery (PA, Figure II.1B),177 a very mild version of this 
model. Following occlusion, laser Doppler imaging revealed an ~80% decrease 
in blood perfusion in the ligated limbs of control mice and blood perfusion was 
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restored to ~60% of the contralateral limbs by day 3 (Figure II.1C and D). In 
striking contrast, even in this mild version of the model, most E3KO mice showed 
complete blockade of blood flow to the limbs following occlusion (Figure II.1C 
and D) leading to severe necrosis of the paws (Figure II.1E) with over 70% of 
mice developing "autoamputation" of the ligated limb (Figure II.1F and G). 
Control mice showed almost no signs of ischemia and only minor movement 
impairments (Figure II.1E-G). Ligation of the FA more proximally at its origin gave 
the same result (Supplementary Figure II.6A and B). It is worth noting that, to our 
knowledge, the severity of the blood perfusion defect in E3KO mice appears to be 
more profound than that of any other genetically modified mouse reported thus 
far. 
 
A similar model of coronary artery occlusion in the heart resulted in significantly 
higher mortality of E3KO mice compared to control mice (Supplementary Figure 
II.6C and D), suggesting that the vascular defects resulting in enhanced blood 
perfusion blockade upon arterial occlusion are not confined to the hindlimb.    
 
Following FAL, blood perfusion blockade and restoration in single Jnk1-/- 
or   Jnk2-/- mice was comparable to WT mice (Supplementary Figure II.6E) 
indicating that JNK1 isoforms and JNK2 isoforms are functionally redundant for 
the process(es) that govern blood perfusion blockade/restoration following 
FAL. E2KO mice, which lack both JNK1 plus JNK2 in the endothelium, performed 
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similarly to E3KO mice (Supplementary Figure II.6F), ruling out a required role for 
JNK3 in the severe phenotype observed in E3KO mice. Of note, we do not detect 
Jnk3 mRNA expression in lung endothelial cells from WT or E2KO mice under 
conditions in which Jnk3 expression is readily detectable in brain tissues. 
Together, these data demonstrate that JNK1 plus JNK2 in the vascular 
endothelium are critically required for the process(es) that determine the extent 
of blood perfusion blockade and/or restoration following occlusion of a major 
artery. 
 
In contrast, JNK in hematopoietic or skeletal muscle cells was dispensable for 
these process(es) because compound JNK1 plus JNK2 deficiency in all 
hematopoietic (Vav1-Cre, H2KO), myeloid (Lyz2-Cre, Φ2KO) or skeletal muscle 
(Ckm-Cre, M2KO) cells had no effect on blood perfusion blockade/restoration or 
ischemic damage following FAL (Figure II.1H-J). 
 
JNK in the vascular endothelium is necessary for proper patterning and 
connectivity of collateral arteries 
Analysis of functional cardiovascular parameters, including blood pressure and 
heart rate in Jnk1-/-, Jnk2-/- or E3KO mice revealed no major JNK-dependent 
perturbations (Supplementary Figure II.7A and B). Echocardiographic analysis 
showed normal cardiac function in E3KO mice (Supplementary Figure II.7C). 
Furthermore, contraction and endothelium-dependent relaxation responses in 
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aortic explants from E3KO mice were comparable to control mice (Supplementary 
Figure II.7D). These data indicated that the severe defect in blood perfusion in 
E3KO mice following FAL is unlikely to be due to overall cardiovascular 
dysfunction or defective vasodilatory responses in these mice. 
 
Much of the blood supply to the limb, particularly in the first few days following 
FAL, is provided by preexisting collateral arteries in the adductor muscles. The 
early and severe blood perfusion blockade in E3KO mice following FAL indicated a 
defect in these arteries and prompted their analysis. While multiple collateral 
arteries course through the adductor muscles at various depths, two highly 
stereotypic arteries (gracilis collaterals) stretch along the gracilis muscle in the 
medial aspect of the thigh (Figure II.1B). Their superficial location affords reliable 
visualization on wholemount preparations following intravascular Microfil 
perfusion and tissue clearing. 
 
In the unligated limbs of control mice, gracilis collaterals were easily identified as 
two lumenized continuous arteries that connected the PCFA to the saphenous 
artery (SA) (Figure II.2A, Unligated). Gracilis collaterals expanded radially by day 
4 following FAL (Figure II.2A, Ligated). In contrast, these arteries were highly 
abnormal in the unligated limbs of E3KO mice. In these mice, arteries emerged 
from both the PCFA and the SA (Figure II.2A), but they were thinner than in 
control mice (Figure II.2A-C) and branched off into multiple smaller vessels 
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forming a disorganized network instead of the continuous larger and very distinct 
collateral arteries that were observed in control mice (Figure II.2A-C). Micro-
computed tomography (µCT) analysis following intravascular contrast injection 
confirmed reduced collateral artery size and continuity in the limbs of E3KO mice 
(Figure II.2D). 
 
The mRNA abundance of endothelial cell specific markers Cdh5 and Pecam1 
was not altered in the adductor muscles and was significantly higher in the calf 
muscles of the unligated limbs of E3KO mice compared to control mice (Figure 
II.2E and Supplementary Figure II.8A) indicating that overall muscle 
vascularization was not reduced in E3KO mice. Following FAL, the mRNA 
abundance of endothelial cell specific markers was further increased in the 
muscles of E3KO mice compared to control mice (Figure II.2E and Supplementary 
Figure II.8A) likely due to enhanced angiogenesis resulting from higher levels of 
hypoxia. Indeed, expression of the hypoxia responsive gene, Glut1, was induced 
significantly higher in the adductor and calf muscles of E3KO mice compared to 
control mice (Figure II.2F).  
 
We also found no significant differences in the mRNA abundance of the 
macrophage marker Emr1 in the hindlimb muscles of E3KO mice compared to 
control mice (Supplementary Figure II.8B), suggesting no impairment in 
monocyte recruitment in E3KO mice.  
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Thus, although endothelial JNK appears to be dispensable 
for angiogenic responses in adult mice, it is critically required for proper 
patterning, connectivity and/or maturation of the collateral circulation. E3KO mice 
have highly abnormal collateral arteries that fail to provide an adequate 
alternative route for blood flow upon FAL, resulting in severe blood perfusion 
blockade that leads to extensive necrosis of the occluded limbs. 
 
The MLK group of MAP3Ks contributes to endothelial JNK activity and is 
important for proper native collateral artery development 
We explored additional molecular components within the MAPK signaling 
network that may mediate JNK activation during vascular development. The 
MAP2Ks, MKK4 and MKK7, have been clearly defined to directly phosphorylate 
and activate JNK.1 However, the role of individual MAP3Ks in mediating JNK 
activation in particular contexts in vivo is unclear. The MLK group of MAP3Ks has 
been shown to mediate TNF-induced JNK activation in a Rac1/Cdc42-dependent 
manner.5,178 Given the crucial role of Rac1/Cdc42 Rho family GTPases in 
endothelial cell cytoskeletal rearrangement and vascular development, we 
explored whether MLKs might mediate JNK activation important for vascular 
development in vivo.  
 
Of the four members of the MLK group of kinases,179 Mlk2 and Mlk3 were the two 
most highly expressed in endothelial cells (Figure II.3A). Mlk2-/-Mlk3-/- endothelial 
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cells displayed reduced bFGF-induced JNK activity as demonstrated by 
decreased cJun phosphorylation levels compared to WT endothelial cells (Figure 
II.3B). Therefore, we subjected Mlk2-/-Mlk3-/- double knockout mice to FAL to test 
if they would phenocopy the defects observed in endothelial JNK-deficient mice.  
 
Indeed, upon FAL, Mlk2-/-Mlk3-/- mice showed significantly more pronounced 
blood perfusion reduction compared to WT mice and almost no blood perfusion 
restoration by day 3 post FAL (Figure II.3C and D). Similarly to E2KO and E3KO 
mice, all Mlk2-/-Ml3-/- mice showed necrotic damage of the toes and paws of the 
ligated limb (Figure II.3E-G). Microphil perfusion analysis revealed abnormal 
gracilis collateral artery patterning in Mlk2-/-Mlk3-/- mice (Figure II.3H). Thus, 
these data strongly support the existence of an in vivo MLK/JNK signaling axis 
that is crucial for proper native collateral artery development. 
 
JNK in the vascular endothelium is dispensable for arteriogenic responses in 
adult mice 
The severe defect in preexisting collateral arteries in Mlk2-/-Mlk3-/- and E3KO mice 
prevented analysis of the role of endothelial JNK signaling in arteriogenesis in 
adult mice. We, therefore, employed the Cdh5(PAC)-CreERT2 driver line180 
to  generate mice, iE3KO (Cdh5(PAC)-CreERT2 Jnk1LoxP/LoxPJnk2LoxP/LoxPJnk3-/-) in 
which disruption of floxed alleles of JNK could be specifically induced in the 
vascular endothelium by tamoxifen administration at a desired time. We 
                                                                                                                                                                                                                                                                         
 
77 
administered tamoxifen to these mice as well as to appropriate Cre+ control 
(iECtrl, Cdh5(PAC)-CreERT2 Jnk1+/+Jnk2+/+Jnk3-/-) and Cre- (EfCtrl, 
Jnk1LoxP/LoxPJnk2LoxP/LoxPJnk3-/-) littermate mice at 6-8 weeks of age (a time when 
the native collateral circulation has been fully established) and following a 
recovery period, subjected them to FAL (Figure II.4A). JNK protein levels in 
purified endothelial cells from iE3KO mice were robustly diminished (Figure II.4B), 
however, in contrast to E3KO mice, blood perfusion blockade in iE3KO mice 
following FAL was similar to control mice, and there were no significant 
differences in blood perfusion recovery over 28 days (Figure II.4C). Intravascular 
Microfil perfusion analysis revealed a normal collateral circulation in 
the unligated limbs of iE3KO mice and these arteries remodeled similarly to those 
of control mice following FAL (Figure II.4D). These data, together with those from 
constitutive E3KO mice, demonstrate that endothelial JNK is dispensable 
for arteriogenic responses in adult mice, but is required for the proper formation 
of collateral arteries at an early time during development. Indeed, iE3KO mice in 
which recombination of floxed alleles of JNK was induced early during embryonic 
development by administering tamoxifen to pregnant females at 12.5 days post 
coitus (dpc) (Figure II.4E) and materials and methods) displayed significantly 
more severe blood perfusion reduction following FAL compared to littermate 
control mice (Figure II.4F). The severity of the blood perfusion blockade in this 
case was not as pronounced as that in constitutive E3KO mice because of highly 
variable recombination efficiency as demonstrated by analysis of Cdh5(PAC)-
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CreERT2, Rosa26-mT/mG (EmTmG) double transgenic reporter mice that were 
subjected to the same tamoxifen treatment protocol (Figure II.4G). 
 
Endothelial MLK/JNK signaling is critically required for muscle collaterogenesis 
during embryonic development 
Prior studies have described the development of the pial collateral circulation, 
which interconnects the distal branches of the middle cerebral and the anterior 
cerebral arteries. However, a detailed analysis of the formation of collateral 
arteries in muscle during ontogeny has not been reported. We, therefore, 
developed several immunofluorescence and 1,1'-Dioctadecyl-3,3,3',3'-
Tetramethylindocarbocyanine Perchlorate (Dil) perfusion protocols and 
generated genetic reporter mice to label the vasculature in order to trace the 
development of muscle collaterals at various stages of development in whole-
mount preparations of adductor muscles. 
 
At P6 and P0 in control mice, gracilis collaterals appeared fully formed 
connecting the PCFA to the SA (Figure II.5A and B). They were lumenized as 
evidenced by Dil perfusion analysis (Figure II.5A and B) and were fully covered 
by smooth muscle cells at P6 (Figure II.5A, SMA), but not P0 (Figure II.5B, 
SMA). In contrast, gracilis collaterals in E3KO mice had not properly formed at 
either P6 or P0 (Figure II.5A and B). Individual vessels did emerge from both 
the PCFA and the SA, but instead of interconnecting to form true collaterals, 
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these vessels branched off into multiple smaller caliber vessels (Figure II.5A and 
B, Dil Perfusion) that lacked smooth muscle coverage even at P6 (Figure II.5A, 
SMA) and appeared to enter the capillary circulation (Figure II.5A and B, Dil 
Perfusion). Similarly, analysis of the abdominal muscle arterial circulation in P0 
pups revealed numerous arteriolar arcades (direct arteriole-to-arteriole 
interconnections) in control mice (Figure II.5C), but this type of arterial 
arrangement was almost entirely absent in E3KO mice. Instead, E3KO mice 
displayed a tree like arterial pattern with very few direct artery-to-artery 
interconnections (Figure II.5C). 
 
Analysis of gracilis collaterals in adductor muscles and arteriolar arcades in 
abdominal muscles from P6 Mlk2-/-Mlk3-/- mice revealed defects similar to those 
observed in E3KO mice supporting a MLK/JNK signaling axis crucial for collateral 
artery formation (Figure II.6A and B). 
 
To understand how the defects in collateral artery patterning/maturation in E3KO 
mice may have arisen, we analyzed the vasculature in whole mount preparations 
of adductor muscles during embryonic life. In control mice at embryonic day 
(E)16.5, large caliber vessels including the FA/SA and PCFA were established in 
their typical positions (Figure II.5D and E) as observed in postnatal mice. 
However, distinct vessels directly interconnecting the PCFA to the SA had not 
been fully established at this time and the gracilis muscle region where collateral 
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arteries are present in postnatal mice was, for the most part, covered by a 
capillary plexus (Figure II.5D and E). Larger, more prominent vessels staining 
more intensely for iB4 could be distinguished to emerge from the PCFA and the 
SA (Figure II.5E, arrowheads), but instead of running the entire course of 
the gracilis muscle length as distinct collaterals, they branched off and entered 
the capillary plexus (Figure II.5E). Thus, it appears that gracilis collateral arteries 
form through a plexus intermediate, whereby certain vessels within the plexus 
undergo extensive remodeling and maturation into distinct arteries that 
interconnect the PCFA to the SA. This process of maturation appears to start at 
the two distal ends, where the future gracilis collaterals emerge from the PCFA 
and the SA and continues toward the middle of the muscle - a pattern of 
remodeling that likely reflects and is driven by the blood flow characteristics 
through these vessels. 
 
Large caliber vessels in E16.5 E3KO adductor muscles were similar to those in 
control mice, however, the capillary network between the PCFA and the SA 
displayed a hyperbranched and more disorganized arrangement of vessels with 
more pronounced thickness variation and that appeared to elaborate more 
filopodia (Figure II.5D and E). These observations suggested that the 
pronounced defects in collateral artery patterning/maturation in E3KO mice may 
arise due to defective sprouting angiogenesis that initially generates 
a hyperbranched, denser and more chaotically organized plexus that later fails to 
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remodel properly. 
 
Endothelial JNK deficiency results in abnormal sprouting angiogenesis during 
retinal vascular development 
To explore the role of endothelial JNK in sprouting angiogenesis in more detail, 
we analyzed retinal vascular development during the early postnatal period as 
this represents a well-characterized system that allows high-resolution analysis 
of sprouting angiogenesis in a developing vascular plexus that initially extends 
from the center towards the periphery of the retina in two dimensions.35,38 
Analysis of retinal flatmounts from P6 E3KO and E2KO mice revealed significantly 
reduced radial extension of the vascular plexus toward the periphery of the retina 
(Figure II.7A-C, L and Supplementary Figure II.9A-C and L). Closer examination 
showed higher vascular density in the region of the growing angiogenic front of 
E3KO and E2KO retinas compared to retinas from respective littermate control mice 
(Figure II.7D-G, H, J, M and Supplementary Figure II.9D-G, H, J, M). Regions of 
higher vascular density were particularly prominent adjacent to veins. Vascular 
extension in the retina occurs through the coordinated interaction, migration and 
proliferation of endothelial tip and stalk cells as well as non-endothelial cells 
including pericytes that help stabilize the vascular plexus.37 We found no 
differences in vessel pericyte coverage (Supplementary Figure II.10), however 
the E3KO and E2KO angiogenic front displayed significantly more tip cells (Figure 
II.7H, J yellow asterisks, N and Supplementary Figure II.9H, J yellow asterisks, 
                                                                                                                                                                                                                                                                         
 
82 
N). Additionally, JNK deficient tip cells exhibited more filopodia (Figure II.7I, K red 
dots, O and Supplementary Figure II.9I, K red dots, O). All retinal vascular 
defects observed in E3KO and E2KO mice were phenocopied in Mlk2-/-Mlk3-/- mice 
(Figure II.8) confirming a MLK/JNK signaling axis critical for restraining excessive 
endothelial cell sprouting during developmental angiogenesis.  
 
Reduced DLL4 – Notch signaling may contribute to the vascular morphogenetic 
defects of endothelial JNK deficient mice 
Endothelial cell hypersprouting in the absence of MLK/JNK signaling provides a 
basis for the defective cellular process that likely underlies abnormal patterning 
and maturation of collateral arteries in E3KO and Mlk2-/-Mlk3-/- mice. To begin to 
understand the molecular mechanisms that contribute to these cellular defects, 
we analyzed gene expression in isolated primary endothelial cells from control 
and E3KO mice by RNA sequencing (RNA Seq). JNK-deficient endothelial cells 
displayed altered gene expression compared to control cells. Of the ~1x104 
genes that were expressed (Fragments Per Kilobase of exon per Million 
fragments mapped  [FPKM] >2) in endothelial cells, 781 genes were significantly 
differentially expressed (log2 fold change ≤ -0.5 or ≥ +0.5; q ≤ 0.05) in E3KO vs. 
ECtrl and EfCtrl endothelial cells. Approximately similar numbers of genes were 
upregulated or downregulated (Figure II.9A). Gene ontology analysis of the group 
of differentially expressed genes identified significant enrichment in genes 
involved in several biological processes including mitosis/cell division/cell cycle, 
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and vascular development and morphogenesis (Figure II.9B).  
 
Differentially expressed genes related to mitosis/cell division/cell cycle identified 
by the gene ontology analysis are presented as a heat map in Figure II.9C; 
however, because we have not detected alterations in proliferation of JNK-
deficient endothelial cells (Supplementary Figure II.3C and D), these changes 
may not be biologically relevant. 
  
We additionally surveyed ~200 genes with known or putative roles in vascular 
development and function and identified 64 significantly differentially expressed 
genes in E3KO vs. ECtrl and EfCtrl endothelial cells, including those revealed by the 
gene ontology analysis. These genes, grouped in several categories, are 
presented as a heatmap in Figure II.9D. Several of these gene expression 
changes could contribute to the vascular defects observed in the absence of 
endothelial JNK signaling and the potential relevance of some is further 
considered in Chapter IV below.  
 
RNA Seq analysis revealed significant perturbations in Notch pathway gene 
expression, including downregulation of the Notch ligand and target gene Dll4 as 
well as the glycosyltransferase Lunatic Fringe (Lfng) and the Notch target gene 
Hey1 (Figure II.9D). We focused on Notch signaling as this represents a pathway 
that plays major roles during developmental angiogenesis, in particular tip/stalk 
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cell specification and endothelial cell sprouting.37 Indeed, the hypersprouting 
defects observed in E3KO and Mlk2-/-Mlk3-/- mice appear to closely resemble 
those previously reported in mice with reduced Dll4/Notch signaling,43,46,47 
including Lfng-/- mice.47 Additionally, Dll4+/- mice display perturbations in collateral 
artery formation82 and along with Notch1+/- mice181 show reduced recovery of 
blood perfusion in models of vascular occlusion.  
 
We confirmed decreased expression of Dll4 and other Notch pathway genes by 
quantitative RT-PCR analysis of mRNA from independent preparations of E3KO 
and control endothelial cells (Figure II.10A). Additionally, we verified reduced Dll4 
protein expression in E3KO endothelial cells compared to control cells by 
immunofluorescence analysis (Figure II.10B). VEGF stimulation is known to 
induce Dll4 expression and Notch signaling. Treatment of endothelial cell 
cultures with VEGF-A lead to increased abundance of Dll4 protein and Notch1 
intracellular domain (NICD) in control cells and reduced levels of both in E3KO 
cells (Figure II.10C). We also found that, similar to VEGF-A, basic fibroblast 
growth factor (bFGF) treatment caused increased Dll4 and NICD levels in 
endothelial cells (Figure II.10D). This response was suppressed in E3KO cells 
(Figure II.10D). Interestingly, in contrast to VEGF-A, bFGF induced marked JNK 
activation and cJun phosphorylation in endothelial cells (Figure II.10D). Thus, 
multiple stimuli may regulate Dll4 levels and Notch signaling in vivo during 
sprouting angiogenesis and some of these intersect with JNK signaling. 
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To provide in vivo evidence for the Dll4-Notch signaling perturbations detected in 
E3KO endothelial cells, we performed immunofluorescence analysis for Dll4 on P6 
retinas. This analysis revealed significantly reduced Dll4 immunostaining at the 
angiogenic front of retinas from E3KO mice compared to retinas from littermate 
control mice (Figure II.10E), suggesting that reduced Dll4-Notch signaling in the 
endothelium of E3KO mice may contribute to the endothelial cell hypersprouting 
observed in these mice.  
 
Thus, JNK may modulate Notch signaling in endothelial cells in vivo by regulating 
Dll4 expression leading to suppression of excessive sprouting angiogenesis and 
ensuring normal vascular morphogenesis. This function of JNK may be important 
for its critical role in ensuring proper formation and maturation of native collateral 
arteries and suppression of ischemic damage following arterial occlusion (Figure 
II.11). 
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Discussion 
 
Formation of properly organized vascular networks is essential for function and 
requires the coordinated interaction of numerous factors and signaling pathways 
that regulate diverse cellular processes. VEGF signaling promotes endothelial 
cell survival, proliferation and motility, while Dll4–Notch signaling suppresses 
some of the effects of VEGF in part by regulating VEGFR 
expression.34,37,39,41,45,46 Thus, the cooperation of VEGF and Notch signaling 
specifies unique endothelial cell phenotypes including highly motile tip cells that 
extend numerous filopodia and trailing stalk cells with low motility that form the 
lumen of nascent tubules. The proper specification and interplay of tip and stalk 
cells is essential for the orchestration of sprouting angiogenesis that mediates 
expansion of vascular networks.34,37,39,41,45,46 This study identifies a MLK – JNK 
signaling pathway that regulates tip cell identity, and filopodia dynamics, in part, 
likely via JNK-dependent regulation of Dll4 expression. Thus, Mlk2-/-Mlk3-/- mice 
or mice with compound endothelial-specific JNK-deficiency display excessive 
sprouting angiogenesis in the retina that is marked by an increased number of 
tips and filopodia, and increased vascular density and is associated with 
decreased Dll4 expression at the angiogenic front of endothelial JNK-deficient 
mice (Figure II.11). 
The hypersprouting defects during developmental sprouting angiogenesis in the 
absence of MLK – JNK signaling may underlie the critical requirement of this 
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signaling pathway for native collateral artery formation. This is supported by our 
analysis of adductor muscle vasculature in Mlk2-/-Mlk3-/- and endothelial-specific 
JNK-deficient mice at various stages of development.  
 
Analysis of muscle collateral artery formation during ontogeny has been 
hampered by technical difficulties. We have generated reporter mice in 
conjunction with compound endothelial-specific conditional deletion of JNK 
isoforms and have adapted and optimized Dil perfusion and immunofluorescence 
protocols that have allowed us to visualize several aspects of the vascular 
morphogenetic processes involved in collateral artery formation during ontogeny 
as well as their perturbations in mice that lack JNK signaling in the endothelium. 
The observations from this analysis lead us to propose a model of collateral 
artery formation in hindlimb adductor muscles that may have features that are 
distinctly different from those described for pial collateral artery formation in the 
brain.61 Thus, our analysis suggests that gracilis collaterals are not formed in 
isolation as distinct sprouts from existing arteries, but may arise through selection 
and maturation of vessels within a pre-formed capillary network that separates 
adjacent arteries. Preliminary analysis suggests that the sites where these 
collaterals form may be dictated by the presence of nerve fibers coursing through 
the gracilis muscle (Supplementary Figure II.11). Presumably, factors secreted 
from these fibers may guide the selection and maturation of vessels in close 
proximity. Additionally, our observation that the maturation of gracilis collaterals 
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appears to start where these vessels emerge from the parent arteries and 
continues towards the middle of the collateral vessels suggests that the 
maturation of gracilis collaterals may also be driven by the blood flow 
characteristics through these vessels.182 
 
At E16.5 when collaterals in control mice have not fully formed, the capillary 
plexus between adjacent arteries in mice with endothelial JNK deficiency 
appears denser and more chaotically organized than that in control mice. High 
variation in vessel thickness and increased numbers of filopodia are also evident 
in the JNK-deficient vasculature. These perturbations appear to mirror those 
seen in the retinal vasculature of Mlk2-/-Mlk3-/- and E3KO mice suggesting that 
similar mechanisms are involved. These morphogenetic defects are likely to 
contribute to the defective maturation of collateral arteries that are observed at 
later developmental timepoints in mice with disrupted MLK – JNK signaling.  
 
At P6 we observed that collateral vessels in control mice were invested with 
smooth muscle cells throughout their length effectively defining them as collateral 
arteries. In contrast, the analogous vessels in the gracilis muscle of Mlk2-/-Mlk3-/- 
and E3KO mice lacked continuous smooth muscle cell coverage suggesting that 
smooth muscle cell recruitment might be defective in these mice. However, at 
P0, smooth muscle cell coverage was absent in control mice, yet continuous and 
distinct gracilis collateral vessels interconnecting the PCFA to the SA were fully 
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formed. In contrast, the analogous vessels in the gracilis muscle of E3KO mice 
were also defective (branching extensively into smaller vessels that entered the 
capillary circulation) at P0, indicating that defective smooth muscle coverage is 
not likely to be a primary defect in these mice, but may occur subsequent to 
defective primary plexus formation. 
 
Our data indicate that the morphogenetic defects in the JNK-deficient capillary 
network arise due to excessive endothelial cell sprouting and that reduced Dll4 – 
Notch signaling may be a significant contributor. This idea is supported by prior 
studies that have investigated the function of Dll4 – Notch signaling during 
sprouting angiogenesis and collateral artery formation. Thus, various Notch loss 
of function mouse models, including loss of Dll4,46 Notch1,46 Lfng,47 RBP-J48,49 or 
chemical inhibition of γ-secretase with N-[N-(3,5–Difluorophenacetyl- L-alanyl)]-S-
phenylglycine t-butyl ester (DAPT)46, exhibit excessive endothelial cell sprouting 
during the postnatal development of the retinal vasculature. Furthermore, Dll4+/- 
mice show increased pial collateral artery branching that is not associated with 
decreased infarct size following medial cerebral artery occlusion, suggesting that 
these vessels, although more numerous, are functionally defective and do not 
result in improved blood perfusion.82 Dll4+/- mice also display defects in blood 
perfusion restoration following FAL,82 however collateral arteries were not 
specifically analyzed in the hindlimb adductor muscles in that study. Micro-CT 
angiography of the occluded hindlimb vasculature revealed significantly 
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decreased arteriolar numbers in the calf muscles of Dll4+/- mice compared to 
control mice,82 but this could have resulted from impaired contrast perfusion due 
to defective collateral artery patterning in the adductor muscles. A more direct 
analysis of the native collateral arteries in the adductors of Dll4+/- mice using 
methods similar to those employed in our study would help clarify the role of Dll4 
in native collateral artery formation.     
 
The collateral artery defects observed in Mlk2-/-Mlk3-/- and E3KO mice in the early 
postnatal period continue into adulthood and underlie the severe blood perfusion 
blockade and exuberant necrosis that follows shortly after FAL in these mice 
(Figure II.11). The severity of the blood perfusion defect and limb necrosis in 
Mlk2-/-Mlk3-/- and E3KO is remarkable and unprecedented, particularly because we 
performed very mild versions of the FAL model that involved only ligation of the 
femoral artery without excision. Despite this, all Mlk2-/-Mlk3-/- and E3KO mice 
develop paw necrosis and over 70% of E3KO mice undergo complete 
autoamputation of the paw on the ligated limb highlighting the critical importance 
of MLK – JNK signaling in native collateral artery development and the essential 
role of pre-existing collaterals in restoring blood perfusion following arterial 
occlusion.  
 
In contrast to its critical function in native collateral artery formation during 
embryonic development, we find that endothelial JNK is dispensable for 
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arteriogenic remodeling in adult mice in the setting of arterial occlusion (at least 
in our mild version of the model). We were able to uncouple the role of JNK in 
these two processes by employing an inducible conditional deletion strategy that 
allowed us to induce JNK ablation from the endothelium in adult mice at a time 
when native collateral arteries are fully established. Indeed, endothelial JNK 
disruption in adult mice had no effect on collateral artery remodeling or blood 
perfusion restoration following FAL. This is consistent with the lack of 
perturbations in the proliferation capacity of JNK-deficient endothelial cells, the 
absence of endothelial cell-dependent recruitment of monocyte/macrophages in 
E3KO mice and the absence of major defects in angiogenic responses in adult 
E3KO mice. Remarkably, though not unexpectedly, inducing deletion of JNK 
during embryogenesis by administering tamoxifen to pregnant mothers at 12.5 
dpc lead to significantly enhanced blood perfusion reduction following arterial 
occlusion compared to control mice, once again pointing to an essential role for 
endothelial JNK in developmental vascular morphogenesis and native collateral 
formation, but not in adult angiogenic and arteriogenic responses in models of 
pathological vascularization.  
 
Although not precise due to differences in ligation protocols, comparison of the 
blood perfusion reduction, the ischemic damage and functional impairment 
following FAL in Mlk2-/-Mlk3-/- and E3KO mice with those reported in Notch loss of 
function mice indicates that loss of MLK – JNK signaling results in more severe 
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defects suggesting that mechanism(s) in addition to reduced Dll4 – Notch 
signaling may be contributing to the collateral artery defects in E3KO mice. Indeed, 
RNA-Seq analysis revealed additional gene expression changes in E3KO 
endothelial cells compared to control cells that may play a role.  
 
In summary, our study provides insight into the mechanism that controls 
formation of muscle collateral arteries, which are critically important for the 
response to arterial occlusive disease. Muscle collaterals provide an alternate 
route for blood flow and serve to protect against ischemic tissue damage.  We 
show that the MLK-JNK pathway is required for collateral artery development and 
patterning, but is not required for angiogenesis or arteriogenesis in adults.  The 
MLK-JNK pathway plays a key role in Notch-regulated angiogenic sprouting 
during capillary plexus formation and remodeling that leads to the development 
of the muscle collateral arteries. Defects in the MLK-JNK pathway result in the 
loss of muscle collateral circulation, profoundly suppressing protective responses 
to arterial occlusion (Figure II.11).  
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Experimental Procedures 
 
Mice 
We have previously described Jnk1LoxP/LoxP, Jnk2LoxP/LoxP, Jnk1-/-, Jnk2-/-, Jnk3-/-, 
ΦKO mice (Lyz2-Cre+ Jnk1LoxP/LoxP Jnk2LoxP/LoxP), ΦWT mice (Lyz2-Cre+ Jnk1+/+ 
Jnk2+/+), and Mlk2-/- Mlk3-/- mice5,161-163183,184. C57BL/6J mice (Stock# 000664), 
B6.SJL-Ptprca Pepcb/BoyJ mice (Stock# 002014), B6.FVB-Tg(Cdh5-cre)7Mlia/J 
mice (Stock# 006137)176, B6.Cg-Tg(Vav1-cre)A2Kio/J mice (Stock# 008610)185, 
B6.FVB(129S4)Tg(Ckmm-cre)5Khn/J mice (Stock# 006475)186, and B6.129(Cg)-
Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J (also known as Rosa26mTmG) mice 
(Stock# 007676)187 were obtained from The Jackson Laboratories. Cdh5(PAC)-
CreERT2 mice180 were provided by Prof. Ralf H. Adams. We generated the 
following mice: 
E3KO (Cdh5-Cre+ Jnk1LoxP/LoxP Jnk2LoxP/LoxP Jnk3-/-) 
EfCtrl (Cdh5-Cre- Jnk1LoxP/LoxP Jnk2LoxP/LoxP Jnk3-/-) 
ECtrl (Cdh5-Cre+ Jnk1+/+ Jnk2+/+ Jnk3-/-)  
E2KO (Cdh5Cre+ Jnk1LoxP/LoxP Jnk2LoxP/LoxP) 
ELoxP (Cdh5-Cre- Jnk1LoxP/LoxP Jnk2LoxP/LoxP) 
EWT (Cdh5-Cre+ Jnk1+/+ Jnk2+/+) 
E2KO:mTmG (Cdh5-Cre+ Jnk1LoxP/LoxP Jnk2LoxP/LoxP Rosa26mTmG) 
EmTmG (Cdh5-Cre+ Rosa26mTmG)  
iE3KO (Cdh5(PAC)-CreERT2+Jnk1LoxP/LoxP Jnk2LoxP/LoxP Jnk3-/-) 
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iEfCtrl (Cdh5(PAC)-CreERT2- Jnk1LoxP/LoxP Jnk2LoxP/LoxP Jnk3-/-) 
iECtrl (Cdh5(PAC)-CreERT2+ Jnk1+/+ Jnk2+/+ Jnk3-/-) 
iE2KO:mTmG (Cdh5(PAC)-CreERT2+ Jnk1LoxP/LoxP Jnk2LoxP/LoxP Rosa26mTmG) 
ELoxP:mTmG (Cdh5(PAC)-CreERT2- Jnk1LoxP/LoxP Jnk2LoxP/LoxP Rosa26mTmG) 
iEmTmG (Cdh5(PAC)-CreERT2+ Jnk1+/+ Jnk2+/+ Rosa26mTmG) 
H2KO (Vav1-Cre+ Jnk1LoxP/LoxP Jnk2LoxP/LoxP) 
HLoxP (Vav1-Cre- Jnk1LoxP/LoxP Jnk2LoxP/LoxP) 
HWT (Vav1-Cre+ Jnk1+/+ Jnk2+/+) 
M2KO (Ckm-Cre+ Jnk1LoxP/LoxP Jnk2LoxP/LoxP) 
MWT (Ckm-Cre+ Jnk1+/+ Jnk2+/+) 
All mice used in this study were backcrossed (≥ ten generations) to the C57BL/6J 
strain. The mice were housed in a specific pathogen-free (SPF) facility accredited 
by the American Association for Laboratory Animal Care. The animal studies 
were approved by the Institutional Animal Care and Use Committees of the 
University of Massachusetts Medical School, Tufts University School of Medicine, 
and Brigham and Women’s Hospital.   
 
Some E2KO and E3KO mice develop tooth abnormalities. We are currently 
investigating this phenotype. Only mice with normal teeth were used for 
experiments in this study. 
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Genotyping 
PCR assays with genomic DNA and the amplimers                                               
5’-TTACTGACCGTACACCAAATTTGCCTGC-3’ and  
5’-CCTGGCAGCGATCGCTATTTTCCATGAGTG-3’ were used to detect the 
Cre+ allele (450 bp). The amplimers 5’CCTCAGGAAGAAAGGGCTTATTTC-3’ 
and 5’-GAACCACTGTTCCAATTTCCATCC-3’ detected the Jnk1+ allele (1,550 
bp), the Jnk1LoxP allele (1,095 bp), and the Jnk1Δ allele (395 bp). The amplimers 
5’-GTTTTGTAAAGGGAGCCGAC-3’ and  
5’-CCTGACTACTGAGCCTGGTTTCTC-3’ were used to detect the Jnk2+ allele 
(224 bp) and the Jnk2LoxP allele (264 bp). The amplimers  
5’-GGAATGTTTGGTCCTTTAG-3’, 5’-GCTATTCAGAGTTAAGTG-3’, and  
5’-TTCATTCTAAGCTCAGACTC-3’ were used to detect the Jnk2LoxP allele (560 
bp) and the Jnk2Δ allele (400 bp). The amplimers  
5’-CCTGCTTCTCAGAAACACCCTTC-3’,  
5’-CGTAATCTTGTCACAGAAATCCCATAC-3’ and  
5’-CTCCAGACTGCCTTGGGAAAA-3’ were used to detect the Jnk3+ allele (437 
bp) and the Jnk3- allele (250 bp). The amplimers  
5’-CTCTGCTGCCTCCTGGCTTCT-3’, 5’-CGAGGCGGATCACAAGCAATA-3’ 
and 5’-TCAATGGGCGGGGGTCGTT-3’ were used to detect the mTmG allele 
(250 bp) and the WT allele (330 bp). The amplimers  
5’-CCTGGTTCTCACTGGGACAACAG-3’, 5’-GTCACATCCACTTTCCTGGGC-3’, 
and 5’-CGCCTTCTATCGCCTTCTTGA-3’ detected the Mlk2+ allele (500 bp) and 
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the Mlk2- allele (600 bp).  The amplimers 5’-AGCAAACTCCGAGCAAGGGAC-3’, 
5’-GGCTAAACCAGAACTCAAGCGTG-3’, and  
5’-GTAGAAGGTGGCGCGAAGGG-3’ were used to detect the Mlk3+ allele (160 
bp) and the Mlk3- allele (280 bp). 
 
Tamoxifen Treatments 
Tamoxifen (Sigma) was dissolved in 2% ethanol 98% sunflower seed oil (Sigma) 
and 1 mg/mouse was administered intraperitoneally (ip) 5 times on alternate 
days to 6-8 week old male mice. To induce cre activity during embryonic 
development pregnant females received 3 mg of tamoxifen once via oral gavage 
at 12.5 days post coitus (dpc). For these experiments, we used Cre- females that 
had been crossed to Cre+ males to avoid induction of Cre activity and 
recombination in the pregnant females. Pups were delivered by C-section at ~ 
19.5 dpc and transferred to foster mothers.    
 
Femoral Artery Ligation Model and Laser Doppler Imaging 
Unilateral femoral artery ligation and laser Doppler imaging was performed using 
10-14 week old male mice as previously described188,189 with the following 
modifications. Two ligation protocols were performed. In one protocol we ligated 
the femoral artery at its origin. The second protocol involved ligation of the 
femoral artery between the proximal caudal femoral artery and 
the popliteal artery as well as ligation of the superficial epigastric artery. The 
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second ligation schema allows for more blood flow to be diverted to the 
gracilis collateral circulation. Quantitative scores for ischemia and movement 
post-FAL were performed as described74. 
 
Congenic B16F10 Tumor Model 
One million congenic B16F10 melanoma cells (CRL-6475, ATCC) were injected 
subcutaneously on both flanks of mice. Tumors were harvested 2 weeks later, 
weighed, imaged on a Zeiss Stereo Discovery.V12 stereomicroscope, fixed in 
4% PFA overnight at 4oC, dehydrated sequentially in 15% and 30% sucrose 
solutions, imbedded in Optical Cutting Temperature (OCT), frozen 
and cryosectioned at 10 µm thickness. Sections were allowed to dry at room 
temperature, rehydrated in PBS, blocked and permeabilized in 10% normal goat 
serum, 0.1% TritonX-100 in PBS for 1 hr at RT and incubated with primary 
antibodies, mouse anti-smooth muscle actin (1:500, Sigma) and rat anti-CD31 
(1:50, BD Biosciences) in 1% BSA PBS for 2 hrs at RT. Sections were washed 3 
x 5 minutes each with PBS and incubated with Alexa Fluor 546-goat anti mouse 
and Alexa Fluor 488-goat anti rat antibodies in 1% BSA PBS for 1 hr at RT. 
Following washing as above, DNA was stained with DAPI, sections mounted in 
FluoromountG (Southern Biotech) and imaged on a TCS SP2 Leica confocal 
microscope. 
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Laser-Induced CNV Model 
Choroidal neovascularization was induced in mice using a 532 nm laser as 
previously described.190 Four laser spots/eye were applied and eyes were 
harvested 7 days post-lasering, fixed in 4%PFA at 4oC overnight and eyecups 
dissected and subjected to wholemount immunofluorescence. 
 
Aortic Ring Assay 
The aortic ring assay was performed in collagen as previously described.191 
 
Blood Pressure and Heart Rate 
Blood pressure and heart rate measurements were done on 10-14 week old male 
mice using a noninvasive computerized tail cuff system (BP-2000, VisiTech 
Systems). Mice were trained for 1 week, and then systolic and diastolic blood 
pressure and heart rate were recorded as the mean of at least 16 successful 
measurements over 1 week. 
 
Measurement of Arterial Contraction / Relaxation Responses 
Aortas were harvested from mice, flushed and cleaned of periaortic fat as 
described191, cut into 2 mm long rings and equilibrated in Opti-MEM containing 
penicillin/streptomycin overnight at 37oC. Contraction and relaxation responses 
were measured using a 6-mL vessel myograph (Danish Myo Technology) as 
previously described188 with the following modifications. Arterial contraction in 
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response to increasing doses of phenylephrine (Phe) was recorded and 
expressed as percent of maximum contraction obtained in response to incubation 
in K-PSS (60 mM potassium-containing physiologic salt solution [mM: NaCl 130, 
KCl 4.7, KHPO4 1.18, MgSO4 1.17, CaCl2 1.6, NaHCO3 14.9, dextrose 5.5, 
CaNa2/EDTA 0.03]). Vasorelaxation in response to increasing doses of 
acetylcholine was recorded following pre-contraction with Phe (10-6 M). 
 
Coronary Artery Ligation Model 
Myocardial infarction studies were done at the Partners Cardiovascular 
Physiology Core at Brigham and Women’s Hospital as previously 
described.192,193 Briefly, adult male mice were anesthetized by IP injection of a 
mixture of ketamine (40 mg/kg) and xylazine (10 mg/kg), intubated, and 
mechanically ventilated. Following thoracotomy, the pericardium was removed, 
and the proximal left coronary artery was permanently occluded with an 
intramural stitch. 
 
Echocardiography 
Echocardiography (Vevo 2100, VisualSonics Inc.) was performed at the Partners 
Cardiovascular Physiology Core at Brigham and Women’s Hospital as previously 
described.193 Two-dimensional and M-mode echocardiographic images were 
obtained from lightly sedated (1% isoflurane in oxygen) mice and recorded. M-
mode images were obtained from the parasternal short-axis view at the level of 
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the papillary muscles and used for measurements. 
 
Microfil and Bismuth/Gelatin Perfusions 
Deeply anesthetized (100 mg/kg ketamine and 20 mg/kg xylazine) and 
heparinized (400 U) mice underwent thoracotomy, the right atrium was severed 
and mice were maximally vasodilated by infusing, via the left ventricle, 30 ml 
normal saline containing 1 g/l adenosine, 4 mg/l papaverine and 100 µg/ml 
heparin followed by 15 ml 2% formalin and ~0.5 ml uncatalyzed blue Microfil to 
help visualize the abdominal aorta during cannulation. Mice were then transected 
just below the diaphragm, the abdominal aorta was cannulated (Mc-28, Braintree 
Scientific) and the vasculature perfused with ~3 ml undiluted catalyzed Microfil or 
10 ml of a warm 50% Bismuth (prepared as described194)/7% gelatin in normal 
saline mixture with the aid of a syringe gun (IGSET-3510, Medco). The aorta and 
vena cava were then clamped and the perfusate allowed to polymerize for at 
least an hour at 4oC before the hindlimbs were harvested, the skin removed and 
the limbs placed in 10% formalin. 
 
µCT Analysis 
Hindlimbs were scanned in air aligned axially on a Scanco µCT 40 at 70kVp, 
114µA and a resolution of 10µm. The region of interest  (ROI) included the entire 
hindlimb. To obtain the bone/vasculature overlay image, a contour around the 
entire ROI was utilized and segmented to include all soft and hard tissue. A 
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second contour of the same ROI with the bone removed was also performed and 
segmented. The segmentation parameters included the values 0.8 Gauss sigma, 
1.0 Gauss support, and a threshold of 212-1000 (density range of 500mg of 
HA/cm3). The two segmented files were overlaid using Scanco’s IPL 
Transparency program and a false color image of the resulting file was created 
using the 3D Display program. 
 
Dil Perfusions 
The Dil solution was prepared as previously described195, with addition of a 
filtration step through a 40 µm filter to remove large undissolved particles. P0 or 
P6 pups were euthanized by Isofluorane inhalation, decapitated and immediately 
perfused via the left ventricle with 3 or 5 ml respectively of Dil solution using a 10 
ml syringe and 27 gauge needle and/or the thoracic aorta using a micro cannula 
(Mc-28, Braintree Scientific). Pups were then rinsed with PBS and fixed/stored in 
4% paraformaldehyde (PFA) at 4oC until dissected. 
 
Dissections 
Eyes were fixed in 4% PFA for 1 hr at RT or 4oC overnight and retinas 
were dissected as previously described.36 For immunofluorescence or to 
visualize GFP, decapitated E16.5 and P0 pups were rinsed in PBS, whereas P6 
pups were perfused with PBS via the left ventricle and all were fixed in 4% PFA 
at 4oC overnight. Working under a stereomicroscope, pups were transected 
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below the diaphragm and a midsagital incision was performed to separate the 
two hindlimbs and the associated abdominal musculature. The skin and 
associated adipose tissue was carefully removed and the abdominal muscles 
isolated via incisions at their attachment to the pelvis and vertebral column. The 
entire medial surface of the hindlimb adductor muscles was harvested en 
block via careful dissection 1-2 mm around the saphenous, femoral and proximal 
caudal femoral arteries. Muscle tissues were then either cleared sequentially 
(70% and 90% glycerol/PBS, at least 5 hrs each) and mounted in 
90% glycerol/PBS for direct visualization of GFP or Dil or processed for 
immunofluorescence analysis. The medial surface of adductor muscles of fixed 
and dehydrated (70 and 100% ethanol) Microfil-perfused hindlimbs from adult 
mice was dissected similarly; muscles were cleared in methyl salicylate (Sigma) 
and imaged on a Zeiss Stereo Discovery.V12 stereomicroscope. 
 
Whole Mount Tissue Lectin and Immunofluorescence Staining 
Muscles were blocked and permeabilized in 1% BSA, 0.5% TritonX-100 PBS 
overnight at 4oC. Tissues were equilibrated by washing 3 x 10 minutes each with 
Pblec buffer (1% Triton X-100, 1 mM CaCl2, 1 mM MgCl2, and 1 mM MnCl2 in 
PBS pH 6.8) and incubated with biotinylated Griffonia Simplifolica isolectin B4 
(iB4, 1:25, Vector Labs) in Pblec buffer. Antibodies were diluted in 1% BSA, 1% 
normal donkey serum (NDS), 1% TritonX-100 PBS and muscle samples were 
incubated in antibody solution for two days at 4oC. We used the following primary 
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antibodies: FITC-conjugated smooth muscle actin (1:500, Sigma), goat anti-
endomucin (1:100, R&D Systems) and mouse anti-Neurofilament-M (2H3; 
Developmental Studies Hybridoma Bank). Following primary detection, samples 
were washed 3 x 20 minutes each with 0.5% BSA, 0.5% TritonX-100 PBS at 
room temperature (RT) and incubated with Alexa Fluor-488-conjugated 
streptavidin (1:100) and/or Alexa Fluor-546-conjugated donkey anti-goat or 
donkey anti-mouse antibodies (1:200, Invitrogen) in 1% BSA, 1% NDS, 1% 
TritonX-100 PBS overnight at 4oC. Samples were washed 3 x 20 minutes each 
with 0.5% BSA, 0.5% TritonX-100 PBS and once with PBS at RT and then 
cleared sequentially (70% and 90% glycerol/PBS, at least 5 hrs each) and 
mounted in 90% glycerol/PBS.  
 
Whole mount retina36 and (RPE/choroid/sclera)190 staining was performed as 
previously described. Samples were stained with biotinylated or Alexa Fluor-488- 
conjugated iB4 (1:25), rabbit anti-NG2 (1:200, Millipore), or goat anti-DLL4 
(1:100, R&D Systems). Fluorescence detection was performed using Alexa 
Fluor-488-conjugated streptavidin, Alexa Fluor-546 or 633-conjugated secondary 
antibodies and Alexa Fluor 546-conjugated Phalloidin (Invitrogen). DNA was 
stained with 1 µM 4,6'-diamidino-2-phenylindole (DAPI) or 10 µg/ml Hoechst 
(both from Invitrogen) in PBS for 10 minutes at RT and retinas and 
(RPE/choroid/sclera) were mounted in FluoromountG (Southern Biotech). 
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Microscopy and Image Analysis 
Whole mount muscle and retinal vasculature imaging was done on a Zeiss 
stereomicroscope or a TCS SP2 Leica confocal microscope. Maximum projection 
confocal images of the adductor muscle vasculature were generated from z-
stacks (30-300 µm, 1-10 µm step size depending on specimen size, staining and 
objective used) acquired starting at the medial surface of the adductor muscle 
specimens. To visualize large areas of the vasculature on the confocal 
microscope, a tile-scanning technique was employed whereby multiple 
overlapping (20-30% overlap) maximum projection images were acquired with a 
10x or 20x objective and a composite image was constructed by arraying the 
individual images in Photoshop. Quantification of vascularized area in whole 
mount retinas was done from fluorescence stereomicroscopic images using ZEN 
software (Zeiss). Retinal angiogenic front vascular density, endothelial sprouts 
and filopodia were quantified using ImageJ and maximum projection confocal 
images acquired with a 10x, 20x and 63x objective respectively. 
 
Histological Analysis of Muscle 
Anesthetized mice were perfusion cleared and vasodilated by infusing, via the 
left ventricle, 20 ml normal saline containing 1 g/l adenosine, 4 mg/l papaverine 
and 100 µg/ml heparin followed by 10 ml 2% formalin. The skin was removed 
and entire hindlimbs were emersion fixed in 10% formalin for 24 hrs. Calf and 
adductor muscles were dissected en block from fixed hindlimbs, dehydrated and 
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embedded in paraffin. Cross sections (7 µm) were prepared and subjected to 
antigen retrieval using 1x antigen unmasking solution (Vector Labs). The 
sections were blocked and permeabilized in 10% normal goat serum, 0.1% Triton 
X-100 in PBS for (RT, 1 hr) and incubated with Alexa Fluor 488-conjugated 
IsolectinB4 (1:25, Vector Labs) and primary antibodies, mouse anti-smooth 
muscle actin (1:500, Sigma) and rat anti-CD31 (1:50, BD Biosciences) in 1% 
BSA in PBS (RT, 2 hr). Sections were washed 3 x 5 minutes each with PBS and 
incubated with Alexa Fluor 546-goat anti mouse and Alexa Fluor 488-goat anti rat 
antibodies in 1% BSA PBS for 1 hr at RT. Following washing as above, DNA was 
stained with DAPI, sections mounted in FluoromountG (Southern Biotech) and 
imaged on a TCS SP2 Leica confocal microscope. 
 
Murine Lung Endothelial Cells (MLEC) 
Lungs were harvested aseptically, rinsed in Dulbecco's modified eagle 
medium (DMEM), cut into small pieces and digested in collagenase 1.7 mg/ml for 
1hr at 37oC. Lung digests were further triturated by pipetting repeatedly through a 
10 ml pipette fitted with a 1 ml pipette tip, passed through a 40 µm filter and the 
cell suspensions were cultured for 2 days in gelatin-coated plates in MLEC 
medium containing 20% fetal bovine serum, 38% DMEM 38% Ham's F-12 with 
100 µg/mL endothelial cell growth supplement (ECGS, Biomedical 
Technologies), 4 mmol/L L-glutamine, 100 µg/mL heparin, and 
penicillin/streptomycin. Endothelial cells were isolated by selection with rat anti-
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mouse intercellular adhesion molecule 2 (ICAM2) antibody (BD Biosciences)-
coupled sheep anti-rat magnetic beads (Invitrogen), cultured for an additional 3-4 
days and a second selection was done as above. Following an additional 2 days 
in culture, cells were used for experiments. Endothelial purity was confirmed by 
staining live cells with 1,1'-dioctadecyl - 3,3,3',3'-tetramethyl-indocarbocyanine 
perchlorate acetylated low-density lipoprotein (BT-902, Biomedical Technologies) 
according to the manufacturer’s recommendations or anti-Cdh5 antibodies 
(Biolegend or BD Biosciences). For the 5-ethynyl-2'-deoxyuridine (EdU) 
incorporation assay, cell cultures were incubated in the presence of 10 µM EdU 
for 6 hours and processed for detection of EdU incorporation using the Click-iT® 
EdU Alexa Fluor® 488 Imaging Kit (Invitrogen) according to the manufacturers 
instructions. Immunofluorescence analysis was done on cells fixed with 4% PFA 
at RT for 15 minutes. Following 3 washes with PBS, cells were incubated in 
permeabilization/blocking buffer (10% normal goat serum (NGS) or NDS 
(depending on the species of secondary antibody used), 0.1% TritonX-100) for 1 
hr at RT, then incubated with primary antibodies including PE-conjugated rat anti-
Ki-67 (1:200, eBioscience), mouse anti-α-tubulin (1:500, Sigma), rat anti-Cdh5 
(1:50, BD Biosciences) and goat anti-Dll4 (1:100, R&D Systems) in 1% BSA, 
0.1% TritonX-100 overnight at 4oC. Following 3 x 10 minute washes with PBS, 
cells were incubated with the appropriate Alexa Fluor- 488, 546 or 633-
conjugated secondary antibodies (1:200, Invitrogen) for 2 hrs at RT. Cells were 
washed 3 x 10 minutes each with PBS, DNA was stained with 4,6'-diamidino-2-
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phenylindole (DAPI) or Hoechst (1 µM, Invitrogen), cells were mounted in 
FluoromountG (Southern Biotech) and imaged on a TCS SP2 Leica confocal 
microscope. 
 
Tube Formation Assay in Matrigel 
Primary MLECs (1x105 cells) in 0.5% FBS DMEM/F12 were seeded in 8 well 
chamberslides (BD Biosciences) layered with 300 µl polymerized growth factor 
reduced matrigel (BD Biosciences) and incubated at 37oC for 8 hrs. Tubular 
networks were imaged on a Zeiss inverted microscope.     
 
Migration Assay 
Confluent monolayers of primary MLECs in 96 well plates were simultaneously 
scratched using a 96-pin wound making tool (WoundMakerTM, Essen 
Bioscience), rinsed twice with media and wound closure was monitored by 
automated live cell imaging on an IncuCyte ZOOM system (Essen Bioscience) 
using a 10x objective. The area between the edges of the wound in images taken 
at different time intervals was quantified using ImageJ. 
 
Immunoblot Analysis 
Cell extracts were prepared using Triton lysis buffer (20 mM Tris at pH 7.4, 1% 
Triton X-100, 10% glycerol, 137 mM NaCl, 2 mM EDTA, 25 mM β-
glycerophosphate, 1 mM sodium orthovanadate, 
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1 mM phenylmethylsulfonylfluoride, 10 mg/mL of aprotinin and leupeptin). 
Extracts (20-50 µg of protein) were examined by protein immunoblot analysis by 
probing with antibodies to JNK (R&D Systems or Pharmigen), pJNK, pERK, 
ERK, cleaved Notch1 (Cell Signaling), Dll4 (R&D Systems), GAPDH (Santa 
Cruz) and αTubulin (Sigma). Immune complexes were detected using the 
Odyssey infrared imaging system (LI-COR Biosciences). 
 
RNA Isolation 
To isolate RNA from tissues, mice were perfusion cleared with PBS via the left 
ventricle. Hindlimb adductor and calf skeletal muscles were harvested en block, 
snap frozen in liquid nitrogen, pulverized on a cryoPREPTM impactor (Covaris), 
RNA extracted with TRIzol® (Life Technologies) and purified using the RNeasy 
kit (Qiagen). RNA from cells and other tissues homogenized in RLT buffer was 
isolated using the RNeasy kit. 
 
RT-PCR 
Complementary (c) DNA was prepared using The High Capacity Reverse 
Transcription Kit (Life Technologies). The expression of mRNA was examined by 
quantitative PCR analysis using a Quantstudio PCR system (Life Technologies). 
TaqMan® assays were used to quantify Cdh5 (Mm00486938_m1), Dll4 
(Mm00444619_m1), Emr1 (Mm00802529_m1), Hes1 (Mm01342805_m1), Hey1 
(Mm00468865_m1), Lfng (Mm00456128_m1), Pecam1 (Mm01242584_m1), 
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Slc2a1 (Mm00441480_m1) and Vegfa (Mm01281449_m1). The relative mRNA 
expression was normalized by measurement of the amount of 18S RNA in each 
sample using TaqMan® assays (catalog number 4308329; Life Technologies). 
 
RNA-Sequencing 
RNA was isolated using the RNeasy kit (Qiagen). RNA quality (RIN > 9) was 
verified using a Bioanalyzer 2100 System (Agilent Technologies). Total RNA 
(10µg) from independent MLEC isolations (lungs from 4 mice per isolation) was 
used for the preparation of each RNA-seq library by following the manufacturer’s 
instructions (Illumina). Three independent libraries were examined for each 
condition. The cDNA libraries were sequenced by Illumina Hi-Seq with a paired-
end 40-bp format. Reads from each sample were aligned to the mouse genome 
(UCSC genome browser mm10 build) using TopHat2.196 The average number of 
aligned reads per library was > 20,000,000. Endothelial cell gene expression was 
quantitated as fragments per kilobase of exon model per million mapped 
fragments (FPKM) using Cufflinks.197 Differentially expressed genes were 
identified using the Cufflinks tools Cuffmerge and Cuffdiff. Gene ontology was 
examined by Kyoto Encyclopedia of Genes and Genome (KEGG) pathway 
analysis198 with the Database for Annotation, Visualization and Integrated 
Discovery (DAVID).199 
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Transplantations 
Bone marrow (BM) was harvested by flushing tibias and femurs from at least 
three 10-12 week old mice with ice cold PBS. Erythrocytes were lysed by 
incubating the BM in ACK lysing buffer (Life Technologies). BM cells were 
then resuspended in PBS and passed through a 100 µm filter. Cells were 
counted and mixtures of test BM cells from the indicated genotypes were 
prepared by mixing test BM cells expressing the CD45.2 allele with competitor 
BM cells from B6.SJL-PtprcaPepcb/BoyJ mice expressing the CD45.1 allele at a 
20 test:80 competitor cell ratio. 1x106 total BM cells were intravenously injected 
via the tail vein into lethally irradiated (11 Gy) 10-12 week old CD45.1/CD45.2 
heterozygous female mice. Transplanted mice were maintained on antibiotic 
water for the first two weeks post transplantation. Blood was harvested via 
the retroorbital sinus using heparinized capillary tubes and EDTA-coated vials at 
5 and 20 weeks post transplantation and subjected to flow cytometry analysis. 
 
Complete blood cell (CBC) analysis.  
CBC analysis was done using a HemaTrue hematology analyzer (Heska) by the 
Department of Animal Medicine, University of Massachusetts Medical School 
 
Flow Cytometry 
Blood was washed in PBS, stained with live/dead fixable blue dead cell staining 
kit (Invitrogen), washed in PBS and blocked in 2% FBS-PBS 0.02% 
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sodium azide plus Fc-block (Anti-CD16/32 antibody 1:200, BD Biosciences). 
Surface antigens were detected by incubation for 30 min at 4oC with conjugated 
antibodies including CD45.1-Pacific Blue, CD45.2-FITC, CD3e-APC, CD19-APC-
H7, CD11b-PE (BD Biosciences) and GR1-Alexa Fluor 700 (Biolegend). 
Following washing with 2% FBS-PBS 0.02% sodium azide, red cells were lysed 
and leukocytes fixed by incubating in lyse/fix solution (BD Biosciences). Cells 
were washed with PBS and analyzed on an LSR-II cytometer (Becton 
Dickenson). Data were processed using FlowJo Software (Tree Star). 
 
Statistical Analysis 
Differences between groups were examined for statistical significance with an 
unpaired Student's test with equal variance or a log-rank (Mantel-Cox) test for 
determining significance of Kaplan-Meier survival curves. 
 
 
 
 
 
 

113 
Figure II.1 Enhanced blood perfusion blockade and severe ischemic injury 
in endothelial JNK-deficient mice upon arterial occlusion.  
 
A) Immunoblot analysis reveals robust reduction in JNK protein abundance in 
purified lung endothelial cells from E3KO mice. Lysates were also examined with 
antibodies to GAPDH.  
 
B) Simplified diagram of the medial aspect of the mouse hindlimb skeletal muscle 
vasculature. The common femoral artery (FA) and its main branches (proximal 
caudal femoral artery [PCFA], popliteal artery [PA] and saphenous artery [SA]) 
supply blood to the proximal and distal hindlimb. Ligation of the FA plus the 
superficial epigastric artery (SEA) as indicated, leads to reduced blood flow to the 
distal hindlimb, while flow through the PCFA and gracillis collaterals is enhanced. 
  
C) Representative laser Doppler images showing blood perfusion (high perfusion 
red, no perfusion dark blue) in the hindlimbs of control and E3KO mice prior (Pre-
FAL) and on days 1 and 3 post ligation.  
 
D) Quantitation of Doppler signals shows significantly enhanced blood perfusion 
blockade following ligation and no recovery 3 days after ligation in E3KO mice 
compared to control mice (mean ± SEM; n = ~7-10 mice per group).  
 
E) E3KO mice undergo severe necrosis of the paws following ligation (Lig.). Paws 
of ligated limbs from control mice never display necrosis. Images are 
representative of paws from ~7-10 mice per group. Unlig. = contralateral 
unligated limb.  
 
F and G) All E3KO mice display paw necrosis with over 70% undergoing complete 
autoamputation of the paw. Ligated limbs of control mice show almost no signs of 
ischemia (F) and only minor movement impairment 4 days post FAL (G), (~7-10 
mice per group).  
 
H - J) Quantification of limb blood perfusion by laser Doppler imaging showing no 
significant differences in blood perfusion blockade and restoration over 28 days 
following FAL between control mice and mice that lack JNK1 plus JNK2 in all 
hematopoietic cells (H2KO, H), in myeloid cells (Φ2KO, I) or skeletal muscle cells 
(M2KO, J) (mean ± SEM; n = ~5-10 mice per group).
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Figure II.2 Endothelial JNK-deficient mice display abnormal native 
collateral arteries.  
 
A) Whole mount preparations of the medial surface of Microfil filled adductor 
muscle vasculature from unligated and 4 days post-ligation limbs showing thin 
and abnormally organized gracillis collateral vessels in the unligated limbs and 
poor Microfil filling of the vasculature in the ligated limbs of E3KO mice. Unligated 
limbs from control mice display distinctly thicker gracillis collateral arteries directly 
interconnecting the PCFA to the SA. These vessels remodel outwardly, 
increasing in diameter and becoming more tortuous 4 days post-ligation. Images 
are representative of at least 5 mice per group.  
 
B and C) Immunofluorescence for smooth muscle actin (SMA) and CD31/iB4 on 
cross sections of adductor muscles. Quantification of artery diameter (C) from 
SMA immunofluorescence images confirms reduced size of gracillis collaterals in 
the unligated limbs of E3KO mice (mean ± SEM; n = ~10-12 gracillis collaterals 
from 5 mice per group).  
 
D) Micro-CT analysis of contrast (Bismuth/gelatin) filled hindlimb vasculature 
illustrates defects in artery size and connectivity in the adductor muscle region of 
E3KO hindlimbs. Images are representative of 7-8 mice analyzed per group.  
 
E and F) Taqman gene expression analysis quantitating the mRNA abundance of 
the endothelial cell specific marker Cdh5 (E) and the hypoxia responsive gene 
Slc2a1 (F) on day 4 post FAL (mean ± SEM; n = ~7-8 mice per group). 
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Figure II.3 Abnormal native collateral arteries, and enhanced blood 
perfusion blockade and ischemic injury in Mlk2-/-Mlk3-/- mice upon arterial 
occlusion.  
 
A) Gene expression analysis (from mouse endothelial cell RNA Seq analysis) of 
the four members of the MLK group showing highest expression of Mlk2 and 
Mlk3 in endothelial cells (mean FPKM [fragments per kilobase of transcript per 
million mapped reads] ± SEM; n = 6 endothelial cell libraries).  
 
B) Immunoblot analysis reveals reduced bFGF-induced phosphorylation of the 
JNK substrate cJun in Mlk2-/-Mlk3-/- endothelial cells compared to WT endothelial 
cells indicating reduced JNK activity in Mlk2-/-Mlk3-/- endothelial cells. Lysates 
were also examined with antibodies to cJun, JNK, Cdh5 and GAPDH. 
  
C) Representative laser Doppler images showing blood perfusion (high perfusion 
red, no perfusion dark blue) in the hindlimbs of WT and Mlk2-/-Mlk3-/- mice prior 
(Pre-FAL) and on days 1 and 3 post ligation.  
 
D) Quantitation of Doppler signals shows significantly enhanced blood perfusion 
blockade following ligation and no recovery 3 days after ligation in Mlk2-/-Mlk3-/- 
mice compared to WT mice (mean ± SEM; n = 7 mice per group).  
 
E) Mlk2-/-Mlk3-/- mice undergo severe necrosis of the paws following ligation 
(Lig.). Paws of ligated limbs from WT mice never display necrosis. Images are 
representative of paws from 9 mice per group. Unlig. = contralateral unligated 
limb.  
 
F and G) All Mlk2-/-Mlk3-/- mice display digit/paw necrosis and severe movement 
impairment. Ligated limbs of WT mice show minor signs of ischemia (F) and only 
minor movement impairment 4 days post FAL (G), (9 mice per group).  
 
H) Whole mount preparations of the medial surface of Microfil filled adductor 
muscle vasculature from unligated and 4 days post-ligation limbs showing thin 
and abnormally organized gracillis collateral vessels in the unligated limbs and 
poor Microfil filling of the vasculature in the ligated limbs of Mlk2-/-Mlk3-/- mice. 
Limbs from control mice display distinctly thicker gracillis collateral arteries 
directly interconnecting the PCFA to the SA. These vessels remodel outwardly, 
increasing in diameter and becoming more tortuous 4 days post-ligation. Images 
are representative of at least 6 mice per group. 

119 
Figure II.4 Endothelial JNK is dispensable for arteriogenic responses in 
adult mice. 
 
A) Diagram illustrating the timeline of tamoxifen administration to induce 
disruption of floxed Jnk alleles in the endothelium of adult mice. FAL was 
performed as described in Fig. I.1B.  
 
B) Immunoblot analysis of lysates from purified lung endothelial cells confirming 
robust reduction in JNK protein abundance in cells from iE3KO mice at least 8 
weeks post tamoxifen administration. Lysates were also examined with 
antibodies to α-Tubulin. Data are representative of two independent endothelial 
cell isolations per group (2-3 mice used / each cell preparation).  
 
C) Laser Doppler quantification of limb blood perfusion showing no significant 
differences in blood perfusion blockade and recovery over 28 days post arterial 
ligation in iE3KO mice compared to Cre+ control (iECtrl) or Cre- litermate (EfCtrl) mice 
(mean ± SEM; n = ~5-10 mice per group).  
 
D) Microfil perfusion analysis of adductor muscle vasculature showing normal 
gracillis collateral arteries in the unligated limbs of iE3KO mice and similar 
collateral artery remodeling to that in control mice 28 days post-ligation. Images 
are representative of ~5-8 mice per group).   
 
E) Diagram illustrating the timeline of tamoxifen treatment to induce 
recombination of Jnk alleles during embryonic development, delivery of pups by 
C-section, rearing of pups by foster mothers and femoral artery ligation 
experiment.  
 
F) Laser Doppler quantification of limb blood perfusion showing significantly 
enhanced blood perfusion reduction in iE3KO adult mice in which mosaic deletion 
of JNK in the endothelium was induced during embryonic development (mean ± 
SEM; n = ~5-6 mice per group). 
 
G) Confocal imaging of adductor muscle vasculature of three iEmTmG embryos 
harvested from a pregnant female that was treated with tamoxifen at 12.5 dpc 
demonstrates highly variable mosaic recombination in the endothelium. The data 
presented are representative of six mice examined. 
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Figure II.5 Endothelial JNK deficiency results in altered collateral artery 
patterning during ontogeny 
 
A) Confocal microscopy analysis of whole mount adductor muscle vasculature 
reveals distinct gracillis collateral arteries interconnecting the PCFA to the SA in P6 
control mice. At this stage, gracillis collaterals are fully invested with smooth muscle 
cells throughout their length as demonstrated by smooth muscle acting (SMA, green) 
immunofluorescence. Analysis of adductor muscle vasculature in P6 E3KO mice 
shows smooth muscle cell covered vessels emerging from both the PCFA and the 
SA, however continuous SMA signal interconnecting the PCFA to the SA is not 
observed. Adductors from at least 7 mice per group were analyzed. Intravascular Dil 
(red) perfusion analysis demonstrates distinct gracillis collaterals interconnecting the 
PCFA to the SA in control mice. Vessels emerging from the PCFA and the SA in 
E3KO mice do not fully interconnect. Instead, they branch off into smaller vessels that 
appear to enter the capillary circulation. Note that Dil perfusion exclusively labels the 
arterial and capillary vasculature, but not veins. Adductors from at least 5 mice per 
group were analyzed.  
 
B) Dil perfusion in control mice at P0 reveals gracillis collaterals as distinct vessels 
interconnecting the PCFA to the SA. At this stage these vessels lack extensive 
smooth muscle coverage. In P0 E3KO mice, vessels emerging from the PCFA and the 
SA do not form distinct interconnecting collaterals, but branch extensively and enter 
the capillary circulation. Adductors from at least 5 mice per group were analyzed.  
 
C) Stereomicroscopic imaging of Dil perfused abdominal muscle arterial vasculature 
at P0 reveals numerous arteriole-to-arteriole arcades in control mice (red arrows). 
The abdominal muscle arterial vasculature of E3KO mice shows very few arteriole-to-
arteriole interconnections. Quantification reveals significantly reduced arteriolar 
arcade numbers in E3KO mice compared to littermate control mice (mean ± SEM; n = 
abdominal muscles from 3 mice per group).   
 
D) Confocal imaging analysis of the vasculature by direct GFP visualization in whole 
mount adductor muscle preparations from control (ECtrl mTmG) and E2KO mTmG E16.5 
embryos showing incomplete remodeling of collateral vessels at this stage. The 
gracillis muscle capillary plexus of E2KO mTmG embryos appears more chaotically 
organized compared to that of control embryos. High magnification images show 
increased branching, higher vessel thickness variation and more filopodia in the 
capillary plexus of E2KO mTmG embryos. Images are representative of adductors from 
~3-4 mice per group. 
 
E) Confocal imaging of E16.5 adductor muscle vasculature immunostained for   
Endomucin (Emcn, red) and isolectinB4 (iB4, green) reveals a denser capillary 
plexus with higher vessel thickness variation in the gracillis collateral region of 
adductors from E3KO mice compared to littermate control mice. Images are 
representative of adductors from ~3-5 mice per group. 
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Figure II.6 Mlk2-/-Mlk3-/- mice phenocopy the defects in native collateral 
artery formation of endothelial JNK deficient mice at P6  
 
A) Confocal microscopy analysis of wholemount adductor muscle vasculature 
immunostained for smooth muscle actin (SMA, green) reveals abnormal gracillis 
collateral arteries in Mlk2-/-Mlk3-/- mice marked by absence of continuous SMA 
signal interconnecting the PCFA to the SA. Endomucin staining labels the 
capillary and venous, but not the arterial vasculature. Adductors from 5 mice per 
group were analyzed.  
 
B) Stereomicroscopic imaging of SMA immunostained abdominal muscle 
vasculature at P6 reveals numerous arteriole-to-arteriole arcades in WT mice 
(red arrows). The abdominal muscle vasculature of Mlk2-/-Mlk3-/- mice shows very 
few arteriole-to-arteriole interconnections. Quantification reveals significantly 
reduced arteriolar arcade numbers in Mlk2-/-Mlk3-/- mice compared to WT mice 
(mean ± SEM; n = abdominal muscles from 5 mice per group).   
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Figure II.7 Abnormal retinal vascular development marked by excessive 
sprouting in endothelial JNK-deficient mice 
 
A-C) Representative examples of whole mount retina iB4 immunofluorescence 
showing reduced vascular extension in P6 E3KO retinas (B and C) compared to 
littermate control retinas (A).  
 
D-K) Closer examination reveals increased vascular density (D-G and H and J), 
increased tip cell numbers (yellow asterisks in H and J) and more filopodia (red 
dots in I and K) at the vascular front region of E3KO retinas compared to littermate 
control retinas.  
 
L-O) Quantitative analysis of vascularized retinal area (L), vascular density within 
angiogenic front regions indicated in E and G (M), tip cell number (N) and 
filopodia (O) demonstrates that differences between E3KO and littermate control 
mice are statistically significant (mean ± SEM; n = ~17-31 retinas from at least 12 
mice per group for quantification of vascular extension; n = ~6-10 retinas from at 
least 5 mice per group for quantification of the other parameters - multiple 
confocal images per retina were quantified and averaged).   
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Figure II.8 Abnormal retinal vascular development marked by excessive 
sprouting in Mlk2-/-Mlk3-/- mice 
 
A-C) Representative examples of whole mount retina iB4 immunofluorescence 
showing reduced vascular extension in P6 Mlk2-/-Mlk3-/- retinas (B and C) 
compared to WT retinas (A).  
 
D-K) Closer examination reveals increased vascular density (D-G and H and J), 
increased tip cell numbers (yellow asterisks in H and J) and more filopodia (red 
dots in I and K) at the vascular front region of Mlk2-/-Mlk3-/- retinas compared to 
WT retinas.  
 
L-O) Quantitative analysis of vascularized retinal area (L), vascular density within 
angiogenic front regions indicated in E and G (M), tip cell number (N) and 
filopodia (O) demonstrates that differences between Mlk2-/-Mlk3-/- and control 
mice are statistically significant (mean ± SEM; n = 5 retinas from 5 mice per 
group - multiple confocal images per retina were quantified and averaged).   
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Figure II.9 RNA-Seq analysis of genes differentially regulated between 
control and JNK-deficient endothelial cells 
 
A) Heatmap of the 781 differentially expressed genes (FPKM > 2; log2 fold 
change ≤ -0.5 or ≥ +0.5; q ≤ 0.05) between E3KO and control endothelial cells 
showing similar numbers of upregulated and downregulated genes in E3KO cells 
(mean; n = 3 libraries per group prepared with RNA from 3 independent lung 
endothelial cell preparations per group. Each endothelial cell preparation 
included lungs from 4 mice). 
 
B) Gene ontology analysis of the group of differentially expressed genes 
identifying significant enrichment in genes involved in several biological 
processes. 
 
C) Genes related to mitosis/cell division/cell cycle processes that were identified 
by the gene ontology analysis are presented as a heatmap. Genes are displayed 
with highest upregulation top and highest downregulation bottom.  
 
D) Genes related to vascular development/morphogenesis and function, 
including those identified by the gene ontology analysis, were grouped in several 
categories and are presented as a heatmap. Genes are displayed with highest 
upregulation top and highest downregulation bottom within each category.  
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Figure II.10 Reduced Dll4 – Notch signaling in the JNK-deficient vascular 
endothelium 
 
A) Quantitative RT-PCR analysis of Notch pathway genes revealing reduced 
expression in E3KO endothelial cells compared to control cells (mean ± SEM; n = 
4). Data shown represent one of three independent experiments with similar 
results. Each experiment was performed with independent endothelial cell 
preparations.  
 
B) Immunofluorescence analysis on endothelial cells showing reduced Dll4 
immunostaining in E3KO cells compared to control cells. Quantification of Dll4 
signal intensity demonstrates the difference is statistically significant (mean ± 
SEM; n = 10 images per group).   
 
C) Endothelial cells were treated with VEGF for 16 hrs. Immunoblot analysis of 
cell lysates revealed reduced levels of Dll4 and Notch intracellular domain 
(NICD) in lysates from E3KO endothelial cells compared to control cells. Lysates 
were also examined with antibodies to JNK and α-Tubulin. Data are 
representative of two experiments with independent endothelial cells 
preparations. 
 
D) Endothelial cells were treated with bFGF for 4 or 16 hrs. Immunoblot analysis 
of cell lysates revealed reduced levels of Dll4 and NICD in lysates from E3KO 
endothelial cells compared to control cells. Lysates were also examined with 
antibodies to phospho-cJun (pSer63), cJun, phospho-JNK (pJNK), JNK, Cdh5 
and GAPDH. Data are representative of two experiments with independent 
endothelial cell preparations. 
 
E) Confocal immunofluorescence analysis of P6 retina wholemounts 
immunostained for Dll4 (red), and isolectinB4 (iB4, green) reveals reduced Dll4 
signal intensity at the angiogenic vascular front of retinas from E3KO mice 
compared to retinas from littermate control mice. Hoechst labels cell nuclei. 
Quantification of Dll4 signal intensity shows this difference is statistically 
significant (mean ± SEM; n = 42-44 images per group, retinas from 6 mice per 
group were analyzed). 
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Figure II.11 Diagram illustrating the functional importance of collateral 
arteries during arterial occlusion, and the collateral artery patterning / 
maturation defects and functional impairment in mice with disrupted MLK – 
JNK signaling. 
 
MLK-JNK signaling (left) contributes to high Dll4-Notch signaling in endothelial 
cells leading to formation of balanced vascular networks and formation of distinct 
collateral vessels that interconnect adjacent arteries.  
 
Disrupted MLK-JNK signaling in the vascular endothelium (right) results in 
excessive sprouting angiogenesis, leading to hyperbranched vascular networks 
and defective formation of collateral arteries, which are smaller, display 
excessive branching and altered organization. 
 
In addition to regulating Dll4-Notch signaling, the MLK-JNK pathway may also 
contribute to proper vascular morphogenesis and collateral artery formation via 
other mechanisms. 
  
Following FAL blood flow (black arrows) through the femoral artery is blocked. 
Under these circumstances due to increased proximal and reduced distal 
pressure, more blood flow is diverted to the collateral circulation. Existing 
collateral arteries in the proximal adductor muscles are capable of restoring a 
significant amount of blood flow to the distal limb immediately following occlusion 
of the femoral artery. The increased pressure and flow stimulates the remodeling 
of existing collateral arteries, which increase in size and restore blood perfusion 
to the distal limb, limiting ischemic damage in control mice (left).  
 
The abnormal collateral circulation in the absence of MLK-JNK signaling 
prevents sufficient blood flow restoration to distal limb tissues following FAL 
resulting in enhanced blood perfusion reduction. The ensuing hypoxia and 
ischemia leads to severe necrotic damage to the distal limb (right). 
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Supplementary Figure II.1 Characterization of endothelial JNK-deficient 
mice and lung endothelial cells.  
 
A-C) Body mass measurements showing no significant differences between E3KO 
and littermate control mice at postnatal day 0 and 6. Adult endothelial JNK-
deficient mice are slightly smaller than control mice (B), but continue to maintain 
their body mass similar to control mice (C), (mean ± SEM; n = ~8-23). 
 
D) Following two rounds of ICAM2 antibody-conjugated magnetic bead 
purification, endothelial cell monolayers show efficient and homogeneous uptake 
of Dil-labeled acetylated low density lipoprotein (Dil-Ac-LDL, red). Mouse 
embryonic fibroblasts (MEF) show no Dil-Ac-LDL uptake. 
 
E) Flow cytometry analysis confirming that ~99% of cells in endothelial cell 
preparations stained for Dil-Ac-LDL.  
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Supplementary Figure II.2 Endothelial JNK-deficient mice have no major 
perturbations in the hematopoietic system.  
 
A) Immunoblot analysis demonstrating no major differences in JNK protein 
abundance in hematopoietic tissues. The data presented are representative of 2 
independent experiments (n=5 mice) 
 
B) Genomic DNA isolated from blood, bone marrow, and lung tissue was 
examined by PCR analysis to detect Cre-mediated recombination of the Jnk1 
gene (n=3 mice). 
 
C) Complete blood cell analysis showing no significant JNK-dependent 
differences in any of the measured indices (mean ± SEM; n = 15). RBC, red 
blood cells; MCV, mean corpuscular volume; MCH, mean corpuscular 
hemoglobin; MCHC, mean corpuscular hemoglobin concentration; RDW, red cell 
distribution width; MPV, mean platelet volume.  
 
D) Flow cytometry analysis demonstrating no significant differences in the 
frequency of myeloid cells (CD11b+), B cells (CD19+) and T cells (CD3e+) in the 
blood of E3KO and control mice (mean ± SEM; n = ~8-10).  
 
E) Flow cytometry analysis of peripheral blood showing no significant differences 
in chimerism at 5 and 20 weeks post-transplantation between mice transplanted 
with bone marrow cells from E3KO or control mice (mean ± SEM; n = ~7-8).  
 

139 
Supplementary Figure II.3 Endothelial JNK is dispensable for proliferation, 
migration and angiogenic responses in vitro.  
 
A) JNK-deficient endothelial cells form tubular networks in matrigel similarly to 
control endothelial cells. Images are representative of two experiments 
performed in triplicate with independent endothelial cell preparations.   
 
B) Representative maximum projection confocal images of collagen imbedded 
aortic ring explants showing similar numbers of VEGF-induced iB4 (green) 
positive microvessels sprouting from aortic rings from control and endothelial 
JNK-deficient mice. Smooth muscle actin (SMA) immunofluorescence (red) 
labels supporting cells. DAPI (blue) labels nuclei. Quantification of microvessel 
number per aortic ring demonstrated no significant differences between aortic 
rings from control and JNK-deficient mice (mean ± SEM; n = ~8-21 rings per 
group). Data presented are from one of three experiments with similar results. 
Aortas from 2-3 mice per group were used in each experiment.   
 
C and D) Representative confocal images and quantification of the percentage of 
endothelial cells incorporating Edu (green, C) following a 6 hour Edu pulse or 
staining positive for the proliferation marker Ki-67 (green, D), (mean ± SEM; n = 
10 images per group). Data presented are from one of three experiments with 
similar results. α-Tubulin (red) labels cell bodies. DAPI (blue) labels nuclei.  
 
E) Endothelial monolayers were wounded using a Woundmaker and wound 
closure was monitored over time. Representative images showing similar 
migratory ability of JNK-deficient endothelial cells. Quantification of wound area 
closure over time demonstrated no statistically significant differences between 
JNK-deficient and control endothelial cells (mean ± SEM; n = 8). Data presented 
are from one of three experiments with similar results.  
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Supplementary Figure II.4 Endothelial JNK is dispensable for in vivo 
pathologic angiogenesis.  
 
A and B) Representative examples of iB4 positive laser-induced choroidal 
neovascular (CNV) tufts 7 days post-lasering in control and E3KO mice (A). 
Quantification of CNV size (B) shows no statistically significant differences 
between the two groups (mean ± SEM; n = ~32-36 CNV tufts) from 5 mice per 
group.  
 
C and D) Images of tumors grown in the flanks of E3KO and control mice following 
subcutaneous transplantation of congenic B16F10 melanoma cells. (D) 
Quantification of tumor weight shows no statistically significant differences 
between E3KO and control mice (mean ± SEM; n = 10 tumors). Data presented 
are from one of two experiments with 5 mice per group.  
 
E and F) Examples of CD31 (green) immunofluorescence images of B16F10 
melanoma tumor cryosections showing similar vascularization of tumors from 
E3KO and control mice. Smooth muscle actin (SMA, red) labels supporting cells. 
DAPI (blue) labels nuclei. (F) Quantification of vessel number in tumor 
cryosections showing no significant differences between tumors from E3KO and 
control mice (mean ± SEM; n = 5 mice, 5-6 images from tumors from each 
mouse were quantified and averaged per mouse).    
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Supplementary Figure II.5 Normal hypoxia responses and VEGF signaling 
in JNK-deficient endothelial cells. 
 
A) Endothelial cells incubated overnight in media containing only 1% FBS were 
placed under hypoxic (1% O2) conditions for the indicated times and extracts 
were examined by immunoblot analysis with antibodies to p-JNK, JNK, p(S63)-
cJun, and α-Tubulin. No change in the phosphorylation of JNK or its substrate 
cJun is detected. Anisomycin (Aniso, 1µg/ml) treatment causes robust JNK and 
cJun phosphorylation. Data presented are representative of two independent 
experiments. 
 
B) Endothelial cells incubated overnight in media containing only 1% FBS were 
treated with VEGFa (100 ng/ml, added directly to existing media) for the 
indicated times and extracts were examined by immunoblot analysis with 
antibodies to p-JNK, JNK, p-ERK, ERK and α-Tubulin. VEGFa treatment leads to 
phosphorylation of ERK at 5 minutes, but not JNK. TNF (20 ng/ml) and 
Anisomycin (Aniso, 1 µg /ml) treatment leads to JNK phosphorylation. Data 
presented are representative of two independent experiments.  
 
C and D) Endothelial cells in media containing only 1% FBS were incubated 
under normoxic (21% O2) or hypoxic (1% O2) conditions for 16 hours. The mRNA 
expression of the hypoxia responsive genes Vegfa (C) and Slc2a1 (D) was 
examined by quantitative RT-PCR analysis (mean ± SEM; n = 4). Data presented 
are from one of at least 2 similar experiments with independent endothelial cell 
preparations.   
 
E) Endothelial cells incubated overnight in media containing only 1% FBS were 
treated with VEGFa (100 ng/ml, added directly to existing media) for 5 minutes 
and extracts were examined by immunoblot analysis with antibodies to p-ERK, 
ERK, JNK and Tubulin. VEGFa-stimulated ERK phosphorylation was similar in 
JNK-deficient and control cells. Data presented are representative of two 
experiments with independent endothelial cell preparations.   
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Supplementary Figure II.6 Compound endothelial deficiency of JNK1 plus 
JNK2 leads to enhanced blood perfusion blockade in models of arterial 
occlusion. 
 
A) Simplified diagram of the medial aspect of the mouse hindlimb skeletal muscle 
vasculature indicating the location of the femoral artery ligation site for the 
experiment shown in panel B. Unlike experiments described in Figure I.1, the 
ligation site indicated here is proximal to the PCFA.   
 
B) Following ligation of the femoral artery at its origin as shown in panel A, 
quantification of limb blood perfusion by laser Doppler imaging shows 
significantly enhanced blood perfusion blockade and no recovery 3 days after 
ligation in E3KO mice (mean ± SEM; n = ~7-14).  
 
C) Simplified diagram of the coronary artery circulation indicating the location of 
the coronary artery ligation site for the experiment shown in panel D.  
 
D) Following coronary artery ligation as shown in panel C, E3KO mice show 
significantly decreased survival (n = ~7-10).  
 
E) Following FAL as shown in panel A, laser Doppler quantification of limb blood 
perfusion shows no significant differences in blood perfusion blockade and 
recovery over 28 days in single Jnk1-/- or Jnk2-/- mice compared to WT mice 
(mean ± SEM; n = 5). 
 
F) Following FAL as shown in Figure I.B, quantification of limb blood perfusion by 
laser Doppler imaging shows significantly enhanced blood perfusion blockade 
and no recovery 3 days after ligation in E2KO mice (mean ± SEM; n = 4). 
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Supplementary Figure II.7 JNK deficient mice show no perturbations in 
overall cardiovascular function. 
 
 
A) Analysis of blood pressure and heart rate in WT and single Jnk1-/- and Jnk2-/- 
mice showing no statistically significant differences (mean ± SEM; n = ~9-15).  
 
B) Analysis of blood pressure and heart rate in E3KO and control mice showing no 
JNK-dependent statistically significant differences between the groups (mean ± 
SEM; n = ~9-15).   
 
C) Echocardiographic analysis of heart function in E3KO and control mice showing 
no statistically significant differences between the groups (mean ± SEM; n = ~12-
15).  
 
D) Segments from thoracic aortas from E3KO and control mice were mounted on a 
myograph and vasocontraction and vasorelaxation in response to increasing 
doses of phenylephrine (PE) or acetylcholine (ACH) respectively were recorded. 
Contraction in response to PE is expressed as a percentage of maximum aortic 
contraction obtained in the presence of K+ containing buffer (K-PSS). 
Vasorelaxation in response to ACH is expressed as a percentage of maximum 
contraction obtained in the presence of 10-3 µM PE (mean ± SEM; n =2 m). Data 
presented are from one of two experiments with similar results. Aortas from 2 
mice per group were used in each experiment.    
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Supplementary Figure II.8 Gene expression analysis in adductor and calf 
muscles of E3KO and control mice. 
 
A and B) Taqman gene expression analysis quantitating the mRNA abundance 
of the endothelial cell specific marker Pecam1 (A) and the macrophage specific 
marker Emr1 (B) on day 4 post FAL (mean ± SEM; n = ~7-8 mice per group). 
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Supplementary Figure II.9 Abnormal retinal vascular development marked 
by excessive sprouting in E2KO mice 
 
A-C) Representative examples of whole mount retina iB4 immunofluorescence 
showing reduced vascular extension in P6 E2KO retinas (B and C) compared to 
littermate control retinas (A).  
 
D-K) Closer examination reveals increased vascular density (D-G and H and J), 
increased tip cell numbers (yellow asterisks in H and J) and more filopodia (red 
dots in I and K) at the vascular front region of E2KO retinas compared to littermate 
control retinas.  
 
L-O) Quantitative analysis of vascularized retinal area (L), vascular density within 
angiogenic front regions indicated in E and G (M), tip cell number (N) and 
filopodia (O) demonstrates that differences between E2KO and control mice are 
statistically significant (mean ± SEM; n = ~4-9 retinas from at least 4 mice per 
group - multiple confocal images per retina were quantified and averaged).   
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Supplementary Figure II.10 No major perturbations in NG2+ pericyte 
coverage in the E2KO retinal vasculature at P6.  
 
Confocal microscopy analysis of whole mount retinal vasculature immunostained 
for the pericyte marker NG2 and isolectinB4 showing no major differences in 
vessel pericyte coverage in retinas from E2KO mice compared to retinas from 
littermate control mice. Data presented are representative of multiple images of 
retinas from 4 mice per group.     
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Supplementary Figure II.11 Intimate association of gracillis collaterals and 
peripheral nerves in adductor muscles. 
 
Confocal microscopy of a whole mount adductor muscle immunostained for 
smooth muscle actin (green) and Neurofilament-M shows close association of 
gracillis collateral arteries with peripheral nerves.  
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Chapter III 
JNK is cell-autonomously dispensable for hematopoietic 
development and hematopoietic stem cell self-renewal 
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Abstract 
 
cJun NH2-terminal kinases (JNK) exist in multiple isoforms with high functional 
redundancy. JNK mediates pleiotropic cellular responses to diverse 
environmental stimuli, including various types of stress as well as numerous 
growth factors and cytokines. JNK has been implicated in immune cell 
differentiation and function, however its role in hematopoiesis or hematopoietic 
stem cell (HSC) self-renewal has not been explored. Here, we employ mice with 
single or compound ablation of Jnk genes and serial competitive bone marrow or 
HSC transplantation assays to dissect the function of JNK in hematopoiesis and 
HSC self-renewal. Unexpectedly, we find that JNK is not required for normal 
hematopoiesis, HSC and progenitor cell homing and engraftment following 
transplantation, HSC self-renewal or 5-FU-induced stress hematopoiesis. These 
results may be medically relevant because JNK inhibitors have reached clinical 
trials.      
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Introduction 
 
c-Jun NH2-terminal kinase (JNK), a member of the stress and mitogen activated 
family of protein kinases, is encoded by three separate genes. JNK1 and JNK2 
are ubiquitously expressed, whereas expression of JNK3 is confined to neurons, 
heart and testis.1 Alternative splicing of the messenger RNA (mRNA) transcripts 
of the three JNK genes generates ten JNK isoforms.3 Studies have demonstrated 
that some of these isoforms have differential substrate binding specificities; 
however, often JNK isoforms show significant functional redundancy.1,200 JNK 
has been implicated in embryonic development, proliferation, apoptosis, 
inflammation and cytokine expression among other processes.1,6 Indeed, JNK is 
required in embryonic development as compound Jnk1-/-Jnk2-/- embryos die in 
utero and murine embryonic fibroblasts (MEFs) from Jnk1-/-Jnk2-/- mice show 
major defects in proliferation.20,183 In contrast, compound Jnk1-/-Jnk2-/- murine 
embryonic stem cells display increased proliferation and self-renewal compared 
to Jnk+/+ stem cells.201 
 
Hematopoiesis is the process that gives rise to all blood cells from hematopoietic 
stem cells (HSCs). In addition to their ability to generate all hematopoietic cells, 
HSCs have the capacity to self-renew (i.e., proliferate without differentiating).202-
204 The processes of blood cell production and HSC self-renewal are regulated 
by a multitude of secreted growth factors and cytokines, cell-cell or cell-
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extracellular matrix interactions as well as numerous signaling pathways, which 
collectively orchestrate hematopoietic cell survival, proliferation, differentiation or 
quiescence.33,205,206 
 
JNK has been implicated in the regulation hematopoietic cell survival, cytokine 
expression, effector T cell differentiation and inflammation.4,24,158,162 However, 
due to the early embryonic death of compound Jnk1-/-Jnk2-/- mice, almost all 
studies have been confined to the examination of Jnk1-/- or Jnk2-/- mice. 
Furthermore, with the exception of one recent study that analyzed hematopoietic 
progenitor cell expansion using whole body single Jnk1-/- or Jnk2-/- mice,170 no 
extensive studies on the role of JNK specifically in HSC self-renewal and function 
have been undertaken. Given the high functional redundancy of JNK isoforms, 
and their different roles in multiple tissues, hematopoietic cell specific compound 
ablation of all JNK isoforms is required to better understand the function of JNK 
in hematopoietic development and HSC self-renewal. In this study, we employ 
hematopoietic cell specific compound mutant mice with dual disruption of both 
Jnk1 plus Jnk2 genes, and surprisingly, find that absence of all JNK isoforms in 
hematopoietic cells does not perturb normal, transplant-induced or drug-induced 
stress hematopoiesis or HSC self-renewal.     
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Results 
 
Normal HSC and progenitor cell development in single Jnk1-/- and Jnk2-/- mice 
To assess if different JNK isoform subsets are important for normal development 
of HSCs or progenitor cells we performed immunophenotyping of bone marrow 
cells from adult WT, Jnk1-/- and Jnk2-/- mice using antibodies against established 
HSC and/or progenitor cell markers (Supplementary Figure III.1). Total bone 
marrow cellularity was not significantly different between WT and Jnk1-/- or Jnk2-/-  
mice (Figure III.1D), and multiparameter flow cytometry analysis revealed no 
significant differences in the frequency of HSCs or any of the progenitor cells 
examined (Figure III.1A-C). Thus, JNK1 or JNK2 isoforms in hematopoietic or 
non-hematopoietic cells are not required for normal development of HSCs or the 
progenitor cell populations that we examined. 
 
HSCs and progenitors from single Jnk1-/- and Jnk2-/- mice have normal 
multilineage reconstitution potential and self-renewal 
To examine the role of different JNK isoform subsets in HSC and progenitor cell 
function, we performed serial competitive bone marrow transplantation assays. 
WT or JNK knockout bone marrow cells expressing the pan-hematopoietic cell 
marker CD45.2 were mixed with competitor bone marrow cells expressing 
CD45.1 at two different ratios (20:80 and 50:50) and transplanted into lethally 
irradiated mice (Figure III.2A). Peripheral blood from recipient mice was 
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examined by flow cytometry analysis for donor cell chimerism and multilineage 
reconstitution as indicated in Figure III.2B. Analysis of peripheral blood 
chimerism in primary recipient mice at 5, 10, 15 and 20 weeks post-
transplantation revealed no consistently significant differences in overall 
reconstitution between recipients that received WT and those that received   
Jnk1-/- or Jnk2-/- bone marrow cells (Figure III.2C, primary transplant). 
Furthermore, we found no consistently significant differences in reconstitution of 
individual myeloid, B and T cell subsets (Figure III.2D, primary transplant), or 
frequency of myeloid, B and T cell subsets (within the CD45.2+ donor population) 
in the blood of recipients that received WT, Jnk1-/- or Jnk2-/- bone marrow cells 
(Figure III.2E, primary transplant). This analysis indicates that HSC and 
progenitor multilineage reconstitution function as well as hematopoietic cell 
differentiation into myeloid, B and T cell lineages is preserved in the absence of 
JNK1 or JNK2. Twenty weeks post-transplantation, we analyzed bone marrow 
from recipient mice and found no significant differences in overall reconstitution 
as well as no significant differences in reconstitution or frequency of HSC and 
progenitor populations in the bone marrow of recipients that received WT, Jnk1-/- 
or Jnk2-/- bone marrow cells (Figure III.3A-C). 
 
To test if absence of JNK1 or JNK2 affected HSC self-renewal potential, we 
pooled bone marrow from primary recipient mice and used it to transplant 
secondary recipients. Peripheral blood analysis over 20 weeks revealed no 
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consistently significant differences in overall CD45.2+ donor cell chimerism, as 
well as no consistently significant differences in reconstitution or frequency of 
myeloid, B and T cell subsets in the blood of secondary recipients that received 
WT, Jnk1-/- or Jnk2-/- bone marrow cells (Figure III.2C-E, secondary transplant). 
This analysis demonstrates that Jnk1-/- and Jnk2-/- bone marrow cells are able to 
maintain blood cell production for extended periods and upon serial 
transplantation, similarly to WT bone marrow cells, indicating that HSC self-
renewal potential is not significantly altered in the absence of JNK1 or JNK2 
isoforms.  
 
Compound deficiency of Jnk1 plus Jnk2 in hematopoietic cells does not perturb 
hematopoiesis or homing of HSC and progenitor cells 
JNK1 and JNK2 isoforms expressed in hematopoietic cells display significant 
functional redundancy. Therefore, the absence of significant perturbations in 
hematopoietic cell function in single JNK knockout mice may be due to functional 
compensation by remaining JNK isoforms. To test if JNK has a role in 
hematopoiesis would therefore require ablation of all JNK isoforms expressed in 
hematopoietic cells. To disrupt both JNK1 plus JNK2 genes simultaneously, we 
employed Jnk1LoxP/LoxPJnk2LoxP/LoxP mice in conjunction with a tamoxifen-inducible 
Cre recombinase system (Rosa26-CreERT2 Jnk1LoxP/LoxPJnk2LoxP/LoxP), referred 
to as J1f/fJ2f/f R-Cre mice and control mice (Rosa26-CreERT2 Jnk1+/+Jnk2+/+), 
referred to as J1+/+J2+/+ R-Cre mice. We, then, assessed the effect of compound 
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disruption of both Jnk1 plus Jnk2 genes on HSC and progenitor function in 
competitive bone marrow transplantation assays. To avoid potentially 
confounding effects of JNK disruption in non-hematopoietic cells and also issues 
with homing of JNK-deficient HSC and progenitor cells following transplantation, 
we performed transplantations with bone marrow from J1+/+J2+/+ R-Cre and 
J1f/fJ2f/f R-Cre mice prior to induction of JNK ablation (Figure III.4A). Two groups 
of recipient mice received J1+/+J2+/+ R-Cre bone marrow cells, while two other 
groups received J1f/fJ2f/f R-Cre bone marrow cells. All four groups also received 
the same number of competitor CD45.1+ bone marrow cells. Ten weeks following 
transplantation we confirmed equal levels of engraftment in all four groups of 
recipient mice by flow cytometry analysis of peripheral blood (Figure III.4C-E, 10 
weeks post transplant timepoint) and then administered either tamoxifen to 
induce Cre activity in donor hematopoietic cells or oil as a control (Figure III.4A). 
Peripheral blood analysis, over 20 weeks following tamoxifen administration, 
revealed no significant alterations in overall CD45.2+ donor cell chimerism, as 
well as no significant changes in reconstitution or frequency of myeloid, B and T 
cell subsets in the blood of recipients from any of the four groups (Figure III.4C-
E). Efficient ablation of JNK in J1f/fJ2f/f R-Cre bone marrow cells ~20 weeks 
following tamoxifen administration was confirmed by immunoblot analysis of 
bone marrow from recipient mice that had received either J1+/+J2+/+ R-Cre alone 
or J1f/fJ2f/f R-Cre alone (i.e., in a non-competitive setting, Figure III.4A and B). 
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This analysis indicates that JNK in hematopoietic cells is not required for normal 
blood cell production in adult mice. 
 
To test if compound JNK-deficiency might affect homing and initial engraftment of 
HSC and/or progenitor cells following transplantation, we administered tamoxifen 
to adult J1+/+J2+/+ R-Cre or J1f/fJ2f/f R-Cre (J1∆/∆J2∆/∆ R-Cre) mice and 5 weeks 
later harvested bone marrow from these mice and performed competitive bone 
marrow transplantations into lethally irradiated recipient mice (Figure III.4F). 
Peripheral blood analysis, over 20 weeks following transplantation, revealed no 
consistently significant differences in overall CD45.2+ donor cell chimerism, as 
well as no consistently significant changes in reconstitution or frequency of 
myeloid, B and T cell subsets in the blood of recipients (Figure III.4G-I), 
indicating that JNK in adult hematopoietic cells is also not required for homing or 
engraftment of HSC and/or progenitor cells following transplantation.  
 
JNK in hematopoietic cells is dispensable for normal HSC and progenitor cell 
development 
Although our data so far indicate that JNK is not required for normal HSC and/or 
progenitor cell function in adult mice, JNK in hematopoietic cells may be 
important for HSC and/or progenitor cell development and function at earlier 
developmental times. To test this possibility we crossed Jnk1LoxP/LoxPJnk2LoxP/LoxP 
or Jnk1+/+Jnk2+/+ mice to mice expressing a constituitive version of Cre 
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recombinase under the control of Vav1 regulatory elements that drive Cre 
expression in all hematopoietic cells including HSCs.185,207 Prior studies have 
reported Vav1 expression in hematopoietic cells as early as embryonic day 
(E)11.5 in blood islands.208 We generated Vav1-Cre+ Jnk1LoxP/LoxPJnk2LoxP/LoxP 
(H2KO) mice. Cre- littermate mice Vav1-Cre- Jnk1LoxP/LoxPJnk2LoxP/LoxP (HfCtrl) and 
Vav1-Cre+ Jnk1+/+Jnk2+/+ (HCtrl) mice served as controls. H2KO mice developed 
normally, showed no obvious morphological defects and had normal body mass 
(Supplementary Figure III.2A). Immunoblot analysis confirmed the absence of 
detectable JNK protein in lysates from H2KO bone marrow cells (Figure III.6F). 
Automated complete blood cell analysis showed no significant perturbations in 
any of the indices examined (Supplementary Figure III.2B). Furthermore, total 
bone marrow cellularity was not significantly different between adult H2KO, HfCtrl or 
HCtrl mice (Figure III.5D), and multiparameter flow cytometry analysis of bone 
marrow cells revealed no significant differences in the frequency of HSCs or any 
of the progenitor cells examined (Figure III.5A-C), indicating normal HSC and 
progenitor cell development in H2KO mice. 
 
JNK in hematopoietic cells is dispensable for normal HSC and progenitor cell 
engraftment, multilineage reconstitution and HSC self-renewal 
To directly examine the role of JNK in HSC function, we sorted HSCs (Lineage-
/low, Sca1+, cKit+, CD150+, CD48-) and transplanted 100 H2KO, HfCtrl or HCtrl HSCs 
together with 2x105 competitor CD45.1+ total bone marrow cells into lethally 
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irradiated recipient mice (Figure III.6A). Peripheral blood analysis, over 20 weeks 
following transplantation, revealed no significant differences in overall CD45.2+ 
donor cell chimerism (Figure III.6B, 1o Transplant), as well as no consistently 
significant JNK-dependent changes in reconstitution or frequency of myeloid, B 
and T cell subsets in the blood of recipients that received H2KO, HfCtrl, or HCtrl 
HSCs (Figure III.6C and D, 1o Transplant), indicating that JNK is not required for 
normal HSC function following transplantation. 
 
To test H2KO HSC self-renewal potential, we pooled bone marrow from primary 
recipients and used it to transplant secondary recipient mice (Figure III.6A). 
Peripheral blood analysis, over 20 weeks following transplantation, revealed no 
consistently significant JNK-dependent differences in overall CD45.2+ donor cell 
chimerism, as well as no consistently significant changes in reconstitution or 
frequency of myeloid, B and T cell subsets in the blood of secondary recipients 
that received H2KO, HfCtrl, or HCtrl bone marrow cells (Figure III.6B-D, 2o 
Transplant).  
 
We also performed competitive bone marrow transplantations with total bone 
marrow cells from H2KO, HfCtrl, and HCtrl mice and competitor mice at two different 
ratios (20:80 or 50:50) of test to competitor cells (Figure III.6E) and found no 
significant differences in overall CD45.2+ donor cell chimerism, as well as no 
consistently significant JNK-dependent changes in reconstitution or frequency of 
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myeloid, B and T cell subsets in the blood of recipient mice that received H2KO, 
HfCtrl, or HCtrl bone marrow cells (Figure III.6G-I). Collectively, these data indicate 
that JNK in hematopoietic cells is not required for normal HSC and progenitor cell 
development, and function following transplantation or HSC self-renewal. 
 
H2KO mice show normal sensitivity to 5-fluorouracil (5-FU) treatment 
Although JNK-deficiency in hematopoietic cells does not appear to affect normal 
hematopoiesis or hematopoiesis following transplantation, JNK may play a role 
during drug-induced stress hematopoiesis. We examined if hematopoietic stress 
induced by treatment of mice with 5-FU affected the survival of H2KO mice 
differently from control mice. Weekly treatments of mice with 150 mg/Kg 5-FU 
resulted in similar mortality between H2KO, HfCtrl and HCtrl mice (Figure III.7), 
suggesting that JNK in hematopoietic cells is also not required for 5-FU-induced 
stress hematopoiesis.  
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Discussion 
 
Hematopoiesis is a complex biological process that involves the integration of 
multiple signaling pathways.33,205,206 Members of the mitogen activated family of 
protein kinases have been shown to play important roles in hematopoietic cell 
development and function.24,167,170 In this study, we explored the role of JNK in 
hematopoiesis and HSC self-renewal. We employed hematopoietic cell specific 
mutant mice with dual disruption of Jnk1 plus Jnk2 genes and found that JNK is 
dispensable for normal and stress-induced hematopoiesis as well as HSC self-
renewal. These findings are unexpected, because JNK has been shown to 
regulate numerous biological processes both in hematopoietic and non-
hematopoietic cells that are important for hematopoietic development. 
 
JNK has been shown to regulate the expression of various cytokines, such as 
TNF-α, TGF-β and INF-γ that regulate various aspects of hematopoiesis, 
including HSC self-renewal, differentiation and survival.163,209-214 It is possible that 
JNK regulates cytokine expression only in specific contexts (e.g., during 
inflammatory responses) and that JNK may not be involved in cytokine 
expression during hematopoietic development in the bone marrow. Furthermore, 
JNK is activated by numerous cytokines, including erythropoietin (EPO), 
thrombopoietin (TPO), stem cell factor (SCF), IL-3, and GM-CSF that are major 
regulators of the hematopoietic process.215,216 The activation of JNK by these 
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cytokines may be important for processes that are not essential for normal 
hematopoiesis or JNK activation by these cytokines may not be physiologically 
relevant.  
 
A recent study reported that JNK in hematopoietic cells is activated by Wnt4 in 
vitro, and that Jnk2-/- mice show increased rates of progenitor cell apoptosis 
associated with decreased numbers of hematopoietic progenitors in the bone 
marrow.170 This finding contrasts with ours, as we found no significant differences 
in the abundance of various progenitor populations in Jnk1-/- or Jnk2-/- mice or in 
compound mutants with disruption of both Jnk1 and Jnk2 genes in hematopoietic 
cells. This discrepancy may be due to mouse background differences between 
our mice, which were on a fully backcrossed C57BL/6J background, while the 
mice in that study were on mixed background. 
 
JNK has also been implicated in embryonic stem cell proliferation, differentiation 
and self-renewal.201 In contrast, here we find that JNK in hematopoietic cells is 
dispensable for HSC self-renewal and differentiation, suggesting that JNK has 
distinct roles in embryonic compared to somatic stem cells in general, or that 
JNK is dispensable in HSCs. 
 
Despite the numerous lines of evidence suggesting a possible role for JNK in 
hematopoietic development and function, our study demonstrates that this is not 
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the case. Collectively, our study shows that JNK in hematopoietic cells is cell-
autonomously dispensable for normal, transplantation-induced and 5-FU-induced 
hematopoiesis as well as for HSC self-renewal. These findings are medically 
relevant because JNK inhibitors are being used in clinical trials.217    
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Experimental Procedures 
 
Mice 
We have previously described Jnk1LoxP/LoxP, Jnk2LoxP/LoxP, Jnk1-/- and Jnk2-/-.161-
163183 B6.Cg-Tg(Vav1-cre)A2Kio/J mice185 expressing an improved version of Cre 
recombinase (iCre) driven by Vav1 regulatory elements,  
B6.129-Gt(ROSA)26Sortm1(cre/ERT2)Tyj/J218 expressing a tamoxifen inducible 
version of Cre recombinase from the Gt(ROSA)26Sor promoter and  
B6.SJL-Ptprca Pepcb/BoyJ mice expressing the CD45.1 allele were obtained from 
the Jackson Laboratories. Here we generated and analyzed the following mice: 
J1f/fJ2f/f R-Cre (Rosa26-CreERT2 Jnk1LoxP/LoxPJnk2LoxP/LoxP) 
J1+/+J2+/+ R-Cre (Rosa26-CreERT2 Jnk1+/+Jnk2+/+) 
H2KO (Vav1-Cre+ Jnk1LoxP/LoxPJnk2LoxP/LoxP)                                                     
HLoxP (Vav1-Cre - Jnk1LoxP/LoxPJnk2LoxP/LoxP)                                                        
HWT (Vav1-Cre+Jnk1+\+Jnk2+\+) 
All mice used in this study were backcrossed  (≥ ten generations) to the 
C57BL/6J strain (The Jackson Laboratories). Mice were housed in a facility 
accredited by the American Association for Laboratory Animal Care. All animal 
studies were approved by the Institutional Animal Care and Use Committee of 
the University of Massachusetts Medical School. 
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Genotyping 
PCR assays with genomic DNA and the amplimers  
5’-GCGAAGAGTTTGTCCTCAACC-3’, 5’-GGAGCGGGAGAAATGGATATG-3’ 
and 5’-AAAGTCGCTCTGAGTTGTTAT-3’ were used to detect the Rosa26 Cre+ 
allele (250 bp) and the WT allele (550 bp). The amplimers  
5’-CTAGGCCACAGAATTGAAAGATCT-3’,  
5’-GTAGGTGGAAATTCTAGCATCATCC-3’,  
5’-AGATGCCAGGACATCAGGAACCTG-3’ and  
5’- ATCAGCCACACCAGACACAGAGATC-3’ were used to detect an internal 
positive control fragment (324 bp) and the iCre+ allele (236 bp). The amplimers 
5’-CCTCAGGAAGAAAGGGCTTATTTC-3’ and  
5’-GAACCACTGTTCCAATTTCCATCC-3’ detected the Jnk1+ allele (1,550 bp), 
the Jnk1LoxP allele (1,095 bp), and the Jnk1Δ allele (395 bp). The amplimers  
5’-GTTTTGTAAAGGGAGCCGAC-3’ and  
5’-CCTGACTACTGAGCCTGGTTTCTC-3’ were used to detect the Jnk2+ allele 
(224 bp) and the Jnk2LoxP allele (264 bp). The amplimers  
5’-GGAATGTTTGGTCCTTTAG-3’, 5’-GCTATTCAGAGTTAAGTG-3’, and  
5’-TTCATTCTAAGCTCAGACTC-3’ were used to detect the Jnk2LoxP allele (560 
bp) and the Jnk2Δ allele (400 bp). 
 
Tamoxifen Treatments 
Tamoxifen (Sigma) was dissolved in 2% ethanol 98% sunflower seed oil (Sigma)  
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and 1 mg/mouse was administered intraperitoneally (ip) 3 times on alternate 
days. 
 
Transplantations 
Bone marrow (BM) was harvested by flushing tibias and femurs from at least five 
10-12 week old mice with ice cold PBS. Erythrocytes were lysed by incubating 
the BM in ACK lysing buffer (Life Technologies). BM cells were 
then resuspended in PBS and passed through a 100 µm filter. Cells were 
counted and mixtures of test BM cells from the indicated genotypes were 
prepared by mixing test BM cells expressing the CD45.2 allele with competitor 
BM cells expressing the CD45.1 allele at various test to competitor cell ratios. 
1x106 total BM cells were intravenously injected via the tail vein into lethally 
irradiated (11 Gy) 10-12 week old CD45.1/CD45.2 heterozygous or CD45.1 
homozygous female mice. Transplanted mice were maintained on antibiotic 
water for the first two weeks post transplantation. Blood was harvested via 
the retroorbital sinus using heparinized capillary tubes and EDTA coated vials at 
5, 10, 15 and 20 weeks post transplantation and subjected to 
flow cytometry analysis. 
 
 
Flow Cytometry 
Blood was washed in PBS, stained with live/dead fixable blue dead cell staining 
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kit (Invitrogen), washed in PBS and blocked in 2% FBS-PBS 0.02% 
sodium azide plus Fc-block (Anti-CD16/32 antibody 1:200, BD Biosciences). 
Surface antigens were detected by incubation for 30 min at 4oC with conjugated 
antibodies including CD45.1-Pacific Blue, CD45.2-FITC, CD3e-APC, CD19-APC-
H7, CD11b-PE (BD Biosciences), GR1-Alexa Fluor 700 (Biolegend). Following 
washing with 2% FBS-PBS 0.02% sodium azide, red cells were lysed and 
leukocytes fixed by incubating in lyse/fix solution (BD Biosciences) and then 
washed with PBS.  
 
Bone marrow cells were stained with live/dead fixable blue dead cell staining kit 
(Invitrogen), washed in PBS and blocked in 2% FBS-PBS 0.02% 
sodium azide plus Fc-block (unconjugated anti-CD16/32 antibody 1:200, BD 
Biosciences). This Fc-block was not done on cells that were going to be stained 
for myeloid progenitors. Instead these cells were incubated with a CD16/32-
AlexaFluor 700 antibody. Cells were incubated for 30 min at 4oC with a lineage 
cocktail that included biotinylated antibodies against CD3e, CD4, CD8, B220, 
CD11b, GR-1 and Ter119. Cells were then washed, and surface antigens were 
detected by incubation with Streptavidin-PE-TexasRed and conjugated 
antibodies including CD45.2-APC, cKit-APC-Cy7, Sca-1-PacificBlue, CD150-PE-
Cy7 and CD48-FITC (Panel 1) or Streptavidin-PE-TexasRed and conjugated 
antibodies including CD45.2-APC, cKit-APC-Cy7, Sca-1-PacificBlue, IL7R-PE-
Cy7, CD34-FITC, and CD135-PE-Cy5.5 (Panel 2). A CD45.1-PE antibody was 
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included when bone marrow cells from chimeric mice were analyzed. Cells were 
washed, fixed with 4% PFA, washed with PBS and analyzed on an LSR-II 
cytometer (Becton Dickenson). Data were processed using FlowJo Software 
(Tree Star). 
 
For HSC sorting, bone marrow cells were lineage depleted using a Lineage Cell 
Depletion kit (Miltenyi Biotec) and MACS columns (Miltenyi Biotec). Cells were 
stained with live/dead fixable blue dead cell staining kit (Invitrogen), washed in 
PBS and blocked in 2% FBS-PBS plus Fc-block. Cells were then stained with 
antibodies from Panel 1 above and HSCs were sorted on a BD FACSAria II Cell 
Sorter. Using the single cell mode live HSCs (CD45.2+, Lin-, cKit+, Sca-1+, 
CD150+ and CD48-) were collected directly into tubes containing competitor total 
bone marrow cells and cell mixtures were immediately transplanted into lethally 
irradiated mice.       
 
Immunoblot Analysis 
Cell extracts were prepared using Triton lysis buffer (20 mM Tris at pH 7.4, 1% 
Triton X-100, 10% glycerol, 137 mM NaCl, 2 mM EDTA, 25 mM β-
glycerophosphate, 1 mM sodium orthovanadate, 1 mM 
phenylmethylsulfonylfluoride, 10 mg/mL of aprotinin and leupeptin). Extracts (20-
50 µg of protein) were examined by protein immunoblot analysis by probing with 
antibodies to JNK (R&D Systems or Pharmigen), GAPDH (Santa Cruz) 
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and αTubulin (Sigma). Immune complexes were detected using the Odyssey 
infrared imaging system (LI-COR Biosciences). 
 
Statistical Analysis 
Differences between groups were examined for statistical significance with an 
unpaired Student's test with equal variance or a log-rank (Mantel-Cox) test for 
determining significance of Kaplan-Meier survival curves. 
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Figure III.1 Jnk1-/- and Jnk2-/- mice have normal HSC and progenitor cell 
composition in the bone marrow.  
 
A) Bone marrow (BM) cells from WT, Jnk1-/- and Jnk2-/- mice were 
immunostained with fluorochrome-conjugated antibodies and analyzed by flow 
cytometry to identify bone marrow cell populations enriched in HSC and 
progenitor cells. The detailed step-by-step gating strategy is presented in 
Supplementary Figure II.1. Lineage negative (Lin-) cells staining positive for Sca-
1 and cKit identify the LSK population that is enriched in long term HSCs (LT-
HSC) and multipotent progenitors (MPP). Staining LSK cells with antibodies to 
CD150 and CD48 defines populations of LT-HSCs and MPPs more specifically. 
Quantitative flow cytometry analysis revealed no significant perturbations in the 
proportions of any of the of BM populations examined between WT and Jnk1-/- or 
Jnk2-/- mice (mean ± SEM; n = ~5-7 mice per group). Data presented are from 
one of two experiments with similar results. 
 
B) A second panel of antibodies that includes antibodies to CD135 and CD34 
also defines populations of LT-HSCs, short-term (ST)-HSCs and MPPs within the 
LSK population. Quantitative flow cytometry analysis using this panel of 
antibodies also revealed no significant perturbations in the proportions of the 
indicated HSC and MPP populations examined between WT and Jnk1-/- or Jnk2-/- 
mice (mean ± SEM; n = ~5-7 mice per group). Data presented are from one of 
two experiments with similar results. 
 
C) Flow cytometry analysis of lymphoid and myeloid progenitors including the 
common lymphoid progenitors (CLP), common myeloid progenitors (CMP), 
granulocyte macrophage progenitors (GMP) and megakaryocyte erythrocyte 
progenitors (MEP) shows no significant differences in their proportion in the BM 
of Jnk1-/- or Jnk2-/- compared to WT BM (mean ± SEM; n = ~5-7 mice per group). 
Data presented are from one of two experiments with similar results. 
 
D) No significant differences were detected in total BM cellularity between Jnk1-/- 
or Jnk2-/- and WT mice (mean ± SEM; n = ~5-7 mice per group). Data presented 
are from one of two experiments with similar results.    
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Figure III.2 Bone marrow cells from Jnk1-/- and Jnk2-/- mice display normal 
multilineage reconstitution potential in serial competitive transplantation 
experiments 
 
A) Serial competitive BM transplantation experimental set up. Test BM cells from 
WT, Jnk1-/- and Jnk2-/- mice expressing the CD45.2 allele were each mixed with 
competitor BM cells expressing the CD45.1 allele at two different ratios, as 
indicated, and transplanted via the tail vein into primary lethally irradiated 
recipient mice expressing both CD45.1 and CD45.2. Peripheral blood from 
primary recipient mice was analyzed at different times over 20 weeks for donor 
cell chimerism and multilineage reconstitution with antibodies to lineage markers. 
Twenty weeks post-transplantation BM from primary recipient mice transplanted 
with the 50:50 ratio of test to competitor BM cells was pooled and used to 
transplant secondary recipient mice that were analyzed similarly to primary 
recipients.      
 
B) Flow cytometry gating strategy for donor cell chimerism and multilineage 
reconstitution analysis of peripheral blood from recipient mice. 
 
C) Primary and secondary recipient mice transplanted with Jnk1-/- or Jnk2-/- BM 
cells show no consistently significant differences in overall peripheral blood 
leukocyte reconstitution compared to recipients transplanted with WT BM cells 
(mean ± SEM; n = ~7-9 recipient mice per group) 
 
D) Primary and secondary recipient mice transplanted with Jnk1-/- or Jnk2-/- BM 
cells show no consistently significant differences in reconstitution of myeloid, B 
and T cells compared to recipients transplanted with WT BM cells (mean ± SEM; 
n = ~7-9 recipient mice per group) 
 
E) Primary and secondary recipient mice transplanted with Jnk1-/- or Jnk2-/- BM 
cells show no consistently significant differences in the frequency of myeloid, B 
and T cells within the donor CD45.2+ leukocyte population compared to 
recipients transplanted with WT BM cells (mean ± SEM; n = ~7-9 recipient mice 
per group) 
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Figure III.3 HSC and progenitor analysis 20 weeks post-transplantation in 
the bone marrow of primary recipients from the experiment in Figure III.2 
 
A) Flow cytometry analysis of BM from primary recipient mice 20 weeks post 
transplantation shows no statistically significant differences in overall donor 
CD45.2+ cell reconstitution in mice that were transplanted with Jnk1-/- or Jnk2-/- 
BM cells compared to recipients that were transplanted with WT BM cells. (mean 
± SEM; n = ~7-9 recipient mice per group) 
 
B) No statistically significant differences in the reconstitution of various 
progenitors and HSCs were detected between primary recipient mice that were 
transplanted with Jnk1-/- or Jnk2-/- BM cells compared to recipients that were 
transplanted with WT BM cells. (mean ± SEM; n = ~7-9 recipient mice per group) 
   
C) No statistically significant differences in the frequency of various progenitors 
and HSCs within the donor CD45.2+ population were detected between primary 
recipient mice that were transplanted with Jnk1-/- or Jnk2-/- BM cells compared to 
recipients that were transplanted with WT BM cells. (mean ± SEM; n = ~7-9 
recipient mice per group) 

184 
Figure III.4 Compound ablation of both Jnk1 plus Jnk2 genes in 
hematopoietic cells of adult mice does not perturb hematopoiesis or BM 
cell homing and engraftment following transplantation. 
 
A) Competitive BM transplantation experimental set up involving in situ ablation 
of both Jnk1 plus Jnk2 genes after engraftment into recipient mice was 
completed. Test BM cells from J1+/+J2+/+ R-Cre or J1f/fJ2f/f R-Cre mice expressing 
the CD45.2 allele were each either transplanted alone (non-competitive 
transplants), or mixed with competitor BM cells expressing the CD45.1 allele, as 
indicated, and transplanted via the tail vein into lethally irradiated recipient mice. 
Two groups of recipient mice received J1+/+J2+/+ R-Cre and another two groups 
received J1f/fJ2f/f R-Cre BM cells in conjunction with competitor cells. Ten weeks 
post-transplantation, successful and similar engraftment in all 4 groups of 
competitively transplanted mice was confirmed by flow cytometry analysis of 
peripheral blood, and recipient mice received either tamoxifen (TAM) to induce 
Cre activity in donor-derived test hematopoietic cells or oil as control. Peripheral 
blood from recipient mice was then analyzed at different times over 20 weeks for 
alterations in donor cell chimerism and multilineage reconstitution. 
 
B) Bone marrow cells from recipient mice that were transplanted with either 
J1+/+J2+/+ R-Cre or J1f/fJ2f/f R-Cre alone (i.e., in a non-competitive fashion) were 
harvested >20 weeks post-tamoxifen administration and examined by 
immunoblot analysis with antibodies to JNK and GAPDH. This analysis revealed 
successful deletion of JNK in BM cells from mice transplanted with J1f/fJ2f/f R-Cre 
BM. 
 
C) Recipient mice transplanted with J1+/+J2+/+ R-Cre or J1f/fJ2f/f R-Cre BM cells 
showed no significant alterations in overall peripheral blood leukocyte 
reconstitution whether they were treated with oil or tamoxifen (mean ± SEM; n = 
10 recipient mice per group). 
 
D) Recipient mice transplanted with J1+/+J2+/+ R-Cre or J1f/fJ2f/f R-Cre BM cells 
showed no significant alterations in reconstitution of myeloid, B and T cells 
whether they were treated with oil or tamoxifen (mean ± SEM; n = 10 recipient 
mice per group). 
 
E) Recipient mice transplanted with J1+/+J2+/+ R-Cre or J1f/fJ2f/f R-Cre BM cells 
showed no significant alterations in the frequency of myeloid, B and T cells within 
the donor CD45.2+ leukocyte population whether they were treated with oil or 
tamoxifen (mean ± SEM; n = 10 recipient mice per group). 
 
F) Competitive BM transplantation experimental set up involving ablation of both 
Jnk1 plus Jnk2 genes before transplantation into recipient mice. J1+/+J2+/+ R-Cre 
and J1f/fJ2f/f R-Cre mice were treated with tamoxifen to induce Cre activity and 
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disrupt Jnk1 and Jnk2 floxed alleles in J1f/fJ2f/f R-Cre mice, now refered to as 
J1∆/∆J2∆/∆ R-Cre. Successful deletion was confirmed by immunoblot analysis. 
Test BM cells from J1+/+J2+/+ R-Cre or J1∆/∆J2∆/∆ R-Cre mice expressing the 
CD45.2 allele were each mixed with competitor BM cells expressing the CD45.1 
allele, as indicated, and transplanted via the tail vein into lethally irradiated 
recipient mice. Peripheral blood from recipient mice was analyzed at different 
times over 20 weeks for donor cell chimerism and multilineage reconstitution with 
antibodies to lineage markers. 
 
G) Recipient mice transplanted with J1+/+J2+/+ R-Cre or J1∆/∆J2∆/∆ R-Cre BM cells 
showed no consistently significant differences in overall peripheral blood 
leukocyte reconstitution (mean ± SEM; n = ~8-10 recipient mice per group). 
 
H) Recipient mice transplanted with J1+/+J2+/+ R-Cre or J1∆/∆J2∆/∆ R-Cre BM cells 
showed no consistently significant differences in reconstitution of myeloid, B and 
T cells (mean ± SEM; n = ~8-10 recipient mice per group). 
 
I) Recipient mice transplanted with J1+/+J2+/+ R-Cre or J1∆/∆J2∆/∆ R-Cre BM cells 
showed no consistently significant differences in the frequency of myeloid, B and 
T cells within the donor CD45.2+ leukocyte population (mean ± SEM; n = ~8-10 
recipient mice per group). 
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Figure III.5 Compound ablation of both Jnk1 plus Jnk2 genes in 
hematopoietic cells starting in embryonic life does not perturb HSC and 
progenitor cell development.  
 
A) Bone marrow (BM) cells from H2KO and control mice were immunostained with 
fluorochrome-conjugated antibodies and analyzed by flow cytometry to identify 
bone marrow cell populations enriched in HSC and progenitor cells. Quantitative 
flow cytometry analysis revealed no significant perturbations in the proportions of 
the indicated HSC and MPP populations examined between H2KO and control 
mice (mean ± SEM; n = 7 mice per group). Data presented are from one of two 
experiments with similar results. 
 
B) Quantitative flow cytometry analysis using a second panel of antibodies also 
revealed no significant perturbations in the proportions of the indicated HSC and 
MPP populations examined between H2KO and control mice (mean ± SEM; n = 7 
mice per group). Data presented are from one of two experiments with similar 
results. 
 
C) Flow cytometry analysis of lymphoid and myeloid progenitors including the 
common lymphoid progenitors (CLP), common myeloid progenitors (CMP), 
granulocyte macrophage progenitors (GMP) and megakaryocyte erythrocyte 
progenitors (MEP) shows no significant differences in their proportion in the BM 
of H2KO and control mice (mean ± SEM; n = 7 mice per group). Data presented 
are from one of two experiments with similar results. 
 
D) No significant differences were detected in total BM cellularity between H2KO 
and control mice mice (mean ± SEM; n = 7 mice per group). Data presented are 
from one of two experiments with similar results.    
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Figure III.6 Compound ablation of both Jnk1 plus Jnk2 genes in 
hematopoietic cells starting in embryonic life does not perturb HSC and 
progenitor function upon transplantation 
 
A) Serial competitive BM transplantation experimental set up using purified HSCs 
from H2KO and control mice. Test HSCs (Lin-, Sca-1+, cKit+, CD150+, CD44-) from 
H2KO and control mice expressing the CD45.2 allele were sorted, mixed with 
competitor BM cells expressing the CD45.1 allele, as indicated, and transplanted 
via the tail vein into lethally irradiated recipient mice. Peripheral blood from 
primary recipient mice was analyzed at different times over 20 weeks for donor 
cell chimerism and multilineage reconstitution with antibodies to lineage markers. 
Twenty weeks post-transplantation BM from primary recipient mice was pooled 
and used to transplant secondary recipient mice that were analyzed similarly to 
primary recipients.      
 
B) Primary and secondary recipient mice transplanted with H2KO HSCs show no 
significant differences in overall peripheral blood leukocyte reconstitution 
compared to recipients transplanted with control HSCs. (mean ± SEM; n = ~5-8 
recipient mice per group) 
 
C) Primary and secondary recipient mice transplanted with H2KO HSCs show no 
consistently significant JNK-dependent differences in reconstitution of myeloid, B 
and T cells compared to recipients transplanted with control HSCs. In some 
instances, significant differences between H2KO recipients and one of the control 
recipient groups, but not the other were detected. These differences were not 
maintained over time. (mean ± SEM; n = ~5-8 recipient mice per group) 
 
D) Primary and secondary recipient mice transplanted with H2KO HSCs show no 
consistently significant JNK-dependent differences in the frequency of myeloid, B 
and T cells within the donor CD45.2+ leukocyte population compared to 
recipients transplanted with control HSCs. In some instances, significant 
differences between H2KO recipients and one of the control recipient groups, but 
not the other were detected. Furthermore, these differences were not maintained 
over time. (mean ± SEM; n = ~5-8 recipient mice per group) 
 
E) Competitive BM transplantation experimental set up. Test BM cells from H2KO 
and control mice expressing the CD45.2 allele were mixed with competitor BM 
cells expressing the CD45.1 allele at two different ratios, as indicated, and 
transplanted via the tail vein into lethally irradiated recipient mice. Peripheral 
blood from primary recipient mice was analyzed at different times over 20 weeks 
for donor cell chimerism and multilineage reconstitution with antibodies to lineage 
markers. 
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F) Immunoblot analysis of BM cell lysates from H2KO and control mice with 
antibodies to JNK and GAPDH confirmed absence of JNK protein in BM cells 
from H2KO mice. 
 
G) Recipient mice transplanted with H2KO BM cells show no significant 
differences in overall peripheral blood leukocyte reconstitution compared to 
recipients transplanted with control BM cells. (mean ± SEM; n = ~9-10 recipient 
mice per group) 
 
H) Recipient mice transplanted with H2KO BM cells show no consistently 
significant JNK-dependent differences in reconstitution of myeloid, B and T cells 
(mean ± SEM; n = ~9-10 recipient mice per group). 
 
I) Recipient mice transplanted with H2KO BM cells show no consistently significant 
JNK-dependent differences in the frequency of myeloid, B and T cells within the 
donor CD45.2+ leukocyte population (mean ± SEM; n = ~9-10 recipient mice per 
group). 
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Figure III.7 Sensitivity to 5-fluorouracil (5-FU) is not altered in H2KO mice. 
 
H2KO and control mice received weakly intraperitoneal injections of 5-FU (150 
mg/Kg) and were monitored over time. H2KO mice showed similar survival kinetics 
compared to control mice (n = ~11-13 mice per group).  
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Supplementary Figure III.1 Gating strategy and fluorescence minus one 
(FMO) controls used for the identification of HSC and progenitor cell 
populations. 
 
A) Bone marrow cell singlets were selected based on forward scatter (FSC-A, 
and FSC-H) and side scatter (SSC-A) properties. Live cells staining negative for 
Live/Dead Blue and positive for the pan-hematopoietic cell marker CD45 were 
then selected and displayed as shown in (B).  
 
C) Lineage (Lin-), IL7Rα+ cells gated in panel B with intermediate cKit and Sca-1 
staining identified common lymphoid progenitors (CLP). IL7Rα FMO antibody 
control that includes all antibodies in the panel except for the IL7Rα antibody is 
shown (right). 
 
D) Lin-, IL7Rα- cells gated in panel (B) were displayed as shown. cKit and Sca-1 
FMO controls are shown (left). 
 
E) Lin-, Sca-1+, cKit+ (LSK) cells gated in panel (D) that stained positive for 
CD150 and negative for CD48 were identified as long-term HSCs (LT-HSC). LSK 
cells staining positive for CD48 were identified as multipotent progenitors (MPP). 
CD150 and CD48 FMO controls are shown (right). 
 
F) LSK cells gated in panel (D) that stained negative for CD135 and CD34 were 
also identified as LT-HSC. LSK cells staining negative for CD135, but positive for 
CD34 were identified as short-term HSCs (ST-HSC). LSK cells staining positive 
for CD135 and CD34 were identified as MPP. CD135 and CD34 FMO controls 
are shown (right). 
 
G) Lin-, Sca-1-, cKit+ (LK) cells gated in panel (D) that stained positive for 
CD16/32 and CD34 were identified as granulocyte/macrophage progenitors 
(GMP). LK cells staining negative for CD16/32, but positive for CD34 were 
identified as common myeloid progenitors (CMP). LK cells staining negative for 
both CD16/32 and CD34 were identified as megakaryocyte/erythrocyte 
progenitors (MEP). CD16/32 and CD34 FMO controls are shown (left).  
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Supplementary Figure III.2 Normal body mass and blood cell indices in H2KO 
mice. 
 
 
A) Body mass measurements showing no significant differences between adult 
H2KO and control mice (mean ± SEM; n =~9-10).  
 
B) Complete blood cell analysis showing no significant JNK-dependent 
differences in any of the measured indices (mean ± SEM; n =~4-6 mice per 
group). RBC, red blood cells; MCV, mean corpuscular volume; MCH, mean 
corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; 
RDW, red cell distribution width; MPV, mean platelet volume.  
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Chapter IV 
Discussion & Future Directions 
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Discussion 
JNK has pleiotropic roles in many areas of biology. Studies have revealed 
important physiologic and pathologic functions of JNK in embryonic development, 
inflammation, metabolism and cancer.1,12,158 The work presented in this 
dissertation uncovers new functions of JNK and expands the repertoire of 
knowledge on the role of JNK in vascular biology and the hematopoietic system.  
 
Prior to our study the role of JNK in endothelial cells and vascular biology was 
limited to in vitro investigations or a few studies that employed Jnk1-/- mice. Thus, 
the role of JNK in endothelial cell-mediated vascular development and function 
was unknown. In Chapter II of this dissertation I have presented a body of data 
that adds considerable insight into the role of JNK in the endothelium, but also 
vascular biology in general. In this study, we generated endothelial-specific 
constitutive and inducible compound mutant mice that lack all JNK isoforms in 
the vascular endothelium. These mice were instrumental in our investigations 
and allowed us to identify critical roles for JNK in retinal and muscle vascular 
morphogenesis as well as native collateral artery development. In contrast to the 
essential function of JNK during the embryonic and early postnatal development 
of the vasculature, our study of mice in which we ablated JNK only after mice had 
reached adulthood demonstrated that endothelial JNK does not play a major role 
in the process of arteriogenesis in the setting of vascular occlusion.  
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Our study of Mlk2-/-Mlk3-/- mice reveals an important role for these kinases in 
vascular morphogenesis and native collateral artery development that in many 
respects mirrors the role of endothelial JNK indicating that MLK mediate JNK 
activation important for vascular development. Although, MLK are known to 
activate JNK, our study demonstrates for the first time that they play a major role 
in vascular development.  
 
In addition to the identification of a MLK – JNK signaling axis that is critical for 
vascular morphogenesis and native collateral artery formation, our study makes 
a significant advance in the understanding of how muscle collateral arteries form 
during ontogeny. Our detailed tracing of gracilis muscle collaterals at different 
times during development have lead us to propose a model in which gracilis 
collaterals form via a plexus intermediate from which vessels within the plexus 
get selected to become collateral arteries due to their proximity to peripheral 
nerves. This model is different from that proposed for pial collateral artery 
formation, which appear to form as distinct sprouts from existing arterioles.61  
Both models may be correct and may reflect the differences in tissue composition 
and architecture between brain and skeletal muscle. 
 
By combining our morphological observations and functional data with 
information from the literature and our RNA Seq results from JNK-deficient and 
control endothelial cells, we were able to identify perturbations in Dll4 – Notch 
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signaling in JNK-deficient endothelial cells and the JNK-deficient retinal 
vasculature that provide a likely mechanism that may contribute to the retinal 
vascular and native collateral artery defects in mice that lack JNK in the 
endothelium. Our RNA Seq data also provides a wealth of gene expression 
information that may fuel many future investigations.  
 
We have identified perturbations in the expression of several guidance molecules 
including downregulation of several class 3 semaphorins as well as upregulation 
of Slit2 and smaller perturbations in Netrin 1 and the semaphorin receptor, Nrp1. 
Semaphorins were originally described as axon guidance factors, but have now 
also been shown to act as attractive or repulsive regulators of angiogenesis.219-
221 Although the role of the alterations in expression of particular semaphorins in 
JNK-deficient endothelial cells and the role of the endothelium as a source of 
semaphorins remains unclear, it is possible that the perturbations in semaphorin 
expression in JNK-deficient endothelial cells may contribute to the dysfunctional 
vascular morphogenesis in E3KO mice. The strong upregulation of the guidance 
molecule Slit2 is also interesting. Slits bind to several Robo receptors that are 
expressed in endothelial cells and mediate cellular motility.222 Indeed, a recent 
study reported a critical role for Slit2 signaling in promoting retinal vascularization 
through endothelial Robo1 and Robo2.223 Although, again, the role of the 
endothelium as a source of Slit2 is unclear, the increased Slit2 expression in the 
JNK-deficient endothelial cells may contribute to the excessive sprouting 
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angiogenesis observed in E3KO mice. 
 
The downregulation of several gap junction proteins including connexin37 (Cx37, 
encoded by Gja4) and connexin40 (Cx40, encoded by Gja5) in JNK-deficient 
endothelial cells may also play a role in the defective formation of native 
collateral arteries in E3KO mice. Cx40-/- mice have been reported to modulate 
arterial identity in response to shear stress and show markedly reduced blood 
perfusion restoration in the FAL model.80,92 The role of Cx40 specifically in the 
formation of native collateral arteries has not been demonstrated. In contrast to 
Cx40-/- mice, Cx37-/- mice81 show significantly enhanced blood perfusion 
immediately after FAL, suggesting that they have improved collateral artery 
function. Connexins are known to form homo or heteromeric hemichannels (or 
connexons). Gap junctions are composed of two hemichannels from neighboring 
cells that provide intercellular communication by facilitating the diffusion of ions, 
small metabolites and second messengers.224 Thus, the phenotype in the 
absence of a particular connexin may reflect altered composition of 
hemichannels. Therefore, the improved bood perfusion recovery following FAL in 
Cx37-/- mice may be due to hemichannels that contain more Cx40 molecules. 
Hence, the reduction in both Cx37 and Cx40 expression in JNK-deficient 
endothelial cells may result in altered hemichannel composition and gap junction 
function and may contribute to the native collateral artery defects in E3KO mice.  
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Another gene whose expression is increased in JNK-deficient endothelial cells 
and may contribute to abnormal vascular morphogenesis in E3KO mice is 
endothelial cell-specific molecule 1 (Esm1). Esm1 is a secreted glycoprotein that 
binds to fibronectin in the extracellular matrix and can displace fibronectin-bound 
VEGF-A165, thus, enhancing regional VEGF-A165 bioavailability.225 Increased 
Esm1 expression by JNK-deficient endothelial cells may result in increased 
regional VEGF-A165 bioavailability that may mediate excessive sprouting 
angiogenesis and altered vascular morphogeneis in E3KO mice.  
 
Other gene expression alterations in JNK-deficient endothelial cells that are 
displayed in the heatmap in Figure II.9D are potentially interesting and open the 
door for much future exploration into the mechanism of JNK-mediated regulation 
of vascular morphogenesis and native collateral artery formation. 
 
Our study points to an important role for JNK-mediated regulation of Dll4 – Notch 
signaling and vascular morphogenesis, and identifies a MLK – JNK signaling axis 
that is critical for native collateral artery formation. Genetically modified mice with 
disruption in this pathway display defective collateral artery patterning and 
undergo severe blood perfusion blockade and severe tissue injury following 
arterial occlusion (Figure II.11). 
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Endothelial and hematopoietic cells are thought to arise from a common 
precursor.33 Although JNK has major roles in endothelial cell biology and 
vascular development, our studies presented in Chapter III demonstrate that JNK 
in hematopoietic cells is dispensable for normal hematopoiesis and HSC self-
renewal. However, JNK in hematopoietic cells may be important in certain 
conditions such as in inflammatory responses to infection or during 
hematopoietic cell transformation.  
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Future Directions 
 
Future research into the role of JNK in the vasculature could include the 
following: 
A synthetic Jag1 peptide has been previously reported to induce Dll4 expression 
and Notch signaling resulting in suppression of endothelial cell sprouting 
activity.46,47,175 To test if the decreased Dll4 expression in the retinal vasculature 
of E3KO mice is biologically relevant, E3KO pups can be treated with Jag1 peptide 
or a scrambled peptide. Analysis of the retinal vasculature should reveal whether 
treatment with Jag1 peptide restores Dll4 levels in the vascualture of E3KO pups 
and whether this normalizes endothelial cell sprouting activity. Suppression of 
excessive endothelial cell sprouting by Jag1 peptide treatment of E3KO mice 
would strongly support the hypothesis that the endothelial cell hypersprouting in 
the E3KO vasculature is mediated by decreased Dll4-Notch signaling. It is unclear 
how Jag1 peptide treatment enhances Dll4 levels and Notch signaling. It is 
possible that Jag1 peptide treatment may not restore Dll4 levels in the E3KO 
retinal vasculature. This would indicate that JNK may regulate Dll4 expression 
and Notch signaling via mechanism(s) that are distinct from those that mediate 
the effects of Jag1 peptide treatment. 
 
A detailed analysis of muscle collateral arteries in Dll4+/- mice via methods 
employed in our study would reveal whether these mice display similar defects to 
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those observed in E3KO mice. This analysis would clarify the role of Dll4-Notch 
signaling in native collateral artery formation.  
 
In addition to perturbations in Dll4-Notch signaling other mechanisms are likely to 
contribute to the vascular defects in JNK-deficient mice. Direct investigation of 
the possible role of other genes that were shown to be differentially expressed in 
JNK-deficient endothelial cells may reveal additional mechanisms through which 
the JNK pathway may contribute to vascular morphogenesis and native collateral 
artery formation. 
 
We found that gracilis collateral arteries form in close apposition to peripheral 
nerves. These data suggest that factors secreted by peripheral nerves may be 
important for formation and maturation of collateral arteries. Investigation of the 
role of peripheral nerves in collateral artery formation would, therefore, be an 
exciting area for future investigations. It is also possible that the vasculature may 
influence peripheral nerve morphogenesis and/or function. Thus the vasculature 
and the peripheral nervous system may have important interdependent functions, 
and perturbations in either system may lead to defects in both systems.  
 
We found that the JNK pathway plays an essential role in endothelial cells, 
however, JNK in hematopoietic or skeletal muscle does not appear to play a role 
in vascular development and function as suggested by the absence of defects in 
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the response to arterial occlusion in mice that lack JNK in these tissues. We did 
not investigate the role of JNK in smooth muscle cells. It is possible that JNK in 
smooth muscle cells may be important for vascular development and collateral 
artery formation and thus analysis of mice with smooth muscle cell-specific 
ablation of JNK may be warranted. 
 
JNK in liver, adipose tissue, pituitary and hematopoietic cells has essential roles 
in the metabolic response to high fat diet consumption.13,163,226,227 The 
endothelium also participates in metabolic homeostasis.228,229 Investigation of the 
role of endothelial JNK in metabolism may reveal important functions of the JNK 
pathway in these cells. We have initiated these studies. 
 
Investigation of the effect of endothelial JNK disruption in experimental tumor cell 
metastasis models also represents an area of research that deserves further 
exploration. We have initiated these studies. 
 
Some E2KO and E3KO mice display defects in tooth development. We have 
initiated studies that indicate that bone development may also be affected. 
Investigation of the role of endothelial JNK in bone and tooth development 
represents an exciting area of future research particularly because recent studies 
have demonstrated an important role for endothelial cells in osteogenesis.230-232 
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Future research into the role of JNK in the hematopoietic system could include 
the following: 
Although an unlikely scenario, low levels of JNK3 expression in hematopoietic 
cells may have compensated for the loss of JNK1 and JNK2 in our mice. We 
have not been able to detect Jnk3 expression in bone marrow cells from WT or 
hematopoietic cell JNK-deficient mice by quantitative RT-PCR analysis. 
Nevertheless, we have now generated mice with hematopoietic cell specific 
compound deficiency of JNK1 plus JNK2 plus JNK3. These mice appear 
morphologically normal. Future experiments will analyze if hematopoiesis is 
perturbed in these mice. 
 
Although we have not found a required role for JNK in normal hematopoietic cell 
development and bone marrow cell function in transplantation assays, assessing 
the role of compound ablation of JNK genes in hematopoietic cell transformation 
induced by BCR-ABL, Pten deletion or other methods may reveal if the JNK 
pathway is important during hematopoietic cell transformation. We have 
generated Vav1-Cre Jnk1LoxP/LoxPJnk2LoxP/LoxPPtenLoxP/LoxP and have initiated their 
analysis.     
 
Assessing the role of compound ablation of JNK genes in infection or 
autoinflammatory disease models may also potentially reveal a role for JNK in 
these processes. 
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